Systems Biological Analysis of Signal Transduction in Telomere Length Maintenance by Dieckmann, Anna Katharina
DISSERTATION
submitted to the
Combined Faculties for the Natural Sciences and for Mathematics
of the Ruperto-Carola University of Heidelberg, Germany
for the degree of
Doctor of Natural Sciences
presented by
Dipl.-Bioinf. Univ. Anna Katharina Dieckmann
Born in: Goch, Germany
Oral-examination: 29 February 2016

Systems Biological Analysis of Signal
Transduction in Telomere Length
Maintenance
Referees: Prof. Dr. Roland Eils
Dr. Brian Luke

To David and Lea, for their patience and endurance. Their
love of life and happiness sweetened the efforts put into this
dissertation.
To Lorenz, if I would not have you.
To my parents. Without their faith in me, their endless backing,
and my fathers teaching to think, I would not have come so far.

Acknowledgements
My great journey of doctoral research has been an incredible experience and a success thanks
to a multitude of supporters. I have learnt so much— thanks a lot.
To begin with, I would like to express my particular gratitude to Prof. Dr. Roland Eils not
only for giving me the opportunity to fulfil my dissertation in his research group, but also
for his scientific advice and strong support, especially during the last third of my PhD and
whenever trouble arose.
Moreover, I thank Prof. Dr. Rainer König who not only offered this interesting research pro-
ject to me, but who also allowed me to follow unforeseen aspects of this project. The lively dis-
cussions with him greatly enriched my work.
I want to acknowledge the generous funding from the German-Israeli Cooperation DKFZ-
MOST (project Ca145 “A Systems-level Dissection of Telomere Biology“). I also thank
the current (Prof. Dr. Peter Angel and Dr. Hagit Schwimmer) and the former (Prof. Dr.
Dr. Wolfgang Semmler, Nurit Topaz, and Dr. Shlomo Sarig) program coordinators for or-
ganising the great workshops in Jerusalem and Heidelberg offering a platform for scientific ex-
change.
Brian, thanks, thanks so much. Undoubtedly, I owe gratitude to you for inviting me to
conduct experiments and your guidance therein. I am deeply grateful for your endless
patience, commitment, and encouragement whenever necessary. I really enjoyed my time
in your lab and I am very sure my doctoral research improved a lot thanks to your sup-
port.
I give thanks to Dr. Jörg Hoheisel for enriching my thesis advisory committee and for his valu-
able ideas and comments on my research.
For serving as examiner in my thesis defense committee, I thank PD Dr. Karsten Rippe.
I am much obliged to Prof. Dr. Martin Kupiec for exchange of data and knowledge and
for giving helpful hints. I very much appreciated the interesting insights into Israeli history as
well as the guided tours of Jerusalem, Ein Kerem, and their environs.
Many thanks to Prof. Dr. Maria Pia Longhese for conducting the resection kinetics assay in
her laboratory.
I thank Dr. Carl Hermann for his precious help and advice as well as for mentoring
me during the critical final phase of my PhD. Thanks for your helpful comments on my
thesis.
I am strongly indebted to Sarah, Martina, Rebecca, André, Arianna, Heiko, Katharina,
Julia, Lisa, Marco, René, Tina, and Vanessa. I deeply appreciated the tremendous help of
you all, enabling me to gain a foothold in the wet lab with its accompanying techniques
and processes. To all of you my greatest thanks for your support in every sense. Working
together with you was a great pleasure, I have learnt a lot from you. Moreover, thanks a lot
for your assistance during my pregnancy which forbid me to complete certain aspects of the
lab work myself; I am grateful for your standing-in for me when proteins had to be extracted,
gels had to be run or zeocin spottings had to be done. Without you, I would not have been
able to finish my thesis. A special thank you to Julia and Katharina for answering every
no matter how silly questions and your patience. Katharina, you were a great bench part-
ner.
I also thank Dr. Barbara Di Ventura for her imaging support and Dr. Tobias Bauer for shar-
ing his enrichment script with me.
Ashwin and Alexandra, I will not forget the many fruitful discussions with you two, your help
and companionship during the last years.
All dear fellow eilslabs members, thanks a lot for the great working environment and atmo-
sphere.
Jan, I am very grateful for your backing and for always having a sympathetic ear.
I say thanks to Corinna and Manuela for their support in all administrative matters and for
boosting my morale every now and then.
I would like to acknowledge the support by the Helmholtz International Graduate School for
Cancer Research in Heidelberg.
My doctoral research would not have been possible without an excellent education and
training preceding it. Thus and hereby, I would like to express my gratitude to Prof. Dr. Hans-
Werner Mewes and Prof. Dr. Thomas Rattei who were convinced of my abilities, supported
me during my studies and continued to do so during my PhD. Bearing this in mind, moments
of self-doubt lost their basis.
In the end, the last four years were only possible because of the wholehearted support by
my family and friends. My PhD would not have been possible without their moral support,
without Sarah, Maria, especially Lea, or my mum spending weekends with us, looking after
David and Lea whenever necessary, or the financial support by Erna. All of you, thanks that
you endured me during the last years. Sarah, thanks a lot for being such a good critic of my
thesis.
Abstract
Eukaryotic chromosomal ends are formed by special structural and functional units, termed
telomeres, protecting them from fusion, degradation, and unwanted DNA damage repair
events. In this way, telomeres preserve genome stability and integrity that are vital to every
cell and organism, whereas genomic instability is a hallmark of cancer and ageing. Telomere
length is maintained mainly by telomerase which is expressed in 85–90% of human malignan-
cies, although most human cancer types arise from somatic tissue that is telomerase negative.
Thus, telomerase can serve as a nearly universal marker for cancer, as well as a drug target
against tumour cells. Genome-wide studies in Saccharomyces cerevisiae identified approxim-
ately 7% of the genome (roughly 400 genes) to be associated with telomere length mainten-
ance (TLM genes).
Based on these studies, a strong enrichment of genes encoding endosomal sorting complex
required for transport (ESCRT) factors has been found within the TLM genes that led to
telomere shortening when deleted. ESCRT factors define a system of five multi-protein
complexes which is involved in deforming and scissioning cytosol filled membrane stalks.
Although they can be linked to genomic stability and integrity, only little literature exists on
the relationship of telomere homoeostasis and the ESCRT machinery. The data presented
here shows that the whole ESCRT system is required to safeguard proper telomere length
maintenance. More in-depth experimental investigations of the ESCRT-0 factor Vps27
suggested a model of impaired Exo1-mediated resection resulting in too little telomeric
overhang such that Cdc13 binding is suppressed, preventing either telomerase recruitment
or telomeric overhang protection. A protein-protein-interaction network analysis indicated
a potential feedback mechanism to regulate telomere homoeostasis via the ESCRT sys-
tem.
The results from the present thesis uncovered the ESCRT system, especially Vps27, as prom-
ising drug candidate directed against malignant growth of cancer or diseases caused by dys-
functional telomeres.

Zusammenfassung
Die Enden eukaryotischer Chromosomen werden durch spezielle strukturelle und funk-
tionelle Einheiten gebildet, sogenannte Telomere, und damit vor unerwünschten DNA
Reparaturmechanismen, Abbau und Chromosomen-Fusionen geschützt. Auf diese Weise
tragen Telomere zum Erhalt von Genom-Stabilität und -Integrität bei, welche lebenswich-
tig für jede Zelle und jeden Organismus sind. Genomische Instabilität ist ein Schlüssel-
merkmal von Krebs- und alternden Zellen. Die Telomerlänge wird hauptsächlich durch
Telomerase aufrechterhalten, welche in 85–90% menschlicher Tumoren exprimiert wird,
obwohl sich die meisten menschlichen Krebsarten aus somatischem Gewebe entwickeln, das
Telomerase-negativ ist. Daher kann Telomerase als nahezu universeller Tumormarker und
als medikamentöser Ansatzpunkt gegen Tumorzellen dienen. In Saccharomyces cerevisiae
wurde für rund 7% des Genoms (ca. 400 Genen) durch genomweite Studien ein Einfluss
auf die Balance der Telomerlänge festgestellt (Telomere Length Maintenance oder TLM Ge-
ne).
Basierend auf diesen Studien wurde innerhalb der TLM Gene eine starke Anreicherung von
ESCRT (Endosomal Sorting Complex Required for Transport) Faktoren gefunden, deren
Deletion zu einer Telomer-Verkürzung geführt haben. ESCRT Faktoren umfassen ein System
aus fünf Multiproteinkomplexen, das an der Verformung und Abschnürung Zytosol-gefüllter
Membranknospen beteiligt ist. Obwohl sie bereits mit genomischer Stabilität und Integrität
in Verbindung gebracht wurden, existiert nur wenig Literatur über ihre Bedeutung für die
Telomer-Homöostase. Die hier präsentierten Daten zeigen, dass das gesamte ESCRT System
erforderlich ist, um die richtige Telomerlänge zu bewahren. Tiefergehende experimentel-
le Untersuchungen des ESCRT-0 Faktors Vps27 führten zu einem Modell, in dem eine
geschädigte durch Exo1 vermittelte Resektion einen zu kurzen telomerischen DNA-Sequenz-
Überhang nach sich zieht, sodass die Cdc13 Bindung unterdrückt wird und entweder
die Telomerase-Rekrutierung oder der Schutz des telomerischen Überhangs verhindert
wird. Eine Protein-Protein-Interaktions-Netzwerk Analyse legte einen möglichen Rückkopp-
lungsmechanismus nahe, um Telomer-Homöostase über das ESCRT System zu regulie-
ren.
Die Ergebnisse der vorliegenden Dissertation verweisen auf das ESCRT System, insbe-
sondere Vps27, als vielversprechenden Medikamentenkandidaten gegen bösartiges Wachs-
tum von Krebs oder Krankheiten, die durch dysfunktionalen Telomere verursacht werden.
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1 Introduction
Not that long ago, biology was considered by many to be a simple science, a pursuit of
expedition, observation and experimentation. [...] The molecular revolution that dawned
with the discovery of the structure of DNA in 1953 changed all that, making biology more
quantitative and respectable, and promising to unravel the mysteries behind everything
from evolution to disease origins.
(Erika Check Hayden, [16])
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1. Introduction
1.1. The Complexity of Life
The basic structural and functional unit of life is the cell [17]. However, life’s complexity is
defined by the interplay of diverse organisational levels from basic cellular building blocks
such as proteins up to tissues and organs [18,19]. Understanding the structure and dynamics
of their functional interplay is a key challenge for biology in the twenty-first century [20]
as it has become increasingly clear that research “limited to individual genes, cells, and
chemical reactions” [21] is insufficient to fully disentangle the complexity of life, visualised
in fig. 1.1. The elementary molecular building blocks of a cell are organised into small
recurrent patterns that form functional modules which in turn assemble into large-scale
entities. Systems biology aims at understanding “how complex systems underlie life” [21].
Figure 1.1.: Complexity of life is defined by the interplay of diverse levels. From left to right, we zoom from the
organism into its cells that are composed of a hierarchy of different levels. Cellular functions are “distributed
among groups of heterogeneous components that all interact within larger networks” [19]. These larger networks
consist of functional modules that are formed by either genetic-regulatory motifs or metabolic pathways. The basic
building blocks for those components are metabolites or gene products encoded in an organism’s genome. “Loops
of interacting downward and upward causation can be built between all levels of biological organisation” [18].
This is already apparent on the very lowest level: the protein machinery decodes genes which in turn encode
proteins. The time and size scale on the left apply for various levels of the human body. The figure has been
devised on the template of the life’s complexity pyramid presented by Oltvai and Barabási [19] and extended with
ideas of the causal chain of life by Denis Noble [18]. It has been drawn using biological entities from ChemDraw
Professional except for the regulatory motifs [22], the TCA cycle [23], and the functional modules as well as the
large-scale network [19]. An enlarged version of this figure can be found in the supplement (fig. B.1).
The entire information for building and maintaining an organism is stored in its genome.
Except for some viruses storing it in a ribonucleic acid (RNA) molecule, the genome
is encoded in a double-stranded and helical deoxyribonucleic acid (DNA) molecule. A
gene is defined as “a union of genomic sequences encoding a coherent set of potentially
overlapping functional products” [24] (e.g. a protein). The genome comprises genes and
non-coding elements. A process termed gene expression, decodes genes into functional
products. Initially, the DNA sequence corresponding to a single gene is transcribed into an
intermediary RNA sequence (messenger RNA or mRNA). The mRNA is either translated
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into a linear amino acid sequence or post-transcriptionally processed into a functional RNA
molecule. Finally, the amino acid sequence is folded into a three-dimensional fully functional
protein representing a cellular building block or molecular machine. The DNA molecule
of each cell is highly condensed into thread-like structures called chromosomes (fig. 1.2).
Figure 1.2.: The different states of DNA condensation from a double-stranded helical structure (A) into a
thread-like structure called chromosome (E). Both schematic and electron microscopic images are depicted.
Green balls represent histones that support and strengthen the folding of the DNA molecule. The images have
been taken from Hafner and Hoff [25].
Every cell of an organism is challenged by the fundamental and continuous need to main-
tain genomic stability [26, 27] while being faced with either endogenous sources of DNA
damage (e.g. routine errors in DNA replication) or exogenous genotoxic agents (e.g. ul-
traviolet light or chemical compounds) [27, 28]. As can be seen by the myriad of human
syndromes, neurodegenerative diseases, and immunodeficiency, as well as cancer associated
with defects in factors sensing and responding to DNA damages [26–30], a proper repair
of DNA lesions is rather critical for cells and organisms. Besides being a hallmark of
cancer, genomic instability is also a hallmark of ageing, since chromosomal instabilities
increase with age [26]. “DNA double-strand breaks (DSBs) are among the most serious
and lethal types of DNA damage, as a single DSB is sufficient to kill a cell or to disturb its
genomic integrity” [27, 30]. For maintaining genomic integrity, a well orchestrated DNA
damage response (DDR) is required [27,31,32], wherein multiple players and processes are em-
ployed.
Thus, understanding the mechanisms leading to genomic instability is crucial for improving
and developing promising treatments and therapeutic targets, successfully tackling cancer
and other health burdens. With its integrative and system-wide view, systems biology is an
auspicious approach unravelling the complex intercellular network of genes, proteins, and bio-
chemical reactions underlying diseases [33]. As “a gene can do nothing without [its] interpret-
ation by the system” [18], we have to strive for the comprehension of biological systems in its
entirety.
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1.2. DNA Maintenance
The following section on DNA Maintenance has been adapted from the book “Molecular Bio-
logy of the Cell” by Bruce Alberts [34].
As stated before, the entire information for building and maintaining an organism is
stored in its genome. The necessity of duplicating the entire DNA sequence previous to
each cell division becomes evident as requirement for growth, development and mainten-
ance of health. “Multicellular organisms like ourselves depend on the remarkably high
fidelity with which their DNA sequences are maintained” [34]. DNA maintenance relies
strongly on accurate DNA replication and transmission to daughter cells as well as on
DNA damage repair. These damages might be caused by radiation, chemicals or naturally
arising errors during DNA replication and transmission. Although species as a whole
can benefit in the long run from occasional genetic changes, each individual relies on
genetic stability for its survival. In humans, most body or somatic cells regularly un-
dergo cell division. Except for germ cells (eggs or sperm), all human cells are somatic.
The sequence of events in the life of a cell from its creation until division is called cell
cycle [35]. Broadly, one cell cycle comprises a phase of growth and activity and a phase of
division. The first phase (interphase) consists of phases G1 (growth), S (DNA replication
or synthesis), and G2 (growth, preparing for division). The actual cell division requires
division of the genetic material (mitosis) followed by division of the cytoplasm (cytokinesis).
At the end of the G1 and G2 phase, cell cycle checkpoints ensure that the cell cycle
faultlessly continuous. Upon detection of any DNA damage or mistakes occurred during
replication, the cell cycle is arrested, allowing the cellular machinery to correct such er-
rors [35,36].
1.2.1. DNA Replication
In order to distribute a full complement of its genome to both of the daughter cells, the
mother cell has to faithfully replicate its whole DNA sequence preceding cell division. The
process of DNA replication, visualised in fig. 1.3, takes place during S phase and engages
various different enzymes that have to properly cooperate. Due to the complementary
and double-stranded structure of the DNA, it can serve as template for its own copy-
ing. Initially, the double helical DNA structure is unwound by an enzyme called helicase
opening the DNA helix into a Y-shaped replication fork. Subsequently, the new strands
are synthesised while both parental strands serve as corresponding templates. Synthesis
is catalysed by a self-correcting DNA polymerase that can act only in 5’ to 3’ direction.
Hence, the leading strand can be continuously extended. As the DNA double helix is
antiparallel, the opposing lagging strand cannot be continuously extended. In fact, it is
processed in so called Okazaki fragments using small RNA primers as starting points. Those
primers are later removed and the resulting gaps are then filled with nucleotides. Once
both strands are completely replicated, each of both newly synthesised DNA molecules
contains a new and an old strand (semi-conservative replication). In this way the whole
genome is copied with remarkable fidelity. In addition to the self-correcting abilities of
DNA polymerases, further proofreading processes minimise the number of inappropriate
nucleotide additions. As soon as replication of the entire genome is achieved and no replic-
ation errors are detected that would lead to a cell cycle arrest, cell division further contin-
ues [35,36].
Semi-conservative replication of linear DNA ends entails the end replication problem. Al-
though it has originally been considered “to be a problem of incomplete lagging strand
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Figure 1.3.: DNA replication describes the process of duplicating the entire genome preceding cell division.
Various enzymes are tightly orchestrated to synthesise two new DNA strands in 5’–3’ direction. The schematic
has been adapted from Campbell et al. [36] using biological entities from ChemDraw Professional.
synthesis” [37], this is only half of the truth. The lagging strand can only discontinuously be
synthesised in short Okazaki fragments, each of which requires its own primer. At the very
end of a chromosome, the removal of the last primer leaves a gap resulting in a 3’ overhang
that “cannot be overcome by the replication complex” [38] and results in 5’ DNA sequence
loss (fig. 1.4a). Without taking care of this lagging strand end problem, the 5’ sequence loss
will potentiate with cell generations [39–42]. The theory of a lagging strand end problem
assumes blunt-ended chromosomal termini, i.e. a dsDNA molecule that ends in a common
base pair. However, single-stranded overhangs at the 3’ chromosomal termini have been
found as “a general feature of eukaryotic chromosomes” [37] and thus the replication of DNA
termini has to be reconsidered. In the presence of a 3’ overhang or sticky DNA ends, lagging
strand synthesis does not cause problems to the DNA replication machinery as the final
RNA primer can be positioned complementary to this 3’ overhang. Thus, no 5’ sequence
loss occurs. In contrast, continuous synthesis of the leading strand results in loss of the
3’ overhang causing a lagging strand problem in the next round of DNA replication [37].
Figure 1.4b illustrates the end replication of sticky DNA termini. Hence, depending on
the DNA terminus either a leading (sticky ends) or a lagging (blunt ends) strand problem oc-
curs.
1.2.2. DNA Damage Response
The error detection and correction of the DNA replication machinery only rarely fails, pro-
ducing permanent changes in the DNA (mutations). Lesions on one strand or even on both
can accidentally occur. If vital positions in the DNA sequence are affected by unintentional
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(a) Blunt DNA termini.
(b) DNA termini with 3’ overhangs.
Figure 1.4.: Depending on the DNA terminus either a lagging or a leading strand end replication problem
occurs. (a) In the case of blunt ends, the DNA replication machinery is incapable of fully synthesising the
lagging strand. Upon removal of the last primer a gap at the newly synthesised DNA strand a 3’ overhang
arises. This end replication problem results in 5’ sequence loss during each cell cycle. (b) In the presence of
3’ overhangs, the final Okazaki primer can be positioned complementary to the overhang such that the lagging
strand is completely synthesised. However, the continuous replication of the leading strand results in loss of the
3’ overhang causing a lagging strand problem in the next round of DNA replication. The figure has been created
according to Lingner et al. [37].
changes or lesions, the resulting cellular imbalance can result in detrimental effects on
the cellular and organismal level. To circumvent severe defects and genome instability, a
multitude of proteins have evolved to tackle those DNA damages. These repair proteins
constantly scrutinise the DNA for damage sites. Base or nucleotide excision repair treat
wrongly inserted bases or nucleotides. Whole double-strand lesions (DNA double-strand
breaks or DSBs) are dealt by either the non-homologous end joining (NHEJ) or homologous
recombination (HR) mechanism. Unlike repair of errors in a single strand, DSB repair
cannot fall back to an intact template. For ensuring the transmission of faultless DNA to
daughter cells, the cell cycle is delayed until DNA repair is completed, otherwise cells would
be prone to apoptosis. In Saccharomyces cerevisiae, the incidence of DNA damage can
interfere at different stages of the cell cycle: (i) the entry into G1 can be blocked, (ii) DNA
replication can be slowed down once begun, and (iii) the transition from S to M phase can be
hindered.
Both, cell type and cell cycle stage influence the type of repair event that also depends on
the kind of the damaged DNA end. Blunt DNA ends initiate NHEJ whereas single-stranded
DNA (ssDNA) stimulates HR [43]. Moreover, NHEJ is active throughout the cell cycle
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although preferred during G1, while HR is most active in the S and G2 phase [44, 45].
(Refer to fig. 1.5 for an outline of the NHEJ and the HR repair mechanisms.) Upon
detection of a DSB, the yeast Mre11-Rad50-Xrs2 (MRX) complex binds to it and de-
pending on the cell cycle phase either NHEJ (G1) or HR (S or G2) is initiated. In case
of NHEJ activation, the Yku70-Yku80 heterodimer (Ku) is recruited to the damage site
and prevents nucleolytic attack at the DSB. The two DNA ends are then simply rejoined
by DNA ligation without the need for a template, making NHEJ an error-prone process.
Figure 1.5.: Two major pathways exist in order to repair DNA double-strand breaks (DSBs). Initially, a DSB
site is bound in yeast by the Mre11-Rad50-Xrs2 (MRX) complex and depending on the cell cycle stage either
non-homologous end joining (NHEJ) or homologous recombination (HR) is initiated. While NHEJ relies on the
simple rejoining of the two DNA ends, HR incorporates several steps to repair the lesion. Following extensive
5’–3’ resection and homology search, strand invasion, synthesis, and annealing take place.
If HR is stimulated, Sae2 degrades the 5’ end into a 3’ ssDNA overhang preparing for
subsequent extensive Exo1-mediated 5’–3’ resection (strand resection). Afterwards, a homo-
logous sequence is searched matching the produced ssDNA sequences, invading the duplex
and forming a heteroduplex DNA (strand invasion). Beginning from the 3’ ends, new DNA
strands are synthesised and the ssDNA tail is annealed to the displaced strand (strand
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displacement and annealing). Finally, the heteroduplex is resolved and the ssDNA is fully lig-
ated to the invaded duplex [45,46]. NHEJ is accompanied by loss of nucleotides at the joining
site [34]. In contrast to the intrinsic mutagenic nature of NHEJ, HR accurately repairs DSBs
as it relies on the usage of an undamaged homologous DNA template and thus fully restores
the lost sequence [47].
Depending on the type of damage, either Mec1 (ssDNA) or Tel1 (DSB) activate Rad9, lead-
ing to Rad53 phosphorylation and subsequent cell cycle arrest until DNA damage repair is
finished [48].
1.3. Telomeres
The natural linear ends of eukaryotic chromosomes — telomeres — resemble DNA
breaks [49]. However, they neither induce DNA damage repair pathways nor DNA damage
checkpoint responses [50]. Telomeres represent essential nucleoprotein caps of the chromo-
somal ends to preserve genomic integrity and cell viability [49,51] by prevention of chromo-
some fusions or degradation and unwanted DSB repair events [51]. Moreover, to maintain
genomic stability, it is crucial that telomeres and DSBs do not interconvert [50]. The homoeo-
stasis of telomeres underlies tightly controlled mechanisms. Telomere dysfunction has not
only been linked to rare disorders such as Ataxia telangiectasia, Werner Syndrome or dysker-
atosis congenita, but also to certain malignancies [49,52].
1.3.1. The Nucleoprotein Structure of Telomeres
Telomeres are nucleoprotein complexes (fig. 1.6) composed of repetitive DNA regions and
well-defined coating proteins [51,53]. The G strand directed from 5’ to 3’ is guanosine-rich
Figure 1.6.: Schematic of the nucleoprotein structure of telomeres. The ends of eukaryotic chromosomes consist
of tandem repeats of guanosine-rich sequences and coating proteins. The 5’ to 3’ strand ends in a 3’ ssDNA
overhang. The schematic has been drawn using entities from ChemDraw Professional.
and extends into a single-stranded DNA overhang (G-tail) [54]. Tandem array GT-rich
repeats are found at every telomere, however their composition and number differ across
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species [50]. In contrast to the human 5’-[T2AG3]n-3’ repeat extending from 2–50 kbp, Sac-
charomyces cerevisiae telomeres bear a more heterogeneous 5’-[TG1-3]n-3’ motif spanning
from 250 to 400 bp [53]. The length of G-tails can range from 50–100 nt in yeast up to
50–300 nt in humans [49, 53, 54]. Alternative telomere structures have been observed in
Caenorhabditis elegans that in addition to 3’ G-tails can also form 5’ C-tails. The lat-
ter have also been detected in mammalian cells while in plants blunt-ended telomeres can be
found [55].
In addition, less conserved DNA elements precede telomeric repeats. These subtelomeric
regions (fig. 1.7) can be found in most organisms and are at least a few hundred base
pairs long. Human individuals as well as yeast strains show high variability in their subte-
lomeric composition [56]. In yeast, two structural and functional distinct subtelomeric
repeats exist, whose distribution separates yeast chromosomes into either the X or the
X-Y’ class. Y’ subtelomeres contain one to four copies of the Y’ element. X elements are
more diverse, despite that they contain a X-core repeat. While X-subtelomeres lack his-
tones, Y’ regions possess high nucleosome density and exhibit transcriptional activity [50,57].
Figure 1.7.: Schematic of the subtelomeric composition of X and Y’ elements extending into the terminal repeat
sequences. Red indicates G-rich and blue indicates C-rich sequences. The X element can be separated into core
and subtelomeric repeated (STR) subregions [58]. The figure has been reproduced according to Wellinger and
Zakian [59].
Telomeric DNA can adopt different topological conformations by invasion of the G-tail into
upstream dsDNA regions (t-loops, fig. 1.8b) or other structural arrangements such as G-
quadruplex structures (fig. 1.8a) [55]. The exact function of t-loops remains to be elucidated.
(a) G-Quadruplex. (b) T-Loop.
Figure 1.8.: Telomeric DNA can adopt different topological conformations. (a) Four hydrogen-bonded guanosine
bases form a plane or a G-tetrad which are stacked on top of each other to form a G-quadruplex. (b) The
3’ telomeric overhang can fold back into a loop and invade into upstream dsDNA regions. The figure has been
adapted from Giraud-Panis et al. [55].
Nonetheless, it has been inferred that t-loops contribute to the protection of chromosomal
ends from being recognized as DSBs and that they influence the access of telomeric DNA
binding proteins to the DNA [55]. Stabilisation of telomeric G-quadruplex structures has
been found to support tumour regression in mice [60,61] and interferes with telomeric main-
tenance mechanisms [55].
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“Because of the unusual properties of telomeres, a bona fide telomeric protein com-
plex has evolved” [49]. This complex comprises proteins endemic at telomeres or pro-
teins that are also involved in the DNA damage response (DDR) and DSB repair. Te-
lomeric proteins ensure the complex interplay of “telomere length regulation, protec-
tion from enzymatic attack [(capping)] and recruitment of required enzymatic activit-
ies” [49]. Furthermore, they are involved in the signalling cascades stemming from the
telomeres [49]. Although protein capping of telomeres is conserved throughout the euka-
ryotic lineage, their organisation shows considerable diversity [55]. In baker’s yeast, the
(a) Saccharomyces cerevisiae. (b) Mammals.
Figure 1.9.: Telomere capping proteins in (a) baker’s yeast and (b) mammals. In yeast the ssDNA overhang
and the dsDNA region are bound by two different complexes whereas the Shelterin complex bridges both DNA
regions in mammals. The figure has been adapted from Giraud-Panis et al. [55].
ssDNA is capped by the Cdc13-Stn1-Ten1 (CST) complex and the dsDNA is bound by
the Rap1-Rif1-Rif2 complexes (fig. 1.9a). The capping complex in mammals (Shelterin,
fig. 1.9b) comprises six proteins and bridges the single-stranded and double-stranded
telomeric DNA [51, 55, 62]. Lack or disruption of those capping protein complexes have
been associated with several telomere phenotypes amongst which are improper length
control, chromosome fusions, DNA damage checkpoint activation or elevated levels of
ssDNA [50].
1.3.2. Telomere Homoeostasis and Maintenance
Linear ends of eukaryotic chromosomes are faced with the leading strand end replication
problem as described above (section 1.2.1 and fig. 1.4b) [37,56,63] by which telomeres gradu-
ally shorten with each cell division (DNA replication) leading to loss of sequence information.
In fungi and flies, telomeres shorten at rather modest rate of approximately 3–5 bp per
chromosome end and cell division. The rate of shortening of human and mouse telomeres is
much faster, namely 50–100 bp per end and cell division [63]. Upon a critical minimal length
defined as the Hayflick limit [64], the progressive shortening leads to replicative senescence
(cell ageing) or apoptosis (cell death) [51]. Telomere erosion occurs in most somatic cells
while germline and stem cells are equipped with a mechanism to counteract telomere attri-
tion [51,63].
Telomere length homoeostasis is mainly achieved by a two-component ribonucleoprotein
enzyme — telomerase — consisting of a highly conserved reverse transcriptase and a
RNA moiety serving as replication template [51,63]. Telomerase shares extensive homology
with viral reverse transcriptases [56,63], both being able to re-transcribe a RNA molecule
into the corresponding complementary DNA sequence. In humans, telomerase activity is
suppressed in soma, whereas it is active in ovaries, testes, and proliferative tissues [63]. This
explains the telomere erosion phenotype in somatic cells. Most unicellular organism (e.g.
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baker’s yeast) express telomerase on housekeeping levels [63]. The constitutive telomerase
expression renders Saccharomyces cerevisiae an excellent model organism for studying
telomere biology. Section 1.5.1 elaborates on the advantages of yeast as a model organism.
The following sections will focus on the telomere maintenance by telomerase mainly in
yeast.
To maintain telomeres in the absence of telomerase, alternative mechanisms on the basis of
homologous recombination exist (reviewed in [65] and [66]).
1.3.2.1. Telomere Replication
In the course of every cell cycle, telomere replication plays an essential part involving
multiple steps and components. Failures in the regeneration of the telomeric nucleopro-
tein architecture lead to DDR and genomic instability [67]. Yeast telomere replication
occurs during the late S phase [51] and requires the divestment of the coating proteins
to allow the access of telomerase to the telomere. Although the general steps of telomere
replication are well conserved, the timing differs amongst various species [67]. Figure 1.10
depicts the integration of telomere extension subsequent to ordinary DNA replication into
the baker’s yeast cell cycle. Following conventional replication of the telomeric dsDNA
region, the chromosomal ends are specifically processed to reconstitute the 3’ G-tail.
Figure 1.10.: Telomere homoeostasis is well integrated into the cell cycle. In yeast, telomere replication takes
place during late S phase.
While the newly synthesised C-strand (lagging strand replication) naturally ends in an
overhang after removal of the final Okazaki fragment, the new G-strand is blunt-ended
(fig. 1.11). Thus, the formation of an overhang requires 5’ to 3’ nuclease digestion (end
resection). Subsequent to end resectioning and in concordance with its reverse tran-
scriptase nature, telomerase extends the 3’ ends of the newly replicated G-strands. Af-
terwards, complementary C-strand fill-in takes place by the DNA polymerase α/primase
complex [50, 51, 56, 63, 67]. The 3’ overhang serves as primer for telomerase, whose in-
herent RNA template is positioned such that it is adjacent to the overhang [63]. Te-
lomerase activity comprises multiple iterations of elongation and translocation to the
3’ end [56].
1.3.2.2. Recruitment of Telomerase
Telomere elongation correlates with the binding of several proteins assisting in this
process [51]. Moreover, telomerase needs to be recruited to the telomeric end and its
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Figure 1.11.: Schematic of telomere replication. While the lagging strand synthesis produces a 3’ overhang
on its own, leading strand replication results in a blunt-ended DNA duplex. 5’–3’ resection reconstitutes the
telomeric overhang enabling telomerase attachment. Telomerase action is followed by C-strand fill-in facilitated
by the DNA polymerase α/primase complex. The figure has been drawn on the basis of Lydall [50] and
Schluth-Bolard et al. [38].
activity has to be tightly regulated to circumvent indefinite elongation. Control of te-
lomerase can be achieved in several ways: (i) at the level of its recruitment, (ii) dur-
ing the initiation of elongation, or (iii) by the rate and processivity of the elongation
cycles [63]. The S. cerevisiae telomerase holoenzyme core (reverse transcriptase, Est2
and RNA template, Tlc1) is complemented by two accessory factors (Est1 and Est3)
that are not required for in vitro telomerase activity. Nevertheless, mutations in any
of the Ever Shorter Telomeres (EST) or the TLC1 genes lead to progressive telomere
shortening [51, 63, 68]. Hence, Est1 and Est3 are necessary for in vivo telomerase func-
tion [53].
Depending on the cell cycle, two different recruitment pathways exit for telomerase in S.
cerevisiae [69]. The initial interaction of Est1 with Cdc13 is essential to the recruitment of
telomerase during S phase [51, 63, 68]. “Cdc13 is a single-stranded DNA binding protein
with a preference for the G-rich strand of yeast telomeric DNA” [63, 70]. It is bound to
the telomere all through the cell cycle [53, 69]. Est1 has been reported to promote te-
lomerase activation [68,71]. Telomerase recruitment (fig. 1.12) continues with an interaction
of Est1 and Tlc1 establishing the linkage Est2-Tlc1-Est1-Cdc13-telomeric DNA [68, 72].
Nuclear localisation of telomerase is mediated by the Yku70-Yku80 heterodimer (Ku). Ku
binds Tlc1 promoting nuclear import of the telomerase ribonucleoprotein in G1. Thereby,
local concentration of telomerase might be increased preparing for and supporting the
assembly of Cdc13 and telomerase in S phase [69]. Besides, Ku is involved in the localisation
of telomeres at the nuclear envelope [63, 68]. Carl Rabl observed that telomeres localise
close to the nuclear envelope on one side of the nucleus opposite of the centromeres [55].
This “Rabl” organisation has been confirmed in various species. Yeast telomeres tether
in three to eight foci at the nuclear envelope [55], which is associated with chromatin
silencing [55,73]. The tethering itself is thought to protect against unwanted recombination
events [55,74].
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Figure 1.12.: Telomerase localisation into the nucleus is facilitated by the interaction of the Yku70-Yku80
heterodimer (Ku) with Tlc1 (telomerase inherent RNA template). Recruitment to the telomeric end is initiated
by the interaction of Cdc13 and Est1 that also binds to Tlc1. The figure has been taken and adapted from
Nandakumar and Cech [68].
Accompanying the recruitment of telomerase, the DNA damage checkpoint kinases Tel1 (in
G1) and Mec1 (during late S phase) have been found to also associate with the telomere.
Furthermore, the Mre11-Rad50-Xrs2 (MRX) complex is required for the efficient progress of
Mec1, Cdc13, and Est1 recruitment [69]. According to Bianchi and Shore, Tel1 and Mec1 are
necessary for telomerase activation [56].
1.3.2.3. Telomere Binding Proteins
As previously touched on, numerous proteins associate with telomeres throughout the cell
cycle. In this way, telomeres become a “unique non-nucleosomal chromatin domain” [53]
whose proteins are necessary for the overall telomere structure. Table 1.1 gives an overview of
these proteins and their role in yeast telomere homoeostasis.
Table 1.1.: Overview of the diverse telomere binding proteins in yeast and their functions. The table has been
taken and adapted from Vega et al. [53].
Factor Functions
Telomerase catalytic
core
Tlc1 RNA template
Est2 reverse transcriptase/catalytic subunit
Telomerase accessory
factors Est1, Est3 Est1 interacts with Cdc13, binds Tlc1
G-tail binding factors Cdc13 binds ssDNA overhang, interacts with Stn1 & Ten1
dsDNA binding proteins Rap1 binds dsDNA, telomere length regulator
Telomeric PPIs Rif1, Rif2 recruited by Rap1, telomere length regulationStn1, Ten1 recruited by Cdc13, G-tail protection
Others
Yku70-Yku80 telomere localisation, binds to Tlc1
Mre11-Rad50-Xrs2 ATP binding, nuclease activity
Mec1, Tel1 activation of telomerase
Pif1 5’–3’ helicase activity
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G-Tail Protection Cdc13 is the major telomeric ssDNA binding protein. In addition to
its function in telomerase recruitment and repression, it is responsible for shading the
G-tail from nucleolytic degradation (together with Stn1 and Ten1) [53, 69]. Overhang
capping by the Cdc13-Stn1-Ten1 (CST) complex, whose encoding genes are all essential,
is critical for cell viability [69]. In the absence of Cdc13, 5’–3’ resection degrades the
C-strand (fig. 1.13) resulting in increased levels of ssDNA that activate a Rad9-mediated
cell cycle arrest [69, 75]. In concordance with its assembly to the extended 3’ overhang,
Figure 1.13.: The 3’ ssDNA is
capped by the Cdc13-Stn1-Ten1
complex of which Cdc13 is the
key component. The CST com-
plex prevents Exo1-mediated de-
gradation of the 5’ end by 5’–3’
resection. Upon telomere uncap-
ping the CST complex is released
leading to Exo1 action and robust
activation of a cell cycle check-
point.
its levels peak during late S phase [69]. Telomerase repression limiting the telomerase-
dependent telomere elongation is facilitated by Cdc13 in conjunction with its complex part-
ners [63,69,76]. There is further evidence that Cdc13 might be also involved in the coordin-
ation of G- and C-strand synthesis, probably by assisting in the recruitment of DNA poly-
merase α [53,69].
Negative Feedback Control Telomere length is kept at a species-specific average value
(see section 1.3.1). Several experiments suggest a model of negative feedback control of
telomere length by a protein-counting mechanism. This model hypothesises that the number
of dsDNA bound proteins correlates with telomere length regulation. In S. cerevisiae the
main actor of this cis inhibition of telomerase is thought to be Rap1 that specifically binds
to the telomeric dsDNA repeats [53,56,63,69]. Approximately 10–20 Rap1 molecules bind
to each telomere [53]. Via its C-terminus, Rap1 recruits Rif1 and Rif2 which are both
contributing to the negative feedback control and whose deletion leads to telomere length-
ening. Furthermore, the silencing proteins Sir3 and Sir4 bind to the C-terminus of Rap1,
too [63]. A schematic of this Rap1-Rif1-Rif2 counting model is shown in suppl. fig. B.2a.
According to the present doctrine, this protein complex remodels telomeric chromatin
structure during the cell cycle together with the Sir proteins, thereby restricting the
telomerase access to telomeres [53]. Due to suppressed telomerase action, telomeres are
exposed to replicative attrition, and shortening of their ends leads to loss of Rap1 binding
sites and reactivation of telomerase. Hence, telomeres are kept in a dynamic length equilib-
rium [56].
One nucleus can bear telomeres having different lengths [63]. However, telomerase is not
acting on every telomere in each cell cycle, but it preferentially acts on short telomeres
(suppl. fig. B.2b). In contrast to only 6–8% telomere elongation frequency at wild-type
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length, telomeres shortened to 100 nt are elongated with a frequency of 50%. Moreover, the
number of nucleotides added to telomeres does not correlate with telomere length; it rather
varies between a few to more than 100 nucleotides. Telomere elongation itself is not regulated
in a length-dependent manner [69,77]. Teixeira et al. have widened the protein counting
model by the knowledge how telomerase is actually inhibited. Their data has suggested
that telomere length homoeostasis is achieved by controlling a binary switch (fig. 1.14) [78].
The longer a telomere, the more Rap1-Rif1-Rif2 complexes are bound and the telomere
Figure 1.14.: Telomere length homoeostasis is achieved by controlling the binary switch between two states.
Depending on their length, telomeres exist either in an extendible (left side) or in a non-extendible state (right
side). Rif1 and Rif2 promote the non-extendible state. Hence, the number of Rap1-Rif1-Rif2 complexes determines
the state of a telomere. The figure has been reproduced according to Teixeira et al. [77].
switches more likely to a non-extendible state. With decline in length, Rap1 complexes
are lost and telomeres adopt an extendible state. According to the model of binary switch
control, the protein complex count determines the state of a telomere. Rif1 and Rif2 have
been identified as critical mediators of the binary switch as they promote the non-extendible
state [69,77,78].
1.3.3. Dysfunctional Telomeres and DNA Damage Response
Genome integrity relies inter alia on cellular distinction between DSBs and telomeres,
albeit both of them represent physical ends of chromosomes [53]. In addition to their
shielding of chromosomal ends, telomeric binding proteins have been shown to suppress
checkpoint and repair responses as well as recombination events [79]. Failure of any of
these capping factors stimulates a DNA damage response [43,79]. Wellinger has called this
phenomenon an identity crisis of telomeres [80] whose outcome ranges from chromosome-
chromosome fusion events to permanent cell cycle arrest and even apoptosis [43, 79].
Figure 1.15 depicts a schematic of the relationship between telomere “health” and DNA
damage associated responses. In yeast already a single DSB is sufficient in causing a
robust cell cycle arrest and is subjected to either homologous recombination (HR) or
non-homologous end joining (NHEJ) [43]. Thus, it is quite conceivable that even a tem-
porary deprotection of a single telomere could trigger DDR. Repair via NHEJ creates
highly unstable dicentric chromosomes by fusion of two telomeres and leads to ongoing
genome instability [67, 79, 81]. The incorrect recognition of telomeres as DNA damage
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is associated with “a diverse number of pathologies, from cellular ageing and tumouri-
genesis to the genetic disease dyskeratosis congenita, obesity, and diabetes” [43, 82–87].
Figure 1.15.: Schematic of the relationship between telomere “health” and DNA damage associated responses.
The figure has been created based on Wellinger [80] and Longhese [79].
Generally, two scenarios of telomere deprotection seem to be plausible. The CST com-
plex could eventually become non-functional uncovering the telomeric overhang, or al-
ternatively, the telomeric DNA erodes to such a degree that the CST complex capping
function is no longer supported (lack of Cdc13 binding sites) [67,80]. Both scenarios have
been described in human cells [49, 80] and seem to be imaginable in baker’s yeast, too.
Due to the constitutive expression of telomerase in yeast, the second situation is usu-
ally prevented. Nonetheless it is possible to engineer a yeast strain lacking telomerase
activity [80, 88, 89]. However, the cellular response to altered telomeric structure (un-
capping) is generally different from eroded telomeres due to the lack of telomerase ac-
tion [77].
Several DNA damage repair proteins have been found at telomeres [53, 63]. Even more,
telomere maintenance relies on the presence of Tel1 and Mec1, both being DNA damage
response kinases that are influenced by the Rap1 complex [63]. Replication of short te-
lomeres and DSB-repair comprise a number of analogous steps applying the same factors,
but it is less well known how these activities are actually driven to telomere elonga-
tion and away from DNA repair [80]. Subsequent to inactivation of Cdc13, the C-rich
telomeric strand is degraded by 5’–3’ resection resulting in drastic elongation of the
ssDNA overhang and loss of viability [43, 79]. The accumulation of very long ssDNA is
referred to as a hallmark of telomere dysfunction by Longhese et al. [79]. The excess-
ive amounts of ssDNA stimulate a Mec1-dependent checkpoint activation culminating
in a robust cell cycle arrest in G2 preventing anaphase entry [43, 75, 79]. Although both
uncapped telomeres and DSB repair employ nuclease activities, they are distinct from
each other. At DSBs the MRX complex initiates resection together with initial Sae2
nucleolytic activity preparing for extensive exonucleolytic resection by Exo1 [43]. In con-
trast, the MRX is suppressing resection at uncapped telomeres [43,90]. Even though Exo1
is not essential for resection at DSBs, it is the major nuclease acting on uncapped te-
lomeres [43,91]. Moreover, the DNA helicase Pif1 has been shown in having a critical role
in the resection of uncapped telomeres while not being involved in DSB repairs [43, 92].
Dewar and Lydall prove that Cdc13 protects telomeres from Pif1- and Exo1-mediated resec-
tion [92].
In addition to the CST, the Rap1 complex interferes with telomeric DDR. Its loss results in
telomere fusion events by NHEJ [79]. Consistent with the model of telomere length homoeo-
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stasis (fig. 1.14), long arrays of Rap1 bound TG tracts prevent exonucleolytic resection and
activation of the Mec1-dependent DNA damage checkpoint [79,93].
1.3.4. Telomeres, Ageing and Diseases
Telomeres are essential to preserve genome integrity [52]. The gradual telomere erosion
results in loss of telomeric function and triggers cells to enter a non-dividing state (replic-
ative ageing or RA) [51,94]. Telomere-dependent RA is considered as a tumour-suppressive
mechanism. In 85% of human malignancies, telomerase expression can be detected [94,95],
although most human cancer types arise from somatic tissue that is telomerase negat-
ive. Figure 1.16 outlines the relationship of telomere length and replicative ageing or
rather the number of cell divisions. Reactivation and overexpression of telomerase enables
tumour cells to gain almost unlimited proliferative capacity [52]. Thus, telomerase can
confer cellular immortality, explaining the great medical interest in it [62]. However, te-
lomerase activation per se is not sufficient to induce neoplastic transformation [63, 94].
Figure 1.16.: Relationship between telomere length and cell divisions (replicative senescence). Germline immor-
tality is achieved by robust telomerase activity leading to continuous telomere length maintenance while ageing.
Somatic stem cells express telomerase, too, however to a smaller extent than germline cells. Thus, with age or
increased number of cell divisions, telomeres do shorten in these cells. The majority of somatic cells is telomerase
negative (TEL−) such that telomere erosion occurs with ongoing cell divisions. Upon a critical minimal length,
cells enter senescence (S), but can continue to divide if the DNA damage checkpoint is deactivated. In this way,
telomere erosion continues eventually leading to crisis which is characterised by extensive genomic instability and
even cell death. Cancer cells can escape this stage by either reactivation of telomerase or alternative telomere
lengthening based on homologous recombination. Afterwards, telomeres are maintained at greatly reduced
lengths, nevertheless enabling limitless proliferation in cancer cells. The figure has been created on the basis of
Baird [94], Buseman et al. [95], and Finkel et al. [26].
Telomere loss also represents a function of age in human tissues. The accumulation of
senescent cells contributes to age-related tissue deterioration and has the potential to
disrupt tissue homoeostasis. The extent of telomere erosion varies greatly between tis-
sues and correlates with the levels of cellular turnover. While it is stable in adulthood,
telomere shortening mainly occurs during early and later life. Telomere length is signi-
ficantly correlated with age-related diseases and life styles, i.e. short telomeres correlate
with physiological stress. Upon short telomere detection in blood, mortality of heart
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disease and infection is increased by 3.2-fold and 8.5-fold, respectively. The latter find-
ings hold true for individuals with an age above 60, but is no longer significant for an
age of 75 and higher. Malfunctioning telomerase is causal of several genetic disorders
that are based on mutations affecting telomerase [94]. A 2-fold reduction of telomerase
function results in “the failure of proliferating tissue” [62] giving rise to e.g. dyskeratosis
congenita. Already a single critical short telomere is sufficient to induce cellular senes-
cence [96].
Furthermore, proteins involved in telomere homoeostasis could have an impact on human
health, as they regulate telomerase action and telomere structure. Future research dealing
with the impact of defective telomere related proteins has to be undertaken [97].
With respect to the strong impact of telomerase dysfunction for human health, thera-
peutic approaches targeting telomerase or its regulation would be beneficial. “The ideal
cancer treatment would specifically target cancer cells yet have minimal or no adverse
effect on normal somatic cells” [95]. Multiple therapeutic strategies utilising telomerase
as target have been devised. Telomerase inhibitors represent a potential chemothera-
peutic agent against cancer (driving cancer to apoptosis) while medicinal reactivation of
telomerase would have to be strictly controlled. The latter could help to cure diseases
caused by accelerated telomere erosion (premature ageing syndromes) [94,97]. Moreover,
telomerase-targeted immunotherapies [95, 98, 99] as well as telomerase-driven virother-
apies [95, 100, 101] have been hatched. Clinical trials are well underway examining the
proposed therapies. Intermediary results emphasise the great potential of telomerase-
based treatments to cure or ameliorate cancer and telomerase syndromes [95]. The
different therapeutic approaches are well described and summarised by Buseman and
Shay [95].
1.4. The Class E Vacuolar Protein Sorting Family
In addition to having chromosomes in a membrane enclosed nucleus, eukaryotic cells
are defined by also possessing membrane-bound organelles. The endomembrane system
comprises the major subcellular compartments that are dynamically interconnected either
by continuous membranes or by vesicles that shuttle back and forth between the individual
parts of the cell. Amongst others, the nuclear envelope, the Golgi apparatus, and the
lysosome/vacuole belong to this system, which is primarily responsible for the biosyn-
thesis, modification, packaging, and transport of proteins [102, 103]. Furthermore, it is
involved in protein degradation, a fundamental mechanism of protein regulation and quality
control [104]. In addition to soluble proteins, transmembrane proteins (e.g. cell surface
receptors) are also subjected to control and degradation to ensure proper cell signalling
and metabolism [103–105]. Proteins slated for degradation are marked by ubiquitylation.
They are delivered to lysosomes (mammals) or the vacuole (yeast) [106] by multivesicu-
lar bodies (MVBs, also referred to as multivesicular endosomes) [105, 107, 108]. In yeast
this process is termed the vacuolar protein sorting (VPS) pathway [108,109]. Its implica-
tion on human health becomes apparent considering the involvement of the MVB (VPS)
pathway in cell death [110], budding of retroviruses (e.g. HIV [111]), and tumour suppres-
sion [112].
Genetic and genome-wide studies in yeast have identified approximately 150 genes in-
volved in vacuolar protein sorting, with approximately 50% having a mammalian homo-
logue [113]. Subsets can be distinguished, depending on the transport step at which they
are required. All twenty [103] class E VPS genes function in MVB biogenesis [114, 115].
Deletion of any of them leads to defects in the formation of MVBs and the accumulation
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of “aberrant structures adjacent to the vacuole” [105]. All members of the class E VPS
family are highly conserved in the eukaryotic lineage as well as is their function in MVB
sorting. Mammalian cells express one or more homologues for each of the class E Vps pro-
teins [105].
1.4.1. The Endosomal Sorting Complex Required for Transport System
The class E Vps proteins form five distinct cytoplasmic complexes — the endosomal sorting
complex required for transport (ESCRT) complexes 0, I, II, III, III-associated [103,106]. In
endosomal sorting, most data suggest a sequential activity of the different sub-complexes to
accomplish cargo-protein recognition and sorting as well as MVB formation [107,116–118].
In addition to endosomal sorting, certain ESCRT complexes are also involved in cytokin-
esis [106,119–121], enveloped viral budding [106,122,123], autophagy [106,124–126], and nuclear
envelope reformation [127]. Figure 1.17 shows the different cellular states of ESCRT factor ac-
tions.
Figure 1.17.: ESCRT factors are involved in several cellular processes that rely on the same topological membrane
deformation and abscission. Those processes are multivesicular body (MVB) biogenesis, cytokinesis, viral budding,
and autophagy. Nuclear functions of certain ESCRT factors are not indicated. The figure has been created on
the basis of Hurley and Hanson [106].
Furthermore, some Vps factors are associated with transcriptional elongation in yeast [128]
and chromatin remodelling in humans [129]. Deletions of ESCRT proteins have been shown
to cause defects in chromosomal segregation in humans [130] as well as in yeast [131], linking
them to genomic stability and integrity.
1.4.1.1. Composition of the ESCRT Machinery
The individual sub-complexes of the ESCRT machinery are recruited one after another
by the preceding complex to accomplish endosomal sorting [103]. The structural bio-
logy of the ESCRTs has been reviewed in detail by Hurley et al. [104, 132] as well
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as by Williams et al. [133]. In the following sections the ESCRT system will be ex-
amined on the basis of S. cerevisiae. Figure 1.18 depicts the composition and molecu-
lar interactions of the ESCRT machinery and table 1.2 lists its individual components.
Figure 1.18.: In multivesicular body biogenesis, the individual sub-complexes of the ESCRT machinery are
sequentially recruited one after another. Interactions between the individual complexes, ESCRT-III accessory
factors, and ubiquitinated cargo or PI(3)P are indicated. The figure has been adapted from Raiborg and
Stenmark [107]. DUB, deubiquitylating enzyme; PI(3)P, phosphatidylinositol 3-phosphate; Ub, ubiquitin; UIM,
ubiquitin-interacting motif; UEV, ubiquitin E2 variant.
ESCRT-0 Initially, endosomal phosphatidylinositol 3-phosphate (PI(3)P) recruits ESCRT-0
to the endosome via the FYVE zinc-finger domain of Vps27 [134,135]. Both ESCRT-0 sub-
units (Vps27 and Hse1) harbour ubiquitin-interacting motifs (UIMs) enabling the binding
of ubiquitylated cargo proteins [135,136]. The C-terminus of Vps27 serves as docking site
for the ESCRT-I complex. The “Vps27 protein appears to direct the compartment-specific
activation of MVB sorting, and Vps27 function is regulated by specific interactions with both
PI(3)P and ubiquitinated cargo at the late endosome” [104].
ESCRT-I ESCRT-I is a heterotetramer comprising Stp22, Vps28, Srn2, and Mvb12 of
which Stp22 binds to Vps27 and ubiquitin (cargo-protein). Recruitment of ESCRT-I is sup-
pressed in absence of ESCRT-0. Vps28 interacts with Vps36, a subunit of ESCRT-II [106,107].
ESCRT-II Vps36 can also bind ubiquitinated cargo and is complemented by Snf8 and
two molecules of Vps25 to form the ESCRT-II complex [106]. This complex connects the
endosomal membrane and ubiquitinated cargo in combination with ESCRT-I and -III com-
plexes [104].
ESCRT-III The ESCRT-III complex is a dynamic polymer of four core proteins (Snf7,
Vps20, Did4, and Vps24) and three accessory subunits having a regulatory role. In
humans the list of ESCRT-III subunits includes twelve proteins [106]. The core sub-
units are assembled “in a highly ordered manner” [137]. Attachment to the ESCRT-II
complex is achieved by the interaction of Vps25 and Vps20. As ESCRT-II comprises
two molecules of Vps25, two filaments of ESCRT-III can be nucleated. Vps20 inter-
acts with Snf7 which assembles into filamentous oligomers capped by a Did4/Vps24
sub-complex [107, 137]. The latter recruits the ATPase Vps4 that can also interact with
Snf7 and other ESCRT-III proteins indicating no strict specificity of Vps4 [104, 107].
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Further ESCRT-III accessory factors are involved in the regulation of the activity and
recruitment of Vps4. Those elements comprise the Ist1–Did2 and the Vta1–Vps60 sub-
complexes [107]. The core subunits of ESCRT-III cycle between a “closed monomeric
state in the cytosol and an open polymerised state on the endosomal membrane” [106].
Table 1.2.: The individual ESCRT subunits, associated proteins and their biological role. Alternative metazoan
names are provided in brackets. The table follows Hurley and Hanson [106] as well as Raiborg and Stenmark [107].
MVB, MVB biogenesis; A, autophagy; V, viral budding; and C, cytokinesis.
Complex Yeast Metazoan Biological Role
MVB A V C
ESCRT-0 Vps27 HRS (HGS) x xHse1 STAM1,2 x x
ESCRT-I
Stp22 TSG101 x x x x
Vps28 VPS28 x x x x
Srn2 VPS37A–D x x x x
Mvb12 MVB12A,B x x x x
ESCRT-II
Snf8 VPS22 (EAP30) x x
Vps25 VPS25 (EAP20) x x
Vps36 VPS36 (EAP45) x x
ESCRT-III
Vps20 VPS20 (CHMP6) x x
Did4 VPS2A,B (CHMP2A,B) x x x x
Vps24 VPS24 (CHMP3) x x x x
Snf7 SNF7A–C (CHMP4A–C) x x x x
ESCRT-IIIa
Did2 DID2A,B (CHMP1A,B) x x x
Vps60 CHMP5 x x
Ist1 IST1 x x
Other
Vps4 VPS4A,B x x x x
Vta1 VTA1 (LIP5) x x x x
Bro1 ALIX (AIP1) x x x x
1.4.1.2. Sequential Activity in MVB Biogenesis
According to the present opinion, different ESCRT complexes act sequentially in the VPS
pathway and the complexes 0 to II “might function as a supercomplex” [107,118]. Raiborg
and Stenmark suggest a reception of cargo proteins by ESCRT-0 that senses ubiquitin-bound
cargo proteins which are then sequentially passed on to other ESCRT complexes in the nu-
merical order (fig. 1.19a) [107]. ESCRT-I and -II induce membrane invagination and stabilise
the resulting membrane bud (figs. 1.19a and 1.19b) [106,138]. Subsequently, ESCRT-III
catalyses scission of the membrane neck (fig. 1.19c) [106,139]. With progressive membrane
budding, the contained cargo proteins are enclosed and their ubiquitin-mark is dissolved by
deubiquitylating enzymes (fig. 1.19b). Finally, Vps4 causes the disassembly of the ESCRT-III
complex [103,140,141].
1.4.2. ESCRTs Beyond Multivesicular Body Formation
Certain ESCRT factors are also found at other sites of membrane deformation (fig. 1.17). Bio-
genesis of MVBs requires the “severing [of] thin stalks of membrane filled with cytosol” [107].
This type of membrane deformation and scission event is equivalently necessary at the mid-
body during cytokinesis and for budding of enveloped viruses. Such membrane fission events
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Figure 1.19.: In the MVB path-
way, the ESCRT system is re-
sponsible for three major steps
to fulfil endosomal sorting. (a)
Recognition and sorting of ubi-
quitinated cargo by ESCRT-0.
(b) ESCRT-I and ESCRT-II in-
duce membrane invagination and
stabilise the resulting membrane
bud. (c) ESCRT-III facilitates the
membrane abscission continuously
assembling into circular arrays.
Vps4 causes the disassembly of
ESCRT-III. The figure has been
adapted from Raiborg and Sten-
mark [107].
(a) Cargo sorting.
(b) Membrane deformation.
(c) Membrane abscission.
are catalysed by ESCRT-III and Vps4 [106,107]. Further, the ESCRT machinery is involved in
autophagy [106,124–126] and several nuclear functions [127].
1.4.2.1. Cytokinesis and Viral Budding
Both mammalian cytokinesis and most enveloped viruses (e.g. HIV) utilise the ESCRT com-
plexes I and III, as well as Vps4 and Alix (mammalian homologue of Bro1) for the final ab-
scission event. While ESCRT-0 recruits those factors in intralumenal vesicle (ILV) budding,
the centrosome/midbody protein Cep55 recruits the ESCRT core machinery to the midbody
during cytokinesis, and viral structural proteins take care of this recruitment in virus bud-
ding. The actual pinch-off is mediated by ESCRT-III, whereas the exact mechanism is still
unknown. The ability of Vps4 to hydrolyse ATP represents the sole energy source for this
process. The assembly of ESCRT-III subunits into circular arrays is essential for membrane
fission [106,107]. Figure 1.20 outlines the just described involvement of ESCRT complexes.
1.4.2.2. Autophagy
In autophagy, cells extract building blocks from superfluous or defective cellular components
such as damaged organelles, aggregated proteins, or even invading microorganisms [107].
Initially, this “rubbish” is enclosed together with cytosol in a double-membrane phagophore
that matures into an autophagosome which finally fuses with a lysosome (autolysosomes)
for degradation of its content [106,107]. Autophagosomes and the phagophore closure are
topologically equivalent to MVBs and the abscission of ILVs into them [106]. Multiple
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Figure 1.20.: The ESCRT machinery is involved at three topologically similar sites of membrane abscission.
The actual abscission of cytosol filled membrane stalks is catalysed by ESCRT-III which is recruited differently
depending on the context. In MVB biogenesis (left) recruitment is achieved by ESCRT-0–II, in cytokinesis (middle)
this is done by the centrosome/midbody protein Cep55, and in virus budding (right) viral structural proteins
take care of ESCRT-III recruitment. The figure has been adapted from Raiborg and Stenmark [107].
evidence show that the entire ESCRT machinery is necessary for autophagy [142], suggest-
ing a “deeper relationship between the two pathways” [106]. On one hand, the number
of autophagosomes increases in the absence of a functional ESCRT system [124,143,144]
and autolysosomes are rare [107], and on the other hand phagophore closure is topologic-
ally equivalent to ILV scission. Raiborg and Stenmark assume that the fusion between
an autophagosome and a lysosome is probably inhibited when the ESCRT machinery is inact-
ive [107].
1.4.2.3. Nuclear Functions of Mammalian ESCRT Factors
In addition to the aforementioned roles, some ESCRT factors have acquired nuclear
functions. Quite recently, Vietri and colleagues have reported the recruitment of human
ESCRT-III and Vps4 to the reassembling nuclear envelope at the end of mitosis [127]. The
exact mode of action remains unknown, but it seems that ESCRT-III is recruited to the inter-
section of the reassembly site and microtubules. Subsequent to the severing of the microtu-
bules by spastin, ESCRT-III and VPS4 mediate “constriction and sealing of the holes in the
nuclear envelope” [127]. The authors emphasise the protection of the genome through mitotic
exit by ESCRT-III [127].
Most of human ESCRT-II and -III factors have been originally identified as nuclear proteins,
as indicated by their naming: EAP for ELL-associated proteins (ELL is a RNA polymerase
II elongation factor) and CHMP for chromatin modifying protein [145, 146]. Thus, both
EAPs and CHMPs control transcription on different levels: CHMPs by modifying chro-
matin for gene silencing [147] and EAPs by regulating RNA polymerase activity [129].
TSG101 (ESCRT-I, mammalian homologue of Stp22) is implicated in several nuclear
functions, too. Depending on the cell-cycle phase, it is translocated to the nucleus (G1
and S phase) while its expression levels are unchanged [148]. During mitosis, TSG101
colocalises with the mitotic apparatus [149] and in Drosophila melanogaster its inactivation
leads to loss of cell polarity. TSG101 even seems to function as a transcriptional regulator
of nuclear receptors that are important transcriptional regulators [150]. For all ESCRT
factor mediated regulatory influences on transcription the exact mechanisms are still un-
known [145,146].
1.4.3. From Cell Division to Garbage Collection
The ESCRT system is well conserved throughout all major eukaryotic taxa [133], although
the different complexes have not evolved simultaneously (fig. 1.21). ESCRT-III is the most
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ancient and conserved complex [107,109], whereas ESCRT-0 has been added just recently and
is unique to the group of opisthokonta (animals and fungi) [109,133]. Furthermore, viability in
baker’s yeast does not depend on the presence of any of the ESCRT factors, however some of
them are essential in mammals pointing to “potential evolutionary differences between yeast
and metazoa” [109,151,152]. In order to achieve minimal ESCRT function, especially mem-
brane deformation and biogenesis of intralumenal vesicles, presence of complexes III and III-
a is sufficient [103,133]. Albeit in Archaea no endocytosis system exists, Did4-like and Vps4-
like family homologues have been found and were suggested to be involved in cytokinesis in
Archaea, too [103,153].
Figure 1.21.: The ESCRT sys-
tem has gradually evolved, be-
ginning at the most ancient
ESCRT-III/-III-a complexes, ran-
ging to the latest ESCRT-0 com-
plex. Initially, the core III com-
plexes have been only involved in
cytokinesis which is also appar-
ent from the fact that those two
are sufficient for minimal ESCRT
function in mammals. With on-
going evolution and development
of endocytosis and MVB biogen-
esis, the ESCRT system has expan-
ded and specialised. The figure has
been created based on Field and
Dacks [103] using building blocks
from Openclipart as base [154].
The current data strongly supports ESCRT-III/-III-a as the most ancient complex ori-
ginally involved in cytokinesis. As the endocytotic system evolved, ESCRT-I and -II
developed and the earlier ESCRT-III system has been co-opted [103,109]. The final addi-
tion of ESCRT-0 “may be important for increased levels of cargo selection and recogni-
tion” [103].
1.4.4. Implications of ESCRT Factors in Human Diseases
The ESCRT machinery is involved in multiple fundamental biological processes by varying
degree: (i) MVB biogenesis being a part of endocytosis, (ii) final abscission at the midbody
during cytokinesis, (iii) autophagy, and (iv) nuclear functions such as transcription elonga-
tion and chromatin remodelling. Furthermore, certain ESCRT factors are hijacked by some
enveloped viruses to mediate their budding from host cells. Not surprisingly, disturbances of
the ESCRT system is associated with several human disorders including cancer, neurodegen-
eration, and bacterial infections [107].
While some viruses take advantage of the ESCRT system for their spread, the ESCRT ma-
chinery “is crucial for lysosomal killing of certain intercellular bacteria and parasites” [155].
The innate immune system utilises the endocytotic and autophagic pathways to engulf and
destroy invading microorganisms [107,155]. A screen in Drosophila melanogaster has identi-
fied several ESCRT factors as host factors restricting mycobacterial replication. This implica-
tion has been verified in mammalian cells [156], although the exact mechanism of the ESCRT
involvement is still unknown [107,155].
According to Nixon and Cataldo, protection against neurodegenerative diseases (e.g.
Alzheimer’s, Huntington’s, or Parkinson’s disease) requires accurate lysosomal functions [157].
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Both, endocytosis/MVB pathway and autophagy, lead to the lysosome and are respons-
ible for garbage collection in order to maintain cellular health. “Individuals with mis-
sense mutations in the ESCRT-III subunit VPS2B develop [...] amyotrophic lateral
sclerosis and frontotemporal dementia” [107], both being characterised by the accu-
mulation of ubiquitin-positive protein agglomerates [107, 155] as a result from impaired
autophagy [124]. Recently, a mouse study has associated ESCRT proteins with an im-
proved therapeutic potential of the immunotherapy of Parkinson’s disease and demen-
tia [158].
Finally, ESCRT factors are implicated in cancer both with positive and negative regulat-
ory roles [159]. On one hand, “incomplete cytokinesis can result in aneuploid cells” [155],
and on the other hand defective endocytosis results in sustained receptor signalling [107].
The relevance of ESCRT factors for tumourigenesis is further underlined by their asso-
ciation to nuclear envelope reformation [127] and chromatin remodelling [129]. As chro-
mosomal segregation [130] is disturbed upon deletion of ESCRT proteins, they are even
more linked to genomic stability and integrity whose disruption is a hallmark of can-
cer.
Stuffers and Stenmark have summarised the effects of individual ESCRT factor dysfunction
in cancer and other diseases [155]. Due to their role in a variety of human diseases and fun-
damental cellular processes, ESCRT factors represent interesting targets for diagnostic and
therapeutic developments [155,159].
1.5. Systems Biology
The tremendous diversity of biological systems (fig. 1.1) and their complex, but well-defined
orchestra of processes maintaining homeostasis, motivate systems biology, a branch of
life sciences aiming at understanding “how complex systems underlie life” [21]. Doubting
the hypothesis of a common origin of life is comprehensible regarding how different e.g.
humans and water fleas are. However, both organisms share the same set of amino acids,
nucleotides, and phospholipids. Beyond the unity in biochemistry, also the organisation on
the cellular level is substantially similar between organisms [160]. Obviously, the reductionist
approach to understand life’s complexity is not sufficient. Studying entire pathways or
organismal processes instead of individual genes or proteins represents a paradigm shift
in modern biological research [161]. Nonetheless, “before systems biology could develop
fully, molecular biology had first to come to maturity on its own right” [21]. Without the
knowledge how to investigate genes or exogenously express proteins, it would be impossible
to characterise “gene–gene, gene–protein, or protein–protein based systems” [21]. Sys-
tems biology employs and integrates methodologies from various fields such as molecular
and computational biology, mathematics, physics, and engineering [19]. Data from the
multitude of genome-wide omics technologies are combined in an iterative procedure of
model construction, testing, and refinement. The iterative interplay between hypotheses
and observation is visualised in fig. 1.22. Based on experimental data or prior knowledge,
either a hypothesis is derived or an existing one is refined (induction or top-down ap-
proach). Conversely, in a bottom-up approach (deduction) e.g. individual well-defined
pathway models are integrated into a model for the entire system [163, 164]. While the
former approach, in general, targets at the identification of new molecular mechanisms (e.g.
regulatory models), the latter aims at “mechanism-based descriptions of subsystems of organ-
isms” [164].
In the early and mid-1990s, the first pioneering large-scale studies have been carried out [161].
Due to the ease of culturing, manipulation and the profound knowledge about its genetics,
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Figure 1.22.: Systems biological
analyses employ an iterative pro-
cedure of elaborating hypothesis,
testing and refining them. By de-
duction biological systems are per-
turbed in a specific and well-
defined manner to monitor the
response(s) and refine the hypo-
thesis. The inductive approach de-
rives a hypothesis based on prior
knowledge and subsequently valid-
ates it. The outline of the schem-
atic has been adapted from West-
erhoff and Kell [162].
most of these studies have been conducted in the baker’s yeast [161,165]. According to Bot-
stein and Fink, yeast has become the pioneer organism “that facilitated the establishment of
[...] systems biology” [166].
1.5.1. Baker’s Yeast as a Systems Biological Tool
Saccharomyces cerevisiae (S. cerevisiae) (colloquially referred to as yeast) might be the
oldest domesticated organism. In addition to its usage for wine production, already
Sumerian and Babylonian have used S. cerevisiae for beer brewing, and in old Egypt
it has been used for dough leaving. That is why S. cerevisiae often is referred to as
baker’s or brewer’s yeast [167]. In the mid-1930s, H. Roman has introduced it as an
experimental organism [167, 168]. Although being an unicellular organism, baker’s yeast
bears all major characteristics of an eukaryote, e.g.: it comprises membrane-bound or-
ganelles (e.g. nucleus, mitochondria) [169]. However, as it grows on defined media, it
allows complete control over environmental parameters [167]. Yeast unites a number of
advantages: (i) it is remarkably inexpensive, (ii) it is readily available, (iii) it grows rapidly,
(iv) it is easy to culture and store, (v) its entire genome is known, and (vi) its genome
can be quite simply manipulated. Under optimal growth conditions, yeast cells divide
every 90min by budding off smaller daughter cells. S. cerevisiae can exist either in a
stable diplophase or in a stable haplophase, wherein it can alternate between both phases
(fig. 1.23). Haploid cells of the two different mating types (MATa or MATα) can mate
with each other forming a/α diploids. Upon starvation, a diploid cell undergoes meiosis
and sporulates resulting in so called tetrads — four haploid spores surrounded by the
wall of the mother cell (ascus) [167, 169]. Thus, yeast cells allow studying both types of
cell division: mitosis and meiosis. Yeast stocks can be stored in glycerol at −80 ◦C [169].
In April 1996, the genome sequencing of S. cerevisiae has been completed [166] by which
it has become the first fully sequenced eukaryote [169]. A haploid yeast cell harbours
roughly 6000 genes on a 12Mb genomic DNA which is wrapped into 16 chromosomes that
also contain centromeres and telomeres. Additionally, yeast cells have a mitochondrial
genome and one plasmid [167, 169]. For about 85% of the protein-coding genes a basic
knowledge of their biological role is known [166] and approximately 17% of them belong
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Figure 1.23.: Budding yeast’s life cycle comprises haplo- and diplophases. Two haploid cells of differing mating
types can mate resulting in a diploid cell. Under nitrogen-poor conditions, diploids undergo meiosis and sporulate
forming four haploid spores. Those spores germinate and join the haplophase of the corresponding mating type.
Both, haploid and diploid cells can proliferate through mitosis increasing the pool of the respective genotype
(marked with an asterisk). MAT, mating type. The figure has been drawn on the basis of Duina et al. [169] and
Masur [170].
to orthologous gene families associated with human diseases [166,171]. The basic cellular
mechanisms such as replication, recombination, cell division, and the metabolism are
well conserved between yeast and mammals. The yeast genome can be easily manipu-
lated, i.e. genes can be introduced by plasmids (transformation), deleted, or otherwise
mutated [167].
“As S. cerevisiae has the most advanced selection of genetic tools available for any euka-
ryotic organism, perhaps even any model organism, it has served as the launch pad for
landmark discoveries in gene regulation mechanisms and other cellular processes over the
past several decades” [169]. Various generally available resources have been established
to be exploited in small- and large-scale studies [166]. Amongst those are comprehensive
mutant collections [172–176], libraries of fusions to GFP [177] or TAP [178] tags, and the
Saccharomyces Genome Database (SGD) [10] which combines all the available data on yeast
(genes) into one resource [165,166,169]. Only recently, the Holstege lab released a collection
of genetic perturbation profiles measuring gene expression for a subset of the mutant collec-
tion under standard growth conditions [179]. A selection of the available tools is collected in
table 1.3.
Such libraries allow systematic screening of all conceivable yeast mutants in order to
search for mutants defective in a certain assay or under a particular condition. Hereto-
fore, myriads of genome-wide screens searching for all kinds of phenotypes have been
conducted. To name only a few, Yoshikawa and colleagues have utilised the deletion
collection to find genes that affect growth under ethanol stress [180]. On a genome-scale,
the Boone lab has explored the genetic interaction of yeast by examining 5.4 million
gene–gene pairs for their synthetic genetic interactions [181,182]. A consortium of Israeli
researchers has explored the mutant libraries to find genes whose deletions affect telomere
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length maintenance [183–185]. The screens in the mutant libraries are complemented
by e.g. comprehensive analyses of protein-protein interactions in baker’s yeast [186–188].
Table 1.3.: Selection of yeast genetics and bioinformatics resources has been adapted from Duina et al. [169].
Name Access/Reference
Saccharomyces Genome Database http://www.yeastgenome.org/ [10]
Yeast deletion project http://www-sequence.stanford.edu/group/yeast_deletion_
project/deletions3.html [172–174]
Yeast deletion collection GE Healthcare Dharmacon Inc. [189,190]
Yeast DAmP Collection GE Healthcare Dharmacon Inc. [175,191]
Yeast temperature-sensitive collection Boone Lab [176]
Yeast GFP-tagged ORF IDs Life Technologies GmbH [177]
Yeast TAP-tagged ORF IDs Open Biosystems [178]
Yeast GFP Fusion Localisation DB http://yeastgfp.yeastgenome.org/ [177,178]
Yeast Deletome http://deleteome.holstegelab.nl/ [179]
Yeast Search & Mining Tool http://yeastmine.yeastgenome.org/ [192]
Yeast Genetic Interactions http://drygin.ccbr.utoronto.ca/ [181,182,193]
However, Saccharomyces cerevisiae lacks some critical regulatory levels of higher eukaryotes,
like hormone signalling and the associated receptors (e.g. nuclear receptors and their co-
regulators), and due to its unicellular nature, yeast cells cannot be used for inferring data on
the multicellular level. Hence, its suitability for the verification of a particular question or hy-
pothesis has to undergo thorough consideration [194].
1.5.2. Systems Biology of Telomeres
As mentioned previously, telomeres represent vital structures to maintain genome integrity
and cell viability. Imbalance in telomere homoeostasis or dysfunction of any involved protein
can impinge severely on human health. Hence, there is a great interest in understanding te-
lomere homoeostasis. S. cerevisiae is an excellent model organism to study telomere biology.
In addition to its advantages as model organism (section 1.5.1), yeast presents all basic
characteristics of mammal telomeres (section 1.3). A fine-tuned equilibrium of positive and
negative regulation keeps telomeres at a steady length. The complex interplay of the two op-
posed mechanisms (elongation by telomerase, degradation by nucleases) and the multitude of
involved factors reach out for a system-wide approach to unravel the principles underlying te-
lomere homoeostasis.
Over the last few years, in particular a consortium of Israeli researchers have carried out
multiple genome-wide screens to widen the knowledge about telomere length mainten-
ance in baker’s yeast. Initially, mutant collections have been systematically screened to
identify roughly 400 mutants that affect telomere length (either shorter or longer than the
wild-type length) [183–185] representing approximately 7% of the yeast genome [165,183].
The corresponding genes are termed telomere length maintenance or TLM genes. Protein-
protein-interaction (PPI) networks have been investigated [195, 196] to find ”pathways
connecting TLM gene functions to telomere length maintenance“ [165]. A third network-
based approach has uncovered that the observed phenotype of a gene deletion is not
necessarily caused due to the consequence of the deletion itself, but rather by the effect the
deletion has on a neighbouring locus [197]. Considering those PPI analyses and correcting
for the neighbouring gene effect, the overall TLM list has been expanded to a near-complete
list of almost 500 TLM genes comprising almost all functions in the cell (e.g. DNA and
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chromatin maintenance, RNA and protein synthesis, metabolic pathways, and mitochon-
drial functions) [165]. Based on this list, various studies have broaden the knowledge about
those genes. Rog and colleagues have analysed the role of vacuolar protein sorting (VPS)
proteins in telomere length maintenance and have revealed that their influence on telomere
length depends on telomerase and the Ku complex while being independent of Tel1 and
Rap1 [165,198]. The influence of environmental stimuli on telomere homoeostasis has been
tested by Romano et al. They have systematically exposed tlm mutants to ethanol and
caffeine and have observed that telomere length is either increased (ethanol) or reduced (caf-
feine) [165,199].
Apart from that, many other telomere related studies have been conducted. The Lydall lab
has contributed immense information about the telomere capping protein Cdc13 by crossing
a temperature-sensitive allele (cdc13-1 ) to the whole non-essential deletion library. A genetic
interaction score has been derived describing whether the second mutant enhances or sup-
presses the telomere capping defect of cdc13-1 mutants exposed to high temperature [200].
This analysis has been extended with the cross of yku70 to the whole deletion library [201].
Visualisation of the three-dimensional conformation of yeast telomeres cannot be done as
in mammals [165]. Nevertheless, the Luke laboratory has devised a genome-wide screening
for finding mutants affecting the fold-back structure of yeast telomeres [202]. Finally, a
genome-wide study aiming for the identification of pathways affecting telomere-initiated
senescence in yeast has been performed by Chang and co-workers [203]. These briefly
introduced studies represent only a small selection of the huge number of telomere related
screens.
The huge efforts in the field of yeast telomere research have led to many valuable and crucial
insights into telomere structure and homoeostasis. Even though many aspects of the telomere
system and also the DNA damage response are highly conserved throughout the eukaryotic
lineage, ”some critical aspects of both [...] have changed over the course of evolution“ [63].
Hence, all regulatory pathways have to be confirmed for every species separately [63]. Find-
ings from one species can only serve as starting points in another species. This is apparent
from the differences of yeast as a model organism and humans, too. Furthermore, the data
from Ben-Shitrit et al. emphasises the importance of validating the identified (key) players
from large-scale experiments [165,197].
1.6. Scope of this Thesis
Genomic instability is a hallmark of cancer and ageing [26]. A myriad of human syndromes,
neurodegenerative diseases, immunodeficiency, and cancer are associated with defects in
factors sensing and responding to DNA lesions [26–30]. Eukaryotic chromosomal ends are
formed by special structural and functional units termed telomeres. Although they resemble
DNA breaks [49], telomeres neither induce DNA damage repair pathways nor DNA damage
checkpoint responses [50]. The proper maintenance of their homoeostasis and the distinction
between DSBs and telomeres is crucial to preserve genome stability and integrity that are vi-
tal to every cell and organism.
Saccharomyces cerevisiae represents an excellent model organism to study telomere bio-
logy. In baker’s yeast, telomere homoeostasis employs several endemic proteins, but also
a multitude of factors involved in DNA damage response pathways to keep telomeres
at a steady length. The constitutive telomerase expression in yeast resembles the te-
lomerase activity in human proliferative tissue, germ cells [63], and tumour cells. Most
of the latter reactivate telomerase to gain almost unlimited proliferative capacity [52].
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Approximately 7% of the Saccharomyces cerevisiae genome (roughly 400 genes) has
previously been associated with telomere length maintenance. Genes whose respective
deletions have been found to affect telomere length (increased shortening or lengthen-
ing) are termed telomere length maintenance (TLM) genes [183–185, 195, 197]. Based on
these TLM genes, the present thesis aims at understanding the genetic regulation that
affects telomere length maintenance and at suggesting novel drug targets to tackle hu-
man syndromes, diseases, and malignancies. The number of TLM genes and the com-
plexity of telomere homoeostasis reach out for a system-wide exploration of those sig-
nals.
An initial analysis of the TLM gene list for over-represented KEGG pathways [5–7] or func-
tional categories (MIPS FunCat; [8,9]) has revealed a strong enrichment of genes encoding
endosomal sorting complex required for transport (ESCRT) factors within the short tlm
mutants. ESCRT factors define a system of five multi-protein complexes which are involved
in deforming and scissioning cytosol filled membrane stalks. Deletion of certain ESCRT
factors causes defects in chromosomal segregation in yeast [131] and in humans [130], linking
them to genomic stability and integrity. As only little literature exists on the relationship
of telomere homoeostasis and vacuolar sorting, a process that the ESCRT machinery is
involved in, a more in-depth experimental analysis of this association has been performed.
The experimental investigations of VPS27, which has been chosen as representative of
the enriched genes, have showed that upon its deletion telomerase-dependent telomere
elongation is disturbed and that it hampers Exo1-mediated resection, leading to a rescue
of cdc13-1 capping-defective telomeres. In addition to proper elongation of telomeres, their
homoeostasis relies on a functional capping system, especially of the 3’ ssDNA overhang.
The Cdc13-Stn1-Ten1 complex shelters this overhang from Exo1-mediated resection as part
of a DNA damage response that is not desirable at telomeres. Besides being the key player
of this capping complex, Cdc13 is also involved in the recruitment of telomerase during
telomere replication. The experimental data from the present thesis suggest that the whole
ESCRT system is required for proper telomere length maintenance. Furthermore, a protein-
protein-interaction network analysis has found that several protein kinases interlink Cdc13
and Vps27, possibly constituting a feedback loop to regulate telomere homoeostasis via the
ESCRT system. Overall, my observations have led to a model which states that impaired
Exo1-mediated resection results in too little 3’ telomeric overhangs such that Cdc13 binding
is suppressed, preventing either telomerase recruitment or telomeric overhang protection.
Moreover, escrt mutants have exhibited an increased sensitivity to DSBs, indicating that
defects in Exo1-mediated resection can cause improper DNA damage repair in these mutants,
too.
Although ESCRT factors are essential to mammals, they could still serve as new targets to
tackle telomerase reactivation and up-regulation in tumour cells. Knock-down of one or mul-
tiple ESCRT factor(s) could hyper-sensitise cancer cells to DNA damage, which would allow
lowering the dosage and side effects of radio- or chemotherapy. Vps27 represents a potentially
promising drug target belonging to a sub-complex of the ESCRT system whose absence
seems to have less severe consequences for human cells. Neothyonidioside could be a good
starting point for these investigations, as it is a compound reported to mimic the morpho-
logical defects of VPS27 deletion [204] on Cdc13 defective cells. Nevertheless, observations
made in S. cerevisiae generally have to be thoroughly verified when translated to humans or
mammals.
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Blues is to jazz what yeast is to bread — without it, it’s flat.
(Carmen McRae, [205])
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2.1. in silico Analyses
All in silico analyses were based on a list of genes that were previously associated with
telomere length maintenance (TLM genes) [183–185, 195, 197] and performed using the
R environment [206]. A TLM gene is defined as a gene whose corresponding yeast dele-
tion strain has an altered telomere length — either shorter or longer than the wild-type
length of 350 bp [183]. The TLM list contained non-essential genes from screening a
haploid, homozygous yeast deletion strain collection [183, 184] and essential genes from
testing the DAmP (Decreased Abundance by mRNA Pertubation) collection [185]. Te-
lomere length was measured by analysing gDNA from different mutant strains compared
to the wild-type on Southern Blots (separation of DNA fragments by electrophoresis).
Figure 2.1a shows an exemplary Southern Blot for gene deletions leading to telomere
shortening (short tlm mutants) and fig. 2.1b depicts a typical Southern Blot for long tlm
mutants.
(a) Short tlm mutants. (b) Long tlm mutants.
Figure 2.1.: Exemplary Southern Blots of tlm mutants as used in the telomere length maintenance (TLM)
screens [183–185,195,197]. The longer a DNA fragment, the slower it migrates through the agarose gel. Numbers
on the left indicate fragment size in kbp. The blots shown here have been adapted from Gatbonton et al. [184].
The TLM gene list was compiled, cleaned from duplicates and identifier (ID) problems using
R [206]. If required, ID mappings were done with the Bioconductor [207] package for yeast an-
notations (org.Sc.sgd.db [208]). The original categorisation of the telomere length phenotype
into six classes (suppl. table C.3) was summarised into either short or long. Of the final 482
TLM genes, 286 referred to short tlm mutants and 182 to long tlm mutants. Thirteen TLM
genes were not annotated with any telomere phenotype upon deletion and one genes was
annotated with both phenotypes. Table 2.1 gives an overview of the composition of the TLM
gene list.
Table 2.1.: Overview of the composition of the TLM gene list.
tlm Phenotype Non-Essential DAmP
short 234 52
long 139 43
no info 13 0
short/long 1 0
As the overall list of screened genes was not tracked, I derived this list from the mutant
collections themselves. To this end, I downloaded the following data: the data sheet
for (i) the yeast haploid MATa knock-out strain collection (YSC1053) [189], (ii) the
yeast haploid MATα knock-out strain collection (YSC1054) [190], and (iii) the yeast
DAmP haploid strain collection (YSC5090) [175, 191] from Open Biosystems. Based on
the union of these tables and the TLM list, I compiled a list of unique gene IDs repres-
enting the list of genes that were tested in the original TLM screens [183–185, 195, 197].
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This list will be later referred to as the TLM universe (containing 5882 genes). Unfortu-
nately there was no list of genes providing information whether a mutant strain showed
wild-type telomere length or whether the measurement failed for it during the original
screens.
As the strains from the DAmP collection behave very heterogeneously in the sense that
results obtained with these strains are not always biologically reproducible, I decided to use
only the non-essential TLM sublist. Thus, the TLM universe comprised the Mata and Matα
collection (4990 genes). The TLM\DAmP universe contained only 189 short and 126 long tlm
mutants.
2.1.1. Enrichment Analyses
In case of simple contingency table tests, the default two-side Fisher’s Exact test functional-
ity from R [206] was employed. For testing the functional association of two gene sets, I used
an R [206] script written by Dr. Tobias Bauer. This script calculates the Fisher Exact test
based on the default R [206] functionality for two user-defined gene sets. Multiple testing
correction was done applying the false discovery rate (FDR) correction provided by R [206].
Either the KEGG pathway [5–7] annotation (KEGG.db package [209]) or the assignment
of functional categories (FunCat v2.1) from the Munich Information Centre for Protein
Sequences (MIPS) [8,9] as well as the aforementioned TLM\DAmP universe were used for
calculating the enrichments. The MIPS FunCat data was downloaded from the MIPS web-
site [210].
2.1.2. Protein-Protein-Interaction Network
A manually curated Saccharomyces cerevisiae interaction network (NW) was provided
by Christine Brun. The network was compiled analogously to the human protein in-
teraction network prepared by Chapple and colleagues [211]. The interaction network
consisted exclusively of experimentally verified binary PPIs making it a highly reli-
able interaction source. The network contained 5592 vertices connected by 28581 edges.
Christine Brun sent the network as Cytoscape session file from which I exported it as
edge table to import it into the igraph [212] library within R [206]. All network examin-
ations were done using the igraph library while network visualisation was done in Cyto-
scape [213].
2.1.3. Knock-Out Gene Expression Data
In April 2014, the Holstege laboratory released a genome-wide mRNA expression dataset
which was measured in the corresponding haploid deletion strains of one quarter of the
yeast genes (1484 deletion mutants) [179]. They selected genes having “a (putative) role in
regulating gene expression” and “also included characteristics such as nuclear location or
the capacity to modify other proteins” [179]. Deletions strains were classified as responsive
(different from the wild-type) if “at least four transcripts showed robust changes” (fold-
change or FC > 1.7 and p-value or P < 0.05) [179]. The data table for all responsive mutants
was downloaded from the supplementary information (http://deleteome.holstegelab.nl/)
and contained all relevant key quantities for expression data (M ratio and p-values).
The M ratio (FC) was calculated for the comparison of a particular mutant versus the
wild-type while the p-value described the significance of this FC. The downloaded data
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table contained expression data for 700 responsive deletion strains (columns, also re-
ferred to as samples) and a total of 6112 target genes (rows). Duplicated target gene
rows (11 altogether) were united by calculating the mean value per sample and target
gene.
This data set was used to perform a gene set enrichment analysis (GSEA) of differentially
expressed genes and to assess whether there is a change in the expression levels of telomere
related protein encoding genes upon deletion of any ESCRT gene. Twelve of the nineteen
ESCRT factor encoding genes were contained within the samples of this data (fig. 3.24). Data
pre-processing and visualisation was done using R [206].
The gene set enrichment analysis for KEGG pathways [5–7] against a pre-ranked list of
genes was carried out using the GSEA software (default settings) offered by the Broad
Institute of MIT and Harvard [214,215]. Initially, I ranked the target genes in descending
order by the t statistic from a Student’s t-Test for all escrt samples versus the remaining
samples. In addition, I extracted the pathway annotations from the KEGG.db R pack-
age [206, 209] to create a gene set database. Figure 2.2 outlines the idea of this analysis.
Figure 2.2.: Scheme of the GSEA run against a pre-ranked gene list to find significantly changed KEGG pathways.
Student’s t-Test was calculated for all escrt samples versus the remaining samples. Subsequently, the target
genes were ranked in descending order by the t statistic.
To assess the change in expression levels of TRP encoding genes upon deletion of any ESCRT
gene, I extracted a sub-matrix of the M values composed of escrt only columns and TRP
rows. For ease of visualisation, I plotted this matrix using the corrplot package for R [206,216].
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2.2. Experimental Analyses
All experimental analyses were performed by myself in the former laboratory of Dr. Brian Luke
at the Zentrum für Molekulare Biologie (ZMBH) of the Heidelberg University.
2.2.1. Materials
Standard chemicals for usual media and solutions were ordered from AppliChem GmbH or
Sigma-Aldrich Co. LLC. Source of supply of any further material is indicated in the following
sections.
2.2.1.1. Yeast Strains
Most of the yeast strains used in this study were derivatives from the BY4741 background (his3∆1, leu2∆0,
ura3∆0, met15∆0). Haploid strains were derived from the listed diploids. Experiment identifiers correspond to
the mapping listed in suppl. table C.1.
Code Genotype Experiment ID
yAM223 MATa vps27∆::KAN B, O
yAM224 MATα vps27∆::KAN D
yAM225 MATa/MATα EST2/est2∆::HIS VPS27/vps27∆::KAN H, I, K
yAM229 MATa CDC13::cdc13-1 HIS vps27∆::KAN T
yAM234 MATα CDC13::cdc13-1 HIS vps27∆::KAN E, L, M, O, P
yAM235 MATa EXO1-TAP (HIS) vps27∆::KAN X
yAM269 MATa/MATα HSC82/hsc82∆::KAN CDC13/CDC13::cdc13-1 HIS T
yAM270 MATa/MATα CDC13-TAP (HIS) VPS27/vps27∆::KAN T, U
yAM274 MATa stp22∆::KAN B
yAM275 MATa vps28∆::KAN B
yAM278 MATa snf8∆::KAN B
yAM282 MATa snf7∆::KAN B
yAM285 MATa did2∆::KAN B
yAM290 MATa bro1∆::KAN B
yAM297 MATα vps27∆::NAT X
yAM325 MATa/MATα SAE2-TAP (HIS) VPS27/vps27∆::KAN X
yAM326 MATa/MATα RAD52/rad52∆::KAN VPS27/vps27::HIS C
yAM329 MATa/MATα ATG5/atg5∆::NAT CDC13/CDC13::cdc13-1 HIS
VPS27/vps27∆::KAN
K
yAM342 MATa CDC13::cdc13-1 HIS exo1∆::ura vps27∆::KAN M
yAM346 MATa exo1∆::ura CDC13::cdc13-1 HIS M
yAM382 MATα EXO1-GFP (HIS) G
yAM386 MATa/MATα CDC13/CDC13::cdc13-1 KAN VPS27/vps27∆::NAT
EXO1-TAP (HIS)
W
yAM387 MATa CDC13::cdc13-1 KAN vps27∆::NAT EXO1-TAP (HIS) V
yAM392 MATa CDC13::cdc13-1 KAN vps27∆::NAT EXO1-GFP (HIS) G
yAM394 MATa CDC13::cdc13-1 KAN EXO1-GFP (HIS) G
yAM396 MATa vps27∆::NAT EXO1-GFP (HIS) G
yAM441 MATa/MATα STN1/STN1::stn1-13 KAN VPS27/vps27∆::NAT R
yAM443 MATa/MATα CDC13/CDC13::cdc13-1 HIS HSE1/hse1∆::KAN L
yAM444 MATa/MATα CDC13/CDC13::cdc13-1 HIS STP22/stp22∆::KAN L
yAM445 MATa/MATα CDC13/CDC13::cdc13-1 HIS VPS28/vps28∆::KAN L
yAM446 MATa/MATα CDC13/CDC13::cdc13-1 HIS SRN2/srn2∆::KAN L
yAM447 MATa/MATα CDC13/CDC13::cdc13-1 HIS VPS4/vps4∆::KAN L
yAM448 MATa/MATα CDC13/CDC13::cdc13-1 HIS VTA1/vta1∆::KAN L
yAM449 MATa/MATα CDC13/CDC13::cdc13-1 HIS MVB12/mvb12∆::KAN L
yAM450 MATa/MATα CDC13/CDC13::cdc13-1 HIS SNF8/snf8∆::KAN L
yAM451 MATa/MATα CDC13/CDC13::cdc13-1 HIS VPS25/vps25∆::KAN L
Continued on next page.
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Continued from previous page.
Code Genotype Experiment
yAM452 MATa/MATα CDC13/CDC13::cdc13-1 HIS VPS36/vps36∆::KAN L
yAM453 MATa/MATα CDC13/CDC13::cdc13-1 HIS VPS20/vps20∆::KAN L
yAM454 MATa/MATα CDC13/CDC13::cdc13-1 HIS SNF7/snf7∆::KAN L
yAM455 MATa/MATα CDC13/CDC13::cdc13-1 HIS VPS24/vps24∆::KAN L
yAM456 MATa/MATα CDC13/CDC13::cdc13-1 HIS VPS2/vps2∆::KAN L
yAM457 MATa/MATα CDC13/CDC13::cdc13-1 HIS DID2/did2∆::KAN L
yAM458 MATa/MATα CDC13/CDC13::cdc13-1 HIS VPS60/vps60∆::KAN L
yAM459 MATa/MATα CDC13/CDC13::cdc13-1 HIS IST1/ist1∆::KAN L
yAM460 MATa/MATα CDC13/CDC13::cdc13-1 HIS BRO1/bro1∆::KAN L
yAM461 MATa/MATα SAE2/sae2::HIS STN1/STN1::stn1-13 KAN
VPS27/vps27∆::NAT
Q
yAM544 MATa/MATα CDC13/CDC13::cdc13-1 HIS RAD53/RAD53::rad53-11
URA VPS27/vps27∆::KAN
N
yAM552 MATa/MATα ARC15/ARC15::arc15-0 KAN VPS27/vps27∆::NAT S
yAM556 MATa/MATα ARP7/ARP7::arp7-E411K KAN VPS27/vps27∆::NAT S
yAM559 MATa/MATα GFA1/GFA1::gfa1-97 KAN VPS27/vps27∆::NAT S
yBL7 MATa B, M, O, Y
yBL679 MATα D, P
yJK162 MATa EXO1-TAP (HIS) X
yJK199 MATα CDC13::cdc13-1 HIS E, M, O, P
yJK244 MATa CDC13::cdc13-1 KAN EXO1-TAP (HIS) V
ySLG60 MATα rad9∆::KAN T
ySLG70 MATα CDC13::cdc13-1 KAN rad9∆::KAN T
Yeast strains used for the DSB-repair experiments (ID A and F, suppl. table C.1) were derivatives from either
JKM139 (MATa) or YKM179 (MATα) having the following background hml∆::ADE1 hmr∆::ADE1 ade1-100
leu2-3,112 lys5 trp1::hisG ade3::GAL-HO [217].
Code Genotype Experiment ID
yAM433 MATa vps27::KAN F
yAM436 MATa vps27::KAN F
yAM437 MATa vps27::KAN F
yBL317 MATα MATinc-URA3 ura3-52 A
yBL319 MATα ura3-52 A
yBL320 MATα A
2.2.1.2. Plasmids
Code Name Genotype Source
pBL211 empty vector pRS425 GAL, LEU2 Matthias Peter
pSLG44 Exo1-OE pBL211-EXO1, LEU2 Bradley Johnson
2.2.1.3. Oligonucleotides
Code Name Sequence Experiment
oBL29 KAN/NAT reverse CTGCAGCGAGGAGCCGTAAT A, F
oBL207 telomeric repeat CACCACACCCACACACCACACCCACA E
oBL358 1L forward GCGGTACCAGGGTTAGATTAGGGCTG H, J
oBL359 oligo dG CGGGATCCG18 H, J, Y
oBL361 6Y’ forward TTAGGGCTATGTAGAAGTGCTG H, J, Y
oJK73 VPS27 forward AGTTAGCACGCGCATATCCA A, F
oJK74 VPS27 reverse AGAACAAGAGCTGGACGGTG A, F
oJK75 VPS27 forward CCTGTGGTATGTTTTGAAGGGC A, F
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2.2.1.4. Yeast Media and Plates
plates (1 l) YPD +KAN +NAT +HYG
YPD Agar 65 g 65 g 65 g 65 g
dd H2O 1 l 1 l 1 l 1 l
Autoclave: 20min, 121 ◦C
KAN (G418, 50mg/ml; f.c. 250 µg/ml) — 5ml — —
NAT (100mg/ml; f.c. 100 µg/ml) — — 1ml —
HYG (100mg/ml; f.c. 300 µg/ml) — — — 3ml
liquid or plates (1 l) YPGal/Raf
Bacto Pepton 20 g
Yeast extract 10 g
Raffinose x 5 H2O (f.c. 1%) 11.8 g
dd H2O 900ml
for solid medium + Agar 20 g
Autoclave: 20min, 121 ◦C
20% Galactose (f.c. 2%) 100ml
plates (60ml) YPD+zeocin(f.c. 5 µg/ml)
YPD+zeocin
(f.c. 10 µg/ml)
YPD+zeocin
(f.c. 15 µg/ml)
YPD Agar 3.9 g 3.9 g 3.9 g
dd H2O 60ml 60ml 60ml
Autoclave: 20min, 121 ◦C
Zeocin (100mg/ml) 3 µl 6 µl 9 µl
liquid or plates (1 l) SC +KAN
Yeast Synthetic Dropout Medium Supplement w/o AAs 1.92 g 1.92 g
Yeast Nitrogen Base w/o AAs 6.7 g 6.7 g
for solid medium + Agar 24 g 24 g
100x AAs 10ml 10ml
dd H2O 950ml 950ml
Autoclave: 20min, 121 ◦C
50% Glucose (f.c. 2%) 40ml 40ml
KAN (G418) 50mg/ml (f.c. 250 µg/ml) — 5ml
liquid or plates (1 l) SC−AA +KAN
Yeast Synthetic Dropout Medium Supplement w/o AAs 1.92 g 1.92 g
Yeast Nitrogen Base w/o AAs 6.7 g 1.7 g
Monosodium Glutamate — 1.0 g
for solid medium + Agar 24 g 20 g
dd H2O 960ml 960ml
Autoclave: 20min, 121 ◦C
50% Glucose (f.c. 2%) 40ml 40ml
KAN (G418) 50mg/ml (f.c. 250 µg/ml) — 5ml
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liquid or plates (1 l) SC−2 AA
Yeast Synthetic Dropout Medium Supplement w/o AAs 1.92 g
Yeast Nitrogen Base w/o AAs 6.7 g
for solid medium + Agar 24 g
100x/50x first AAs 10ml/20ml
100x second AAs 10ml
dd H2O 940ml/930ml
Autoclave: 20min, 121 ◦C
50% Glucose (f.c. 2%) 40ml
liquid or plates (1 l) SD
Yeast Nitrogen Base w/o AAs 6.7 g
for solid medium + Agar 24 g
dd H2O 960ml
Autoclave: 20min, 121 ◦C
50% Glucose (f.c. 2%) 40ml
liquid or plates (1 l) SGal/Raf complete SGal/Raf−AA
Yeast Synthetic Dropout Medium
Supplement w/o AAs
1.92 g 1.92 g
Yeast Nitrogen Base w/o AAs 6.7 g 6.7 g
Raffinose x 5 H2O (f.c. 1%) 11.8 g 11.8 g
for solid medium + Agar 20 g 20 g
100x AAs 10ml —
dd H2O 890ml 900ml
Autoclave: 20min, 121 ◦C
20% Galactose (f.c. 2%) 100ml 100ml
plates (1 l) Pre-Sporulation
Standard nutrient broth 30 g
Yeast extract 10 g
Agar 20 g
dd H2O 900ml
Autoclave: 20min, 121 ◦C
50% Glucose 100ml
liquid medium (100ml) Sporulation Medium
Potassium acetate 1 g
Zinc acetate 5mg/ml 1ml
dd H2O 100ml
Autoclave: 20min, 121 ◦C
plates (5 l) LB ampicillin
LB Agar 200 g
dd H2O 5 l
Autoclave: 20min, 121 ◦C
Ampicillin 100 µg/ml
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liquid medium (500ml) 2x YT + carb Medium
2x YT medium 500ml
Carbenicillin disodium salt (100mg/ml) 500 µl
2.2.1.5. Stock Solutions and Buffers
10x TBE (1 l)
Tris base 108 g
Boric Acid 55 g
EDTA (0.5M, set to pH 8.0 with NaOH) 20ml
dd H2O 1 l
Autoclave: 20min, 121 ◦C
10x PBS (1 l)
NaCl 80 g
KCl 2 g
Na2HPO4 – 7x H2O 26.8 g
KH2PO4 2.4 g
Adjust to pH 7.4 with HCl
dd H2O 1 l
Autoclave: 20min, 121 ◦C
1x PBS + 0.1% Tween 20 (1 l)
10x PBS 100ml
dd H2O 900ml
Tween 20 1ml
SDS (200ml) 10% SDS 20% SDS
SDS 20 g 40 g
dd H2O (sterile) 200ml 200ml
Sterilise: millipore filter 0.22 µm
Solution 1 (20ml)
10M NaOH (f.c. 1.85M) 3.7ml
14.34M β-mercaptoethanol (f.c. 1.09M) 1.52ml
dd H2O 14.78ml
Solution 2 (20ml)
100% TCA (f.c. 50%) 10ml
dd H2O 10ml
Solution 3 (20ml)
100% Acetone 20ml
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10x Running buffer (1 l)
Tris base 30 g
Glycin 144 g
SDS 10 g
dd H2O 1 l
1x Running buffer (1 l)
10x running buffer 100ml
dd H2O 900ml
Urea loading buffer (10ml)
1M Tris-HCl (pH 6.8; f.c. 120mM) 1.2ml
70% Glycerol (f.c. 5%) 714 µl
Urea (f.c. 8M) 4.8 g
14.3M β-mercaptoethanol (f.c. 143mM) 100 µl
20% SDS (8%) 4ml
dd H2O 4ml
Add bromophenol blue to color the buffer
0.2M NaOH (5ml)
2M NaOH 0.5ml
dd H2O 4.5ml
20x SSC (1 l)
NaCl 175.3 g
Sodium citrate 88.2 g
Adjust to pH 7.0 with HCl
dd H2O 1 l
Autoclave: 20min, 110 ◦C
SSC (1 l) + 0.1% SDS
2x 2x 0.5x 0.2x
20x SDS 100ml 100ml 25ml 10ml
10% SDS — 10ml 10ml 10ml
dd H2O 900ml 890ml 965ml 980ml
PIPES 1M pH 6.4 (100ml)
PIPES (f.c. 1M) 30.2 g
dd H2O 100ml
Adjust to pH 6.4 with NaOH
Autoclave: 20min, 121 ◦C
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Hybridisation solution (100ml)
Formamide 50ml
20x SSC 25ml
50x Denhardt’s solution 10ml
0.5M EDTA 1ml
PIPES (1M pH 6.4) 1ml
Yeast RNA (heat to 65 ◦C, filter sterilise) 40mg in 3ml H2O
10% SDS 10ml
Sterilise: heat to 65 ◦C, use millipore filter 0.22 µm
TMAC buffer (1 l)
TMAC (f.c. 3M) 328.8 g
1M Tris-HCl (pH 8.0; f.c. 50mM) 50ml
0.5M EDTA (pH 8.0; f.c. 0.1mM) 200 µl
dd H2O 950ml
Maleic acid buffer (1 l)
Maleic acid (f.c. 0.1M) 11.67 g
Adjust to pH 7.5 with NaOH
NaCl (f.c. 0.15M) 8.76 g
dd H2O 1 l
Autoclave: 20min, 121 ◦C
10x Blocking solution (100ml)
Blocking solution powder 10 g
Maleic acid buffer 100ml
Heat on thermoblock while mixing; aliquot & store at −20 ◦C
1x Blocking solution (40ml)
10x Blocking solution 4ml
Maleic acid buffer 36ml
5x DIG wash buffer (1 l)
Maleic acid (f.c. 0.5M) 58 g
Adjust to pH 7.5 with NaOH
NaCl (f.c. 0.75M) 43.8 g
Tween 20 (f.c. 1.5%) 15ml
dd H2O 1 l
Autoclave: 20min, 121 ◦C
1x DIG wash buffer (1 l)
5x DIG wash buffer 200ml
dd H2O 800ml
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DIG detection buffer (1 l)
Tris base (f.c. 0.1M) 12.1 g
NaCl (f.c. 0.1M) 5.8 g
dd H2O 1 l
Adjust to pH 9.5 with HCl
Autoclave: 20min, 121 ◦C
10x TE (4 l)
TRIS (1M, set to pH 7.5 with HCl; f.c. 0.1M) 400ml
EDTA (0.5M, set to pH 8.0 with NaOH, autoclaved; f.c. 10mM) 80ml
dd H2O 4 l
Autoclave: 20min, 121 ◦C
LiAc Mix (100ml)
1M LiAc (sterile; f.c. 0.1M) 10ml
10x TE (sterile; f.c. 1x) 10ml
dd H2O (sterile) 80ml
PEG Mix (100ml)
Polyethylene glycol 4000 40 g
LiAx mix (sterile) 100ml
Autoclave: 20min, 121 ◦C
10x Telomere PCR Buffer (10ml)
Tris base (f.c. 670mM) 810mg
(NH4)2SO4 (f.c. 160mM) 211mg
70% Glycerol (f.c. 50%) 7.1ml
Tween-20 (f.c. 0.1%) 10 µl
mq H2O 2.9ml
Adjust to pH 8.8 with 37% HCl approx. 125 µl
Store 1ml aliquots at −20 ◦C
Zeocin stock solution (100mg/ml)
Aliquot and store at −20 ◦C in the dark
2.2.1.6. Other Materials
Enzyme Source Item No.
Exonuclease (E. coli) New England Biolabs GmbH M0293L
Phusion® HF 2x Master Mix New England Biolabs GmbH M0536S
Phusion® Hot Start Flex DNA Polymerase New England Biolabs GmbH M0535L
Proteinase K QIAGEN GmbH 19131
Q5® HF DNA Polymerase New England Biolabs GmbH M0491S
Taq 2x Master Mix New England Biolabs GmbH M0270L
Terminal transferase New England Biolabs GmbH M0315L
Lyticase (zymolyase yeast lytic enzyme) Sigma-Aldrich Co. LLC L4025
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Kit Source
DIG Oligonucleotide 3’ End Labeling Kit, 2nd generation Roche Diagnostics GmbH
Gentra Puregene Yeast/Bact. Kit (200ml) QIAGEN GmbH
QIAprep® Spin Miniprep Kit QIAGEN GmbH
QIAquick® PCR Purification Kit (250) QIAGEN GmbH
Ladder Source Item No.
Broad range protein ladder New England Biolabs GmbH P7708L
100 bp DNA ladder New England Biolabs GmbH N3231L
1 kbp DNA ladder New England Biolabs GmbH N3232L
Primary Antibody Source Item No. Host Dilution
α-Actin Merck Millipore, Merck KGaA MAB1501 Mouse 1:1000
α-PAP Sigma-Aldrich Co. LLC P1291 Rabbit 1:3000
α-PAP Sigma-Aldrich Co. LLC P1291 Rabbit 1:6000
α-Pgk1 Life Technologies GmbH 22C5D8 Mouse 1:20000
α-Pgk1 Gift from Michael Knop — Mouse 1:25000
AP-coupled α-DIG Fab Roche Diagnostics GmbH 11093274910 Sheep 1:5000
Secondary Antibody Source Item No. with 1st Dilution
α-mouse-HRP Bio-Rad Laboratories GmbH 1705047 Actin 1:3000
α-mouse-HRP Bio-Rad Laboratories GmbH 1705047 Pgk1 1:15000
α-mouse IRDye® 680RD LI-COR Biosciences GmbH 926-68070 Pgk1 (Knop) 1:10000
α-rabbit IRDye® 800CW LI-COR Biosciences GmbH 926-32211 PAP 1:10000
Additional Material Source
β-mercaptoethanol Fluka
4–15% Mini/Midi-PROTEAN® TGX™ Precast Protein Gels Bio-Rad Laboratories GmbH
50x Denhardt’s solution AppliChem GmbH
6x LB buffer New England Biolabs GmbH
Agarose AppliChem GmbH
Amersham Hybond-N+ (Dot Blot membrane) GE Healthcare Europe GmbH
Blocking solution powder Roche Diagnostics GmbH
Bromophenol blue indicator Sigma-Aldrich Co. LLC
Cycloheximide (CHX) Sigma-Aldrich Co. LLC
CPD-Star Roche Diagnostics GmbH
Dimethyl sulfoxide (DMSO) Sigma-Aldrich Co. LLC
dNTPs New England Biolabs GmbH
Ethanol Sigma-Aldrich Co. LLC
Exonuclease I Reaction Buffer New England Biolabs GmbH
G418 (kanamycin) AppliChem GmbH
Glycin Sigma-Aldrich Co. LLC
NAT (nourseothricin) WERNER BioAgents GmbH
NEBuffer 4 New England Biolabs GmbH
Ponceau S solution Sigma-Aldrich Co. LLC
RedSafe Nucleic Staining Acid Solution iNtRO Biotechnology
SDS Fluka
SuperSignal™ West Pico Chemiluminescent Substrate Thermo Firsher Scientific Inc.
TCA Sigma-Aldrich Co. LLC
Trans-Blot® Turbo™ Mini/Midi Nitrocellulose Transfer Packs Bio-Rad Laboratories GmbH
Tween 20 Sigma-Aldrich Co. LLC
Yeastmaker™ Carrier DNA Clontech Laboratories Inc.
Zeocin (phleomycin D1) Invitrogen™ Life Technologies
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2.2.1.7. Electronic Devices and Software
Electronic device Source
Astacus LifeScience (dd H2O machine) MembraPure GmbH
Bio-Dot Microfiltration Apparatus (dot blot) Bio-Rad Laboratories GmbH
C1000 Touch™ Thermal Cycler Bio-Rad Laboratories GmbH
Centrifuge 5430R Eppendorf AG
Centrifuge 5417R Eppendorf AG
Centrifuge Heraeus Pico 17 Thermo Fisher Scientific Inc.
Centrifuge MCF-2360 neoLab Migge Laborbedarf-Vertriebs GmbH
Dissection Microscope MSM manual Singer Instruments
DNA Gel chambers Feinmechanische Werkstatt, ZMBH, Heidelberg Uni-
versity
Hybridisation oven MS incubator UniEquip Laborgerätebau- und Vertriebs GmbH
LAS-4000 Fujifilm Life Science
Mini-PROTEAN® Tetra Cell Bio-Rad Laboratories GmbH
MIR-154 cooled incubator SANYO E&E Europe BV
Multishaker (e.g.WB-wash) neoLab Migge Laborbedarf-Vertriebs GmbH
Multitron Standard incubation shakers Infors AG
NanoDrop 2000c Thermo Fisher Scientific Inc.
Odyssey® Infrared Imaging System LI-COR Biosciences GmbH
PowerPac™ Basic Power Supply Bio-Rad Laboratories GmbH
PowerPac™ HC High-Current Power Supply Bio-Rad Laboratories GmbH
Rotator MBT-TTR79 (“wheel”) neoLab Migge Laborbedarf-Vertriebs GmbH
Spectrophotometer Ultrospec 2100 pro GE Healthcare Europe GmbH
Stratalinker® UV Crosslinker 2400 Stragagene
Superflake ice machine MF41 Scotsman Ice Systems
Thermoblock (item No. 2-2504) neoLab Migge Laborbedarf-Vertriebs GmbH
Thermomixer F1.5 Eppendorf AG
Trans-Blot® Turbo™ Bio-Rad Laboratories GmbH
Vortex Mixer (7-2020) neoLab Migge Laborbedarf-Vertriebs GmbH
Zeiss Axio Observer.Z1 microscope Carl Zeiss AG
Software Source
ChemDraw Professional 15 Suite (free trial) PerkinElmer Informatics
Cytoscape (v3.2.1) cytoscape.org [213]
DotBlotAnalyzer image.bio.methods.free.fr/dotblot.html
Excel 2010 Microsoft Corporation
Fiji Is Just ImageJ (v1.49g) fiji.sc
FileMaker Pro 10 FileMaker Inc.
GSEA software (v2.2.1.0) Broad Institute of MIT & Harvard [214,215]
GIMP (v2.8.10) gimp.org
ImageStudio™ (v4.0) LI-COR Biosciences GmbH
Inkscape (v0.48) inkscape.org
JabRef (v2.10b2) jabref.sourceforge.net
Kile (v2.1.3) kile.sourceforge.net
LATEX (TEXLive 2013) tug.org/texlive
Multi Gauge (v3.2) Fujifilm Life Science
R (v3.2.1) r-project.org [206]
Word 2010 Microsoft
All schematic drawings and figure annotations were prepared using Inkscape.
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2.2.2. Methods
The following sections give detailed information about the experimental procedures I
applied in the present thesis. All procedures comply to the protocols used in the laboratory
of Dr. Brian Luke and as described before [218–221]. Section 2.1 provides the details about the
in silico analyses I performed.
2.2.2.1. Yeast Preparatory Workflow
Preceding any experiment described below, the required yeast strains had to be prepared.
If a particular strain did not already exist in the laboratory-own yeast stock, it either
had to be obtained from mutant collections (single mutants) or had to be established by
crossing suitable haploid strains carrying the desired mutations. In case of single (non-
essential) gene deletions (e.g. any ESCRT deletion), haploid strains can be received from
e.g. the EUROSCARF BY4741 deletion strain collection [174]. Essential genes (e.g. CDC13 )
can be investigated by utilising temperature-sensitive alleles [176]. If available, required
mutants were thawed in a single-colony streak-out from the corresponding −80 ◦C stock
and incubated at appropriate temperature. The permissive temperature of temperature-
sensitive strains used in this study was 23–25 ◦C which was used for routine incubations
whereas all other strains were standard incubated at 30 ◦C. Unless specified otherwise,
strains were grown on or in standard yeast extract peptone dextrose (YPD) complete me-
dium.
Figure 2.3 depicts a schematic overview of the general workflow for creating a yeast
mutant strain from crossing two haploid strains harbouring mutations that should be
combined into one strain. This workflow will be exemplified for crossing two haploid
single mutants leading to one double mutant strain. However, it is basically possible
to generate mutants of any number of mutations depending on the underlying haploid
strains.
Initially, two different haploid strains with distinct mating types and markers (e.g. KAN
or NAT) are crossed by mixing corresponding single colonies on YPD plates. Assume the
mutant yfg∆A::KAN (yfg, your favourite gene) carries the deletion of gene A and has mat-
ing type MATa while yfg∆B::NAT has mating type MATα and gene B is deleted. Crossing
both strains would result in a yfg∆A::KAN yfg∆B::NAT double mutant. After incubation
for at least four hours or overnight, the colony is partly streaked out for single colonies on
double-selective (KAN and NAT) media to select for diploid (MATa/MATα) cells. Typically,
single colonies require 2-3 days to grow to sufficient size to proceed with sporulation. Single
colonies are patched on pre-sporulation medium plates overnight and the patches are partly
dissolved in sporulation medium (2ml) the next day. The cultures sporulate at 23 ◦C for
3–5 d. Upon sporulation yeast cells enter sexual reproduction, undergo meiosis, and form
asci containing haploid ascospores (fig. 1.23). Sporulated cultures contain asci with differing
numbers of spores as well as unsporulated vegetative cells [194]. To derive the desired
mutant, tetrads (asci with four spores) have to be identified and each ascospore has to be
relocated to a separate position on a YPD plate to allow forming isolated spore colonies.
10 µl of sporulation culture is mixed with 10 µl of Zymolyase and incubated for 10–15min
to digest the ascus wall. Subsequently, 10–15µl of this culture is applied in one straight line
to a YPD plate. Tetrads are divided by micromanipulation and dissection as described by
Fred Sherman [222]. Dissection will result in a matrix of single spore colonies, in which each
column contains the four ascospores of an individual ascus. Once the spore colonies have
grown to sufficient size (after approximately 2 d), the dissection plate is replica plated onto
different plates carrying the markers matching the used haploids. From the evaluation of
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these plates (after 2–3 d of growth), the genotypes of the individual spore colonies are derived.
Figure 2.3.: General preparatory workflow to derive mutants from crossing haploid strains. Depicted are the four
basic building blocks for deriving a new mutant. Numbers in parentheses represent the amount of incubation
days required for a particular step. Initially, two haploid strains of different mating types and carrying the desired
genotypes or tags that shall be combined are crossed. Diploid selection on double selective plates allows growth
only for diploids which are induced to sporulate and thus undergo meiosis. The four haploid ascospores of one
ascus or tetrads are divided by micromanipulation and dissection. As soon as the dissected ascospore colonies
have grown to sufficient size, they are replica plated on the corresponding selective plates whose evaluation
allows the genotype assignment to the individual spore colonies. The visualisation for tetrad dissection has been
adapted from Sherman [194]. An enlarged version of the figure can be found in the supplement (fig. B.3).
Finally, experiments can be initiated from single colonies, spore colonies from dissection
plates, or patches of those.
2.2.2.2. Transformation of Yeast
Competent Cells overnight (ON) cultures were diluted in 25ml of appropriate medium
to a final concentration (f.c.) of OD600 0.15 and incubated at appropriate temperature
until exponential growth phase was reached (OD600=0.4 – 0.8). Cultures were pelleted
at 3000 rpm for 5min at RT, the supernatant was thrown and cells were resuspended
in 5ml of LiAc mix. Subsequent to repeated centrifugation, cultures were resuspended
in 250 µl of LiAc mix (100 µl of LiAc mix per 10ml culture) again. For the storage of
competent yeast cells, aliquots of 93µl of cell suspension and 7 µl of DMSO were frozen at
−80 ◦C.
Transformation 100 µl of competent cell suspension (one aliquot) was used for transform-
ation with 150 ng of plasmid or 1–2 µg of DNA or PCR product for integration. Following
the addition of 10 µl of yeastmaker carrier DNA, 700 µl of PEG mix was added and cells
were incubated for 30min at RT cycling on a rotator. Cells were heat-shocked at 42 ◦C
for 15min and pelleted at 3000 rpm for 5min at RT. After resuspension in 300 µl of YPD
medium, cells were incubated at appropriate temperature for 30min in case of plasmid
uptake or for 3–4 h for DNA/PCR product integration. Finally, cells were spread on
appropriate selective media plates using sterile glass beads and incubation was contin-
ued.
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2.2.2.3. Genomic DNA Extraction
Genomic DNA was purified on ice from 2ml of an ON culture using the Gentra Puregene
Yeast/Bact. Kit from QIAGEN. All centrifugation steps were performed at 13 000 rpm and
thermoblocks were used for incubation at 37 ◦C and 65 ◦C. After the addition of Lytic En-
zyme Solution (step 6 of the corresponding protocol from QIAGEN), samples were incubated
for 45min instead of 30min at 37 ◦C to improve cell lysis. Purified DNA samples were stored
at 4 ◦C for few days or at−20 ◦C for prolonged storage.
2.2.2.4. Amplification of vps27 ::KAN Cassette
The vps27 ::KAN cassette was amplified by PCR (1.5 µl of 100 ng/µl of DNA from yAM223
and 48.5µl of PCR master mix) while the master mix (8 reactions) contained 148 µl of
mq H2O, 200 µl of Phusion HF 2x MM, 20 µl of forward primer (oJK73), and 20µl of
reverse primer (oJK74). The PCR program was as follows: 98 ◦C for 30 s (initial tem-
perature), 34 cycles of 98 ◦C for 10 s, 64 ◦C for 30 s, 72 ◦C for 60 s, followed by final
extension at 72 ◦C for 10min and holding at 12 ◦C. PCR product correctness was con-
firmed on a 1.2% agarose gel (0.005% Red Safe, 100V for 35min). The PCR product
was purified using the QIAquick PCR Purification Kit from QIAGEN and stored at
−20 ◦C.
2.2.2.5. Telomere Length Measurement – Telomere PCR
All reactions were performed using a Bio-Rad thermal cycler. 150 ng DNA in 10 µl of
1x NEBuffer (1.5 µl of 100 ng/µl DNA, 0.9 µl of NEBuffer 4, and 6.6 µl of mq H2O) was
denatured at 96 ◦C for 10min and cooled down to 4 ◦C. For the C-tailing reaction, 1 µl
of tailing mix was added and samples were incubated at 37 ◦C for 30min, at 65 ◦C for
10min, and at 96 ◦C for 5min. Per 10µl reaction, the tailing mix contained 0.2 µl of
terminal transferase at 20U/µl, 0.1 µl of 10x NEBuffer 4, 0.1 µl of 10mM dCTPs, and
0.6µl of mq H2O. After cool-down to 65 ◦C, PCR-cycling was initiated by the addition
of 30 µl (3x the reaction volume) of pre-heated PCR-mix. Per reaction, the PCR-mix
contained 0.5µl of Q5 HF or Phusion Hot Start DNA polymerase, 0.3 µl of oligo-dG
reverse primer (oBL359), 0.3 µl of telomere-specific forward primer (6Y’, oBL361 or 1L,
oBL358), 4 µl of 2mM dNTPs, 4 µl of 10x PCR buffer, 21 µl of mq H2O. PCR-cycling:
3min at 95 ◦C followed by 45 cycles of 95 ◦C for 30 s, 63 ◦C for 15 s, 68 ◦C for 20 s. Fol-
lowing additional 5min at 68 ◦C, cool-down to 4 ◦C for holding. Samples were separated
using an 1.8% agarose gel (0.005% Red Safe) at 100V. Depending on the gel size, it
was run for 30min (50ml; 6 cm× 9 cm, W×L) or for 2.5 h (150ml; 12 cm× 14 cm, W×L).
After signal detection (LAS-4000), telomere length was quantified using Multi Gauge.
Fragment separation on a larger gel allowed more precise band quantification. The te-
lomere PCR product was stored at 4 ◦C (short-term storage) or −20 ◦C (long-term stor-
age).
2.2.2.6. Senescence Curve
Spore colonies derived from diploid dissection were dissolved in 500 µl of dd H2O. Cultures
were diluted in 5ml of YPD medium to a f.c. of OD600 0.01 and incubated at 30 ◦C for 24 h.
Using a spectrophotometer, cell density was measured and cells were re-diluted in 5ml of
YPD medium to a f.c. of OD600 0.01. Cultures were re-diluted and incubated in this way for
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eight days. Every 24 h cell samples were taken, pelleted and stored at −20 ◦C. Population
doublings (PDs) were calculated as log2(OD24 h600 /0.01). All PD values base on PDs after the
spore colony had grown to saturation on the dissection plate and had been diluted in water
(about 25 generations).
Rate of Telomere Shortening Genomic DNA was prepared from cell pellets of the indic-
ated days (section 2.2.2.3) and used to run telomere PCR (section 2.2.2.5) to infer the rate of
telomere shortening during senescence.
2.2.2.7. Viability Spotting
Unless specified otherwise, cells were spotted onto standard YPD plates, 1:10 serially
diluted in dd H2O, and incubated at 30 ◦C. Initial cell concentration was OD600 0.5. Im-
ages were taken after 2–3 d of growth. For testing the sensitivity to DNA damage, YPD
plates containing zeocin (phleomycin D1) with f.c. of 5 µg/ml, 10 µg/ml, or 15µg/ml were
used.
UP-DOWN Assay The UP-DOWN protocol was adapted from Addinall et al. [200]. Tem-
perature oscillation was performed in a pre-heated (23 ◦C) programmable Sanyo incubator.
Controls were incubated at 23 ◦C.
2.2.2.8. Measurement of Telomeric ssDNA – Dot Blot Assay
ON cultures were diluted in 40ml of YPD medium to a f.c. of OD600 0.2 and incubated
at 23 ◦C until exponential growth phase was reached. Culture volumes corresponding to
10 OD600 units were spun-down by centrifugation at 3000 rpm for 4min (control samples).
Remaining cultures were heat-shocked at 30 ◦C by addition of pre-warmed (44 ◦C) YPD
medium and incubation for one hour at 30 ◦C. Again, culture volumes corresponding to
10 OD600 units were pelleted (telomere capping-defective samples). DNA was purified for all
samples as described in section 2.2.2.3.
All steps involving incubation at 47.5 ◦C were performed in a pre-heated hybridisation
oven. DNA samples were kept on ice in all steps. Per sample, 8 µg of DNA was diges-
ted by E. coli Exonuclease 1 (2 µl of Exo1, 5 µl of Exo1 buffer, and mq H2O to 50µl
total volume) for 2 h at 37 ◦C (digested samples). Further, 1 µg of DNA was diluted
in 100 µl of 0.2M NaOH and denatured for 15min at 65 ◦C (denatured samples). For
native samples, 8 µg of DNA was diluted in 400 µl of 2x SSC which was also added to
digested and denatured samples to a final volume of 400 µl. All samples were spotted
in duplicates (190 µl each) onto a positively charged nylon membrane (GE Healthcare
Amersham Hybond-N+, rinsed in 2x SSC) using a Bio-Dot Microfiltration Apparatus.
The membrane was washed thrice in TMAC and once in 2x SSC (1min per wash). Sub-
sequent to crosslinking (Stratalinker UV Crosslinker 2400 with auto setting), the membrane
was rinsed in 2x SSC and incubated in 10ml of pre-warmed hybridisation solution for
30–60min at 47.5 ◦C. Afterwards, the hybridisation solution was replaced by a DIG-
labelled telomeric CA probe (oBL207, denatured for 5min at 95 ◦C) diluted in 1–2ml
pre-warmed hybridisation solution. The membrane was incubated overnight rotating at
47.5 ◦C.
Washing solutions were pre-heated at 47.5 ◦C. The membrane was washed twice for 5min
in 25ml of 2x SSC + 0.1% SDS and twice for 20min in 25ml of 0.5x SSC + 0.1%
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SSC at 47.5 ◦C. All following steps were performed at RT. Subsequent to rinsing in
1x DIG wash buffer, the membrane was blocked for 30min with 1x blocking solution
shaking at 100 rpm and incubated afterwards with an AP-coupled α-DIG Fab antibody
(1:5000 diluted in 1x blocking solution) for 30min. The antibody was spun-down for
5min at 3000 rpm. The subsequent membrane washing steps were: four times 1x DIG
wash buffer and once DIG detection buffer for 15min each. Finally, the membrane was
put into a transparent film, CDP-star solution was pipetted directly onto the membrane
and spread by letting the transparent film slide onto the membrane. The membrane
was incubated in the dark for 5min, drained (removal of CDP-star solution), and put
into a new transparent film. Subsequent to further incubation in the dark for 5–10min,
the membrane was exposed to chemiluminescent light for signal detection on a LAS-
4000. Signal quantification was done using the Dot Blot Analyzer tool. The amount of
telomeric overhang was calculated as [(native DNA − Exo1 digested DNA)/denatured
DNA].
2.2.2.9. Protein Level Measurement – Western Blot
Control and telomere capping-defective samples were prepared analogously as described in
section 2.2.2.8.
Protein Extraction Culture volumes corresponding to 2.0 OD600 units were collected by
centrifugation at 13 000 rpm for 2min at RT. Cell pellets were resuspended in 150 µl of
solution 1 and incubated on ice for 10min. Following the addition of 150 µl of solution 2,
samples were incubated on ice for 10min. Samples were centrifuged at 13 000 rpm for 2min
at 4 ◦C, the cell pellets were resuspended in 1ml of acetone and centrifuged at 13 000 rpm
for 2min at 4 ◦C again. Finally, the cell pellets were resuspended in 100 µl of urea buf-
fer.
Western Blot Subsequent to incubation at 75 ◦C for 5min and spin-down at 13 000 rpm,
protein samples were loaded onto either a mini or a midi PROTEAN TGX TM Precast pro-
tein gel (4–15%). The gel was run at 100V for roughly 1.5 h and blotted onto a nitrocellulose
membrane with a Trans-Blot Turbo machine (high-molecular weight program). Initially,
the membrane was rinsed in Ponceau for unspecific staining, washed with dd H2O and
imaged on a LAS-4000. Then, it was blocked in blocking solution (1x PBS + 0.1% Tween
20 containing 5% skim milk powder) for one hour at RT shaking on a multishaker. Incuba-
tion with primary antibody diluted in blocking solution was performed at 4 ◦C overnight.
Preceding incubation for one hour at RT with the secondary antibody (diluted in blocking
solution), the membrane was washed. Washing differed depending on the type of signal detec-
tion.
Chemiluminescent-Based WB First washing steps were four times for 15min in 1x PBS +
0.1% Tween 20. After the secondary antibody incubation, the membrane was washed thrice
for 15min in 1x PBS + 0.1% Tween 20 and once for 15min in 1x PBS. Protein signals were
detected using SuperSignal West Pico Chemiluminescent Substrate (mixed 1:1, membrane
was kept dark) on a LAS-4000 and quantified in Fiji.
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Fluorescence-Based WB Following incubation with primary or secondary antibodies,
the membrane was washed four times for 15min in 1x PBS. The membrane was al-
ways kept dark during antibody incubation or washing. Image acquisition was done on
an Odyssey Infrared Imaging System (LI-COR). Bands were quantified using Image Stu-
dio.
Protein Degradation Kinetics Assay For measuring the kinetics of protein degradation,
different samples of the same cultures were taken at different time points and evaluated for
their content of the protein in question. ON cultures were diluted in 25ml of YPD medium
to OD600 0.2, grown to OD600 0.5 – 0.6 at 23 ◦C and control samples (denoted as “bs”) were
taken. Afterwards, cultures were heat-shocked by addition of pre-warmed (44 ◦C) YPD
medium and incubation at 30 ◦C. One hour later, samples used as heat-shocked controls (de-
noted as time point zero) were taken and cycloheximide (CHX, Sigma Aldrich) was added to
the cultures to a f.c. of 200 µg/ml. Incubation at 30 ◦C was continued. After 30, 45, 60, and
75min of CHX-addition, further samples were taken. All samples correspond to 2.0 OD600
units, cells were spun-down at 3000 rpm for 5min and cell pellets were stored at −20 ◦C.
Protein samples were prepared and analysed with a fluorescence-based WB as described
above.
2.2.2.10. Resection Kinetics Assay
DSB end resection was analysed in the laboratory of Prof. Maria Pia Longhese as described
by Trovesi et al. [223]. As preparatory steps for this assay, VPS27 was replaced in the under-
lying HO-cut strain by a kanamycin cassette amplified from yAM223. All incubation steps
were performed at 30 ◦C. The HO-cut was induced by growth in or on galactose-containing
medium. YPD medium or plates were autoclaved when already containing glucose which
might convert partly to galactose due to the heat from the autoclave. Thus, SD-complete
medium was used in all preparatory steps to avoid unintentional HO-cuts as glucose was
added to it after autoclaving the medium itself. Subsequent to receipt of the basal strain
from the Longhese lab, it was frozen and stored at −80 ◦C as yBL1018 and yBL1019, respect-
ively.
As it was impossible to thaw these strains from −80 ◦C on SD-complete plates, they were
thawed on YPD plates and single colonies from streak-outs on SD-complete plates were used
for further processing. Competent cells were prepared from ON cultures in SD-complete
medium as described in section 2.2.2.2, transformed with a vps27 ::KAN cassette amplified
from yAM223 (sections 2.2.2.2 and 2.2.2.4), and spread on SD-complete + KAN plates.
The integration of the vps27 ::KAN cassette was confirmed by ordinary PCR reaction using
a forward primer (yJK75) upstream of VPS27 and a reverse primer (yBL29) inside of the
kanamycin cassette. DNA was extracted as usual (section 2.2.2.3). The PCR master mix (8
reactions) contained 8 µl of forward primer (oJK75), 8 µl of reverse primer (oBL29), 200 µl
of Taq 2x MM, and 168 µl of mq H2O. PCR was run with 2 µl of 100 ng/µl DNA and 48µl
of PCR master mix. The PCR program comprised 95 ◦C for 30 s (initial temperature), 30
cycles of 95 ◦C for 20 s, 52 ◦C for 30 s, 68 ◦C for 60 s, followed by final extension at 68 ◦C for
5min and holding at 12 ◦C. PCR products were analysed on a 1.2% agarose gel (0.005%
Red Safe, 100V, and 35min). Colonies with confirmed integrations were streaked out for
single colonies on SD-complete and SGal/Raf-complete plates. Strains with confirmed
integration and no growth on SGal/Raf-complete plates were frozen at −80 ◦C (yAM402,
yAM403, and yAM433) and sent to the Longhese laboratory for running the desired assay.
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Nature is inherently messy.
(Denis Noble, [18])
Approximately 7% of the Saccharomyces cerevisiae genome (roughly 400 genes) have previ-
ously been associated with telomere length maintenance. Genes whose respective deletions
were found to affect telomere length (increased shortening or lengthening) are termed
telomere length maintenance (TLM) genes [183–185,195,197]. The number of TLM genes and
the complexity of telomere homoeostasis reach out for a system-wide exploration of the sig-
nals regulating telomere length maintenance.
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3.1. Functional Association of TLM Genes and ESCRT Factors
Initially, I tested the TLM gene list for enrichment of specific KEGG pathways [5–7] or func-
tional categories (MIPS FunCat; [8,9]) to get a first impression of the contained genes and
their biological functions. Due to the unreliability of the DAmP collection (section 2.1.1),
only the non-essential TLM genes were included into these calculations (denoted as
TLM\DAmP). Surprisingly, the top-ranking KEGG pathway for short tlmmutants was endo-
cytosis with a corrected p-value of 2.612e−5 (two-sided Fisher’s Exact test, table 3.1). The re-
maining pathways (table 3.1) represented biological functions like different DNA repair mech-
anisms or nucleotide biosynthesis. Those pathways were to be expected in the context of te-
lomere maintenance.
Table 3.1.: KEGG pathways [5–7] enriched with tlm mutants corresponding to non-essential genes. The
enrichment was calculated based on the default two-sided Fisher’s Exact test within R [206]. Multiple testing
correction was done with the FDR correction method.
tlm Phenotype KEGG Pathway P-Value Corrected P-Value
short
Endocytosis 1.306e−5 2.612e−5
Non-homologous end-joining 0.000 13 0.000 27
Homologous recombination 0.001 27 0.002 53
Purine metabolism 0.003 15 0.006 29
Biosynthesis of secondary metabolites 0.003 59 0.007 18
Metabolic pathways 0.007 23 0.007 23
DNA replication 0.003 64 0.007 28
Pyrimidine metabolism 0.022 49 0.044 98
long
Ribosome 7.123e−8 1.425e−7
RNA transport 0.000 31 0.000 63
Metabolic pathways 0.000 48 0.000 95
Base excision repair 0.000 54 0.001 08
Spliceosome 0.005 03 0.010 06
DNA replication 0.020 06 0.020 06
Similarly, I conducted an enrichment test with the functional categories as defined by
MIPS [8, 9]. Among the top-ranking FunCats (suppl. table C.2), categories were found
which mirror the biological functions of the top-ranking KEGG pathways (table 3.1) such
as FunCats corresponding to vesicular transport. Hence, both analyses delivered coherent res-
ults.
Having found the striking and unexpected association of short tlm mutants and endocytosis,
I took a closer look at the KEGG map for endocytosis (ID sce04144). The KEGG Mapper –
Search&Color Pathway tool [224] was used to highlight the enriched TLM genes in the partic-
ular map (fig. 3.1). Conspicuously, the gene products of the affected genes clustered around
the late endosome and almost all of them represented endosomal sorting complex required for
transport (ESCRT) factors.
Nine out of nineteen ESCRT factor encoding genes were TLM genes. A Fisher’s Exact
test of this overlap revealed a p-value of 8.84e−9 (TLM\DAmP data). The respect-
ive contingency table is given in table 3.2. Table 3.3 lists those ESCRT factors that
were contained in this overlap. Eight of them were found by the KEGG Mapper tool
and were highlighted in red in fig. 3.1. BRO1 denoted with its mammalian symbol
(ALIX) was marked manually, as it was not found by this tool due to naming differences.
As described in section 1.4, ESCRT factor encoding genes belong to the larger vacuolar pro-
tein sorting (VPS) gene family [104]. Some of the VPS genes were described to be involved in
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Figure 3.1.: KEGG pathway map for endocytosis (ID sce04144). Proteins were coloured using the KEGG
Mapper – Search&Color Pathway tool [224]. BRO1 (ALIX) was marked manually. Map was downloaded from
the KEGG website [5–7]. Green coloured boxes represent pathway elements existing in Saccharomyces cerevisiae
and red coloured boxed highlight short tlm mutants.
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Table 3.2.: Contingency table of the overlap of short
tlm mutants and ESCRT genes. The p-value of this
overlap was 8.84e−9 (TLM\DAmP data).
ESCRT ESCRT
short 9 180 189
short 10 4791 4801
19 4971
∑
4990
Table 3.3.: List of ESCRT factors that were enriched
in the TLM\DAmP gene set.
Yeast ESCRT Complex Metazoan
VPS27 0 HRS
STP22 I TSG101
VPS28 I VPS28
SNF8 II EAP30
VPS25 II EAP20
VPS36 II EAP45
VPS20 III CHMP6
SNF7 III CHMP4A-C
BRO1 other ALIX
telomere length maintenance before [198]. Amongst other genes involved in vesicular traffic,
vps mutants exhibit shorter telomeres. Rog et al. tested a subset of these vps mutants to gain
insights into the functional relationship between telomere homoeostasis and vacuolar sorting
mechanisms. Although they found indications that the tested VPS genes influence telomere
length regulation in a telomerase-dependent pathway, Rog and colleagues could only hy-
pothesise about the causal link between telomere homoeostasis and vacuolar sorting mechan-
isms [198].
3.2. Experimental Investigations
With respect to the significant enrichment of ESCRT factors within the short tlm mutants
and the little knowledge about the relationship of telomere homoeostasis and vacuolar sort-
ing, I chose to perform a more in-depth experimental analysis of this association. For this, I
decided for VPS27 as representative of the enriched genes for the experimental investigations
reported on in the following sections. Unless specified otherwise, I conducted all experiments
myself, in the former laboratory of Dr. Brian Luke at the ZMBH of the Heidelberg University,
and under his supervision.
3.2.1. Telomerase-Dependent Telomere Elongation is Disturbed in vps27
Mutants
Initially, I tested the telomere shortening of vps27 mutants. Telomere length was measured
by telomere PCR for different telomeres (six different Y’ telomeres and the 1L telomere)
and for both wild-type and vps27 cells, respectively. To ensure telomere shortening, the
respective yeast strains were grown for at least 150 generations by serial restreaks on
standard yeast extract peptone dextrose (YPD) medium plates and incubation at 30 ◦C.
A shortening effect in vps27 cells could be reproduced for the Y’-element containing
telomeres (6 Y’, fig. 3.2a) as was previously shown by Shachar et al. [195]. For the X-
only telomere (1L) the shortening effect was not as pronounced as for the Y’ telomeres,
but nonetheless still present (fig. 3.2b). Thus, observable from this test, the deletion
of VPS27 did not affect all telomeres equally. As telomere length is mainly maintained
by telomerase, I explored whether telomerase is disturbed in a VPS27 deleted back-
ground. Telomerase is a holoenzyme whose catalytic subunit is encoded by the EST2 gene.
Cells missing this gene senescence faster after a certain number of passages because the
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Figure 3.2.: Telomere length was measured by telomere PCR for wild-type and vps27 cells after growth to at
least 150 generations. Length was examined for (a) six Y’ telomeres and (b) the 1L telomere. Bars represent the
median of the respective data points. Each data point refers to one individual telomere length measurement.
Figure B.4 depicts the images of the underlying agarose gels that were quantified. As the fourth lane for the
vps27 mutant and 1L telomere showed no clear band, this lane was not quantified.
telomerase-dependent telomere elongation is malfunctioning in those cells [88]. Senescence
(fig. 3.3a) and the corresponding rate of telomere shortening (fig. 3.3c) was recorded for the
double mutant est2 vps27 and compared to est2 single mutants. The est2 vps27 double
mutants senesced equally fast as compared to the est2 single mutants, and telomeres
did shorten in both mutants with a roughly similar rate. This result is supported by
data from Chang et al. who combined the deletion of EST1, another telomerase subunit
encoding gene, with the systematic yeast deletion collection and measured senescence for
the resulting est1 yfg∆ double mutants [203]. Deletion of EST1 leads to the disruption
of telomerase and accelerated senescence. Ten mutant strains corresponding to ESCRT
factor encoding genes were included in this data. Chang et al. defined three different
senescence archetypes: (i) accelerated entry into senescence (est1 rad52 archetype), (ii)
accelerated entry into and recovery from senescence (est1 rif1 archetype), and (iii) nor-
mal senescence [203]. From the provided supplemental material, the different archetypes
were extracted and compared to the average of the mean density profiles (MDPs) for the
contained ESCRT factors (fig. 3.3b, dark red line). The profile of the escrt est1 double
mutants was more similar to the average of the double mutants comprising the class of
accelerated senescence (fig. 3.3b, light blue line) than to those showing normal senes-
cence (fig. 3.3b, light grey line). Hence, telomerase-dependent telomere elongation seemed
corrupted in VPS27 deleted cells and most likely this holds true for the whole ESCRT fam-
ily.
3.2.2. VPS27 Deletion Rescues cdc13-1 Capping-Defective Telomeres
The effect of deleting VPS27 on telomere length was mild, which is why also other pos-
sible relationships between ESCRT factors and telomere maintenance were considered. In
addition to proper telomere elongation, telomere homoeostasis also relies on a functional
capping system. The 3’ ssDNA overhang of telomeres is protected by the Cdc13-Stn1-Ten1
(CST) capping complex from Exo1-mediated resection as part of a DNA damage response
(DDR). Refer to section 1.3.2.3 and fig. 1.13 for a more detailed description. Cdc13 is the
key player in this capping complex and thus the question arose whether deletion of VPS27
affects telomere capping. CDC13 null-mutants are not viable, but telomere uncapping
can be induced with a temperature-sensitive allele of CDC13 (cdc13-1 ) [43]. Incubation
of cdc13-1 mutants at non-permissive temperatures (> 27 ◦C) or shifting them to these
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(a) Senescence curve. (b) Senescence archetypes.
(c) Rate of telomere shortening.
Figure 3.3.: (a) Senescence curve of est2 single and est2 vps27 double mutants. Error bars represent the
standard error of mean. At each time point six individual samples were measured per mutant type. (b) Senescence
archetypes as defined by Chang et al. and reproduced from their supplemental data [203]. Represented are the
different mean density profiles (MDPs) of the double mutants that define a certain archetype, as well as the
average of those MDPs that belong to one archetype. The class of accelerated senescence (AS) is defined by the
est1 rad52 double mutant (depicted in dark blue), the est1 rif1 double mutant defines the accelerated entry into
and recovery from senescence (AERS, depicted in dark green) and normal senescence (NS) is depicted in dark
grey. x denotes average of MDPs. (c) Telomere length was measured for samples 1–5 d of the senescence curve
in (a) to derive the rate of telomere shortening. Samples referred to three individual initial spore colonies. The
underlying agarose gels are represented in suppl. fig. B.5.
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temperatures (heat shock) induces telomere uncapping. Subsequently, Exo1-mediated
resection takes place activating a cell-cycle arrest as schematically depicted in fig. 3.4.
Figure 3.4.: Model of telomere uncapping upon temperature shift and subsequent Exo1-mediated resection
leading to a robust cell-cycle arrest.
For investigating whether CST-mediated telomere capping is defective in vps27 mutants, a
VPS27 deletion strain and a cdc13-1 strain were crossed. The resulting double mutant was
examined for its viability at permissive (23 ◦C and 25 ◦C) and non-permissive temperatures
(27 ◦C and 28 ◦C) and compared to the wild-type as well as both single mutants (vps27
and cdc13-1 ). As apparent from fig. 3.5, the wild-type and the vps27 cells grew well at
wild-type
vps27
cdc13-1
cdc13-1vps27
wild-type
vps27
cdc13-1
cdc13-1vps27
@23°C @25°C @27°C @28°C
Figure 3.5.: Viability spotting assay of cdc13-1 vps27 double mutants at permissive (23 ◦C and 25 ◦C) and
non-permissive temperatures (27 ◦C and 28 ◦C). The assay was performed on normal YPD plates and cells were
10-fold serially diluted. Cells were incubated for three days. Two biological replicates were spotted.
all temperatures, while the cdc13-1 cells grew well at 23 ◦C and 25 ◦C only, but not at
higher temperatures. However, the double mutants grew at 28 ◦C. Hence deletion of VPS27
increased the viability of cdc13-1 mutants at non-permissive temperatures (rescue of tem-
perature sensitivity). Addinall et al. found a similar suppression of temperature sensitivity
of cdc13-1 mutants by deletion of HSE1 [200]. This finding is in concordance with the rescue
result presented herein as HSE1 encodes the ESCRT-0 complex partner of VPS27. These ob-
servations suggested that deletion of the ESCRT-0 complex protects cells from uncapped te-
lomeres.
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3.2.3. Exo1-Mediated Resection of Uncapped Telomeres
Uncapped telomeres are recognized as DNA double-strand breaks (DSBs), inducing 5’–3’
Exo1-mediated resection and a subsequent robust cell cycle arrest [43] (fig. 3.4). Therefore,
both reduced Exo1-mediated resection and defective cell cycle checkpoint activation would
explain rescue of a cdc13-1 capping-defective telomere [200].
3.2.3.1. Slightly Decreased Amounts of 3’ Telomeric Overhang in cdc13-1 vps27
Mutants
First, I explored whether deletion of VPS27 influences Exo1-mediated resection of uncapped
telomeres. Degradation of the 5’ end of uncapped telomeres leads to increased amounts of
telomeric single-stranded overhang (fig. 3.4). The amount of telomeric single-stranded DNA
was measured by a Dot Blot assay in cdc13-1 single and in cdc13-1 vps27 double mutants.
Genomic DNA (gDNA) samples were taken from cultures of both mutant types in exponen-
tial growth phase at 23 ◦C and after one hour heat shock at 30 ◦C (induction of telomere
uncapping). Figure 3.6 describes the basic principles of this assay. Parts of the DNA samples
were treated with a bacterial Exo1 (bactExo1), which is degrading 3’ ssDNA. Untreated (nat-
ive) and the bactExo1 digested DNA samples were spotted together with denatured DNA
samples (background) onto a positively charged nylon membrane. The samples were incub-
ated with a digoxigenin (DIG)-labelled probe that specifically binds to the telomeric repeats.
The amount of telomeric overhang was than quantified with eq. (3.1) from the individual DIG
signals.
Figure 3.6.: Principles of the Dot Blot assay for measuring the amount of telomeric overhang. Parts of native,
denatured and bactExo1 treated DNA samples were spotted onto a positively charged nylon membrane and
incubated with a DIG-labelled probe that is specific to the telomeric repeats. The amount of telomeric overhang
was quantified using eq. (3.1) from the individual DIG signals.
telomeric overhang = native DNA− bactExoI digested DNAdenatured DNA (3.1)
An extrapolated model of the detected spot intensities is represented in fig. 3.7a and an im-
age of the underlying membrane can be found in suppl. fig. B.6. As expected elevated levels
of 3’ single-stranded DNA in cdc13-1 cells were present after heat shock treatment (fig. 3.7).
Strikingly, the amount of 3’ telomeric overhang was slightly decreased in the double mutants
(fig. 3.7c). This finding strongly suggested that Exo1-mediated resection is not working prop-
erly in cdc13-1 vps27 mutants.
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(a) Extrapolated model of spot intensities.
(b) Telomeric overhang per biological replicate. (c) Telomeric overhang per mutant and tem-
perature.
Figure 3.7.: Dot Blot assay for quantifying the amount of 3’ ssDNA at telomere ends in cdc13-1 single and
cdc13-1 vps27 double mutants at permissive temperature and after heat shock at 30 ◦C. (a) Model of the Dot
Blot outcome as extrapolated pixel intensities. Two technical (rows) and six biological (columns) replicates
were spotted altogether. An image of the underlying membrane can be found in suppl. fig. B.6. (b) Amount
of telomeric overhang plotted as barplot individually for each biological replicate. (c) Boxplot indicating the
amount of telomeric ssDNA for the individual mutants before and after heat shock treatment.
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3.2.3.2. Overexpression of EXO1 Abolishes Rescue of cdc13-1 by Deletion ofVPS27
Having found that Exo1 is affected in VPS27 deleted cells, I explored the consequences of
Exo1 perturbation for cdc13-1 vps27 mutants. If a corrupted Exo1 function rescues telomere
uncapping, then overexpressing EXO1 in cdc13-1 vps27 cells should abolish the temperature
rescue seen beforehand. Therefore, wild-type, cdc13-1, vps27, and cdc13-1 vps27 cells carry-
ing either an EXO1 OE or the corresponding empty vector control (EV) were monitored for
their viability at different temperatures.
wild-type EV
wild-type OE
@28°C @30°C@23°C @27°C@23°C, SD-Leu
cdc13-1 EV
cdc13-1 OE
cdc13-1vps27 EV
cdc13-1vps27 OE
SGalRaf-Leu
wild-type EV
wild-type OE
cdc13-1 EV
cdc13-1 OE
cdc13-1vps27 EV
cdc13-1vps27 OE
Figure 3.8.: Viability spotting assays at the indicated temperatures. Cells of the indicated genotypes were
spotted 10-fold serially diluted onto SGalRaf-Leu plates (overexpression is induced by growth on galactose) and
incubated for three days. Controls were grown on SD-Leu plates. The cells carried either an Exo1 overexpression
plasmid (OE) or the corresponding empty vector control (EV).
Overexpression of EXO1 in cdc13-1 vps27 cells (but not the empty vector) abolished the
aforementioned rescue effect (fig. 3.8), supporting the idea of a defective Exo1-mediated re-
section upon VPS27 deletion.
3.2.3.3. Protein Levels of Exo1 are Not Affected
So far, all findings strongly suggested a malfunction of Exo1 that can be caused either
by decreased protein levels or improper localisation. Thus, the protein levels of Exo1
were assessed in vps27 single mutants as well as in cdc13-1 vps27 double mutants after
induction of telomere uncapping by heat shock (one hour at 30 ◦C) using a TAP-tagged
Exo1 strain. As Sae2 is also involved in the resection at uncapped telomeres — although
to a lower extent than Exo1 — protein levels of this second nuclease were examined, too.
Figure 3.9 depicts the respective Western Blots and their quantifications. Clearly, nuclease
levels were not affected in VPS27 deleted cells (fig. 3.9b). Although the quantification
suggested a slightly decreased amount of Exo1 in the double mutant, this was not clearly
apparent from the corresponding band intensities. Moreover, the two biological replicates
were quite heterogeneous, which is why the indicated difference is probably not depend-
able.
Moreover, measuring the kinetics of Exo1 protein degradation revealed no difference
between cdc13-1 single and cdc13-1 vps27 double mutants (fig. 3.10). For this, cultures
were incubated at permissive temperature (23 ◦C) and heat shocked for one hour at
30 ◦C to induce telomere uncapping. Subsequently, cycloheximide (CHX) was added
to the cultures and samples were taken at 30/45/60/75min following the addition of
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Figure 3.9.: Western Blot for
measuring the protein levels of
nucleases involved in the resection
of uncapped telomeres. Protein
samples of the indicated mutants
were collected after heat shock
treatment for one hour at 30 ◦C to
induce telomere uncapping. Pro-
tein levels were measured for two
biological replicates. (a) and (c)
represent images of the underly-
ing membranes, and (b) and (d)
contain the accompanying quanti-
fications. The upper lanes of the
membranes represent the Exo1 or
Sae2 signal and the lower lanes
correspond to either actin or Pgk1
as loading controls. The quan-
tification indicates the relative
amount of Exo1 or Sae2 over load-
ing control, respectively. Images
with the corresponding Ponceau
stained membranes are depicted
in suppl. figs. B.10a and B.10b.
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CHX which blocks the translational elongation and by this inhibits protein synthesis.
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Figure 3.10.: Western Blot for measuring Exo1 degradation kinetics. Cultures were incubated at permissive
temperature (23 ◦C) and heat shocked for one hour at 30 ◦C to induce telomere uncapping. Afterwards, cyclo-
heximide (CHX) was added to the cultures and samples were taken at 30/45/60/75min following the addition
of CHX. (a) depicts the underlying membranes whose upper lanes (row 1 and 3) refer to the Exo1 signal and the
lower lanes (row 2 and 4) represent the loading control (Pgk1). Its quantification is given in (b). The experiment
was conducted for two biological replicates. “bs” denotes samples at 23 ◦C and time point zero reflects samples
at 30 ◦C before addition of CHX. Figure B.10c depicts an image of the corresponding Ponceau staining.
Hence, as there were no detectable changes in the protein levels of Exo1, I attempted
to image GFP-labelled Exo1 to test for localisation defects. Therefore, an Exo1-GFP
labelled strain was crossed to the cdc13-1 vps27 double mutant. Afterwards, the de-
rived wild-type, cdc13-1, vps27, and cdc13-1vps27 mutants were examined. As previ-
ously done, samples were taken at 23 ◦C and subsequent to heat shock treatment (one
hour at 30 ◦C). Imaging was performed in the laboratory of Dr. Barbara Di Ventura
and with her support using a Zeiss Axio Observer.Z1 microscope, equipped with: ob-
jective, Zeiss Plan Apochromat 63x/1.4NA; light source, HXP-120 (Vistron Systems
GmbH); camera, Zeiss AxioCam MRm; and filter set, 38 HE (GFP). Unfortunately, a
very weak GFP-signal prevented the observation of any difference between the wild-
type and any mutant, regardless of the different temperature treatment. Due to the
weak GFP-signal, I decided not to further pursue the investigation of possible localisa-
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tion problems and therefore the possibility of Exo1-localisation problems cannot be ex-
cluded.
3.2.3.4. vps27 Mutants are Sensitive to DNA Double-Strand Breaks
In addition to acting on uncapped telomeres, 5’–3’ Exo1-mediated resection is also important
for the homologous recombination (HR) in the DSB repair pathway (section 1.2.2). Upon
detection of DNA double-strand breaks, 5’–3’ resection by Exo1 is initiated for preparing for
the subsequent strand displacement and annealing process [225]. Figure 3.11 briefly describes
the involvement of Exo1 in this respect.
Figure 3.11.: Schematic of Exo1 involvement in homologous recombination during DSB repair. Subsequent to
the detection of a DNA double-strand break, 5’–3’ resection by Exo1 is initiated. Subsequently, the break is
repaired by strand displacement and annealing [225].
This is why sensitivity of vps27 mutants to DNA damage was tested. Hereto, growth
ability of these mutants was verified when incubated on normal yeast complete medium
plates (YPD) containing varying concentrations of zeocin (5 µg/ml, 10µg/ml, and 15 µg/ml;
fig. 3.12). Zeocin (phleomycin D1) induces DNA double-strand breaks (DSBs) as described
by Chankova and colleagues [226]. Growth was compared to the wild-type. As clearly indic-
ated in fig. 3.12, vps27 mutants were sensitive to higher levels of zeocin indicating that these
mutants are defective for DNA damage repair. For this experiment, YPD plates containing
increasing amounts of zeocin were prepared by Martina Dees who also spotted the cultures
onto those plates.
wild-type
vps27
vps28
stp22
snf8
snf7
did2
bro1
YPD 5µg/ml zeocin 10µg/ml zeocin 15µg/ml zeocin
Figure 3.12.: Spotting growth assay for DNA damage sensitivity. Wild-type, vps27, and other escrt mutants
were spotted in 10-fold serial dilutions onto yeast complete medium plates containing increasing concentrations
of zeocin. Plates were incubated for three days at 30 ◦C. Two biological replicates were spotted. Plates were
prepared by Martina Dees who also spotted the cultures onto those plates.
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For the proper progress of HR, initiation of DNA strand annealing by Rad52 is essen-
tial [227,228], which is why the genetic interaction of VPS27 and RAD52 was tested. After
construction of the double mutant rad52 vps27, it was subjected to an analogous DNA dam-
age spotting as the vps27 single mutant before. Both genes were found to show an additive ef-
fect (fig. 3.13).
Figure 3.13.: Spotting growth assay for testing the sensitivity of rad52 vps27 double mutants to DSBs caused
by zeocin. The indicated mutants and the wild-type were spotted in 10-fold serial dilutions onto YPD plates
containing increasing amounts of zeocin. Plates were incubated for three days at 30 ◦C. Two biological replicates
were spotted.
Having found indications that DSB repair by HR is impaired upon deletion of VPS27, I ex-
amined an HR proficient strain in the presence of VPS27 deletion (vps27HR) for its viability.
Comparing the wild-type HR-proficient strain (WTHR) with the VPS27 deleted one, a slight
decrease in the growth capabilities was discovered. There were smaller and less dense colon-
ies in the vps27HR mutant than in the WTHR (fig. 3.14). This effect was pronounced by the
circumstance that in the corresponding control strain colonies were thicker and more dense.
Figure 3.14.: Viability spotting for DNA damage repair proficient cells in the presence of VPS27 deletion. Cells
were spotted in 10-fold serial dilutions onto standard YPD or YPGalRaf plates. Incubation lasted for three days
at 30 ◦C. Two biological replicates were spotted.
In concordance with the previous results, this assay suggested an impaired HR pathway in
vps27 mutants. In order to obtain a complete picture of DNA damage repair pathways,
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a NHEJ-proficient strain was included in this experiment. However, no effects were observed
for NHEJ in the absence of VPS27.
Figure 3.15.: DNA damage spotting of vps27 single mutants in the presence of EXO1 overexpression. Wild-type
or vps27 cells carrying either an EXO1 overexpression plasmid or the corresponding empty vector control were
spotted in 10-fold serial dilutions onto SGalRaf-Leu plates (EXO1 OE is galactose induced) containing increasing
concentrations of zeocin. Controls were spotted onto SD-Leu plates or SGalRaf plates without zeocin. Two
biological replicates were tested. Incubation lasted for three days at 30 ◦C.
With respect to the data indicating a corrupted Exo1 function, it was tested whether overex-
pression of EXO1 in vps27 mutants diminishes the sensitivity of those mutants to DSBs in-
duced by zeocin. Similar to the initial DNA damage spotting (fig. 3.12), wild-type and vps27
cells carrying either an EXO1 overexpression plasmid or the corresponding empty vector con-
trol were spotted onto media plates harbouring different concentrations of zeocin (fig. 3.15).
Overexpression of EXO1 did not have any effect on the sensitivity to zeocin for VPS27 de-
leted cells.
3.2.3.5. Examination of the Resection Efficiency in vps27 Mutants
Finally, the efficiency of 5’–3’ Exo1-mediated resection was verified. The laboratory of
Prof. Maria Pia Longhese developed an assay that allows to follow the 5’–3’ resection
after induction of a DSB at the mating type (MAT) locus [223, 229]. The DSB is in-
duced by the homothallic switching endonuclease (HO) that naturally occurs in certain
fungi enabling them to switch between their mating types (homothallic switch) [230,231].
By taking advantage of this assay, it can be examined whether resection in a certain
mutant is progressing as fast as in the wild-type. Figure 3.16a gives a schematic of
the “system used to detect DSB resection” [229]. Genomic DNA is separated on al-
kaline agarose gels subsequent to digestion with a SspI restriction endonuclease. The
gel is then hybridised with a ssRNA probe that specifically binds to the unresected
strand of the MAT locus. The probe indicates HO-cut and uncut fragments at 0.9 kbp
and 1.1 kbp, respectively. With progress of 5’–3’ resection, SspI sites are gradually re-
moved “producing larger SspI fragments” that are detected by the probe [223, 229].
As described in section 2.2.2.10, the VPS27 deletion was introduced into the underly-
ing HO-cut strain while the actual resection assay was performed in the laboratory of
Prof. Longhese. No difference in the efficiency of 5’–3’ resection was obtained between the
wild-type and the vps27 mutants (fig. 3.16c vs. fig. 3.16d). Although this assay indicated
correct functioning resection in vps27 mutants, its outcome was not interpretable as the
induction of a DSB site by the HO-cut mechanism did not work properly. Neither Prof.
Longhese nor our lab was able to explain this cut deficiency that made it impossible to
infer conclusions about the efficiency of Exo1-mediated resection in vps27 mutants from
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(a) Schematic of the detection of resection
at a DSB [229].
(b) Alkaline agarose Gel.
(c) Quantification of for the wild-type.
(d) Quantification of for the vps27 mutant.
Figure 3.16.: (a) 5’–3’ resection is examined after a HO-induced DSB. DNA fragments are separated on alkaline
agarose gels subsequent to digestion with SspI. Gels are hybridised with a ssRNA probe that binds to the
unresected strand of the MAT locus. As resection progresses, SspI sites (S) are gradually eliminated leading to
larger SspI fragments (r1–r7) detected by the probe. SspI sites are located 1.7/3.5/4.7/5.9/6.5/8.9/15.8 kbp
centromere-distal from the HO-cut site. The sub-figure and its description were taken from [229]. (b) Alkaline
agarose gel for the wild-type and vps27 mutants. The experiment itself was run in the laboratory of Prof. Longhese
after the VPS27 deletion was introduced into the underlying HO-cut strain. (c) Quantification of the wild-type
lanes in (b) and (d) quantification of the vps27 lanes. (b) – (d) were provided by the Longhese lab.
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the previously described resection assay which is accepted as the gold standard for this is-
sue.
3.2.3.6. Improved Viability of cdc13-1 exo1 vps27 Mutants
Moreover, the genetic interaction of CDC13, EXO1, and VPS27 was tested by gener-
ating a triple mutant (cdc13-1 exo1 vps27 ) and examining it in another temperature
rescue spotting assay (fig. 3.17). Due to less resection of uncapped telomeres by delet-
ing EXO1, cdc13-1 exo1 mutants are more viable at non-permissive temperatures [200].
@23°C @27°C @28°C @30°C @32°C
wild-type
cdc13-1
cdc13-1exo1
cdc13-1vps27
cdc13-1exo1vps27
wild-type
cdc13-1
cdc13-1exo1
cdc13-1vps27
cdc13-1exo1vps27
Figure 3.17.: Viability spotting assay at the indicated temperatures. Mutants of the indicated genotypes were
spotted in 10-fold serial dilutions. Cells were spotted in duplicates onto standard YPD plates and incubated for
three days.
The growth ability of cdc13-1 exo1 vps27 cells surpassed the cdc13-1 exo1 and cdc13-1 vps27
mutants suggesting that Exo1 and Vps27 function independently in the context of dysfunc-
tional telomere capping. This observation was contradictory to the ideas of a defective Exo1-
mediated resection due to deletion of vps27.
3.2.4. DNA Damage Checkpoint Upon Telomere Uncapping
Other than a defective Exo1-mediated resection, improper DNA damage checkpoint ac-
tivation could explain the rescue of cdc13-1 capping-defective telomeres (fig. 3.4). An
UP-DOWN assay was developed by the Lydall laboratory in which cells are subjected to
cycles of high and low temperature [200]. As the temperature sensitivity of cdc13-1 mutants
is reversible, the cells can maintain viability on short exposures to the non-permissive
temperature (> 27 ◦C) when returned to permissive temperature afterwards. Mutants
defective for the DNA damage checkpoint activation fail to arrest in response to DNA
damage and recovery is not possible [200]. Under these conditions, mutations in EXO1
suppress cdc13-1 defects, whereas a deletion of the RAD9 checkpoint gene is unable
to do so [200]. Figure 3.18 indicates that, contrary to cdc13-1 rad9 mutants, cdc13-1
vps27 mutants were viable in this assay, indicating that checkpoint is normal in these cells.
However, the UP-DOWN assay is merely an indicator of checkpoint defects because in
RAD9 deleted cells MEC1 -mediated auto-phosphorylation of Rad53 could still activate the
cell cycle checkpoint in response to DNA damage as outlined in fig. 3.19 [232,233]. Hence,
the viability of cdc13-1 vps27 mutants was examined in the absence of proper Rad53 function
(rad53-11 mutants [234,235]).
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Figure 3.18.: UP-DOWN assay [200]
for testing proper cell-cycle checkpoint
function in cdc13-1 vps27 mutants.
Cells were spotted in 10-fold serial di-
lutions onto standard YPD plates that
were incubated at oscillating temper-
atures for three days. Two biological
replicates were spotted.
@23°C @up-down
wild-type
vps27
cdc13-1
rad9
cdc13-1rad9
cdc13-1vps27
wild-type
vps27
cdc13-1
rad9
cdc13-1rad9
cdc13-1vps27
Figure 3.19.: Schematic of checkpoint activation by Rad53 in response to DNA damage. Either Mec1-dependent
auto-phosphorylation or Rad9 activate Rad53.
As carried out for the cdc13-1 vps27 double mutants before, a triple mutant was constructed,
spotted onto standard YPD plates and incubated at permissive (23 ◦C and 25 ◦C) and non-
permissive (27 ◦C and 28 ◦C) temperatures. This spotting suggested that VPS27 and RAD53
function independently of each other and supported the indication of a proper checkpoint in
vps27 mutants.
@23°C @25°C @27°C @28°C
wild-type
cdc13-1
rad53-11
vps27
cdc13-1rad53-11
cdc13-1vps27
rad53-11vps27
cdc13-1rad53-11vps27
wild-type
cdc13-1
rad53-11
vps27
cdc13-1rad53-11
cdc13-1vps27
rad53-11vps27
cdc13-1rad53-11vps27
Figure 3.20.: Viability spotting of the indicated strains in duplicate at permissive (23 ◦C and 25 ◦C) and non-
permissive (27 ◦C and 28 ◦C) temperatures. Cells were spotted in 10-fold serial dilutions onto standard YPD
plates. Incubation lasted for three days. Two biological replicates were spotted.
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3.2.5. All Escrt Factors Show the Same Effects as VPS27 Deletion
Regarding the fact that only nine out of nineteen ESCRT factor encoding genes were en-
riched in the TLM gene list, the question arose what distinguishes those nine and the remain-
ing ten ESCRT factors. Table 3.4 lists all ESCRT factors and whether an interaction with
CDC13 is known.
Table 3.4.: List of all nineteen ESCRT factor encoding genes from baker’s yeast. ESCRT complex membership
and knowledge about CDC13 interactions are provided as well as the assignment of the different rescue categories
to the escrt mutants. A) clear viability at 28 ◦C, B) clear viability at 27 ◦C and slight viability at 28 ◦C, C) viable
at 27 ◦C and D) no enhanced viability. EXP, experimentally derived; DB, database knowledge; ¬, no defect in
experimental examination;  , contradiction.
Complex cdc13-1 RescueEffect
Sensitivity to
Zeocin
Interaction with
CDC13 (SGD)
VPS27 0 A X(EXP, DB)
HSE1 0 C synthetic rescue
STP22 1 B X(EXP, DB)
VPS28 1 B X(EXP, DB)
SRN2 1 B synthetic rescue
MVB12 1 C
SNF8 2 B X(EXP, DB)
VPS25 2 B
VPS36 2 B X(DB)
VPS20 3 D X(DB)
SNF7 3 B X(EXP)
VPS24 3 B X(DB) positive genetic
VPS2 3 B
DID2 3-a B  (DB, ¬EXP) synthetic rescue
VPS60 3-a D synthetic rescue
IST1 3-a C
VPS4 a D synthetic growthdefect
VTA1 a D
BRO1 a A  (¬EXP)
With respect to the heterogeneous distribution of the tlm phenotype and the annotation
of known interactions with Cdc13 over the ESCRT family, I examined all cdc13-1 escrt
double mutants in a temperature rescue spotting, in the same way as vps27. Strikingly,
almost all ESCRT deletions rescued the temperature sensitivity of cdc13-1 mutants to
a varying degree (suppl. fig. B.7). For assessing the overlap of those escrt mutants that
showed telomere shortening (escrt ∩ tlmshort) with those that rescued the temperature
sensitivity of cdc13-1 cells, the viability of all cdc13-1 escrt mutants was categorised
as: A) clear viability at 28 ◦C, B) clear viability at 27 ◦C and slight viability at 28 ◦C,
C) viable at 27 ◦C, and D) no enhanced viability (table 3.4). Afterwards, the overlap
of escrt ∩ tlmshort mutants with a corresponding cdc13-1 escrt double mutant categor-
ised as either A or B was evaluated. Eight of the nine escrt ∩ tlmshort mutants showed a
cdc13-1 rescue of type A or B. A Fisher’s Exact test revealed a p-value of 0.0399 for this over-
lap.
Moreover, the DNA damage sensitivity of six additional escrt mutants was tested, too. Four
of these six mutants showed a clear sensitivity to zeocin (fig. 3.12 and table 3.4) as seen be-
fore for vps27 mutants. To further support this result, I explored the phenotype information
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provided by the SGD [10] for known sensitivities of all ESCRT factors against DNA dam-
aging agents. For ease of access, a bipartite drug-sensitivity network was derived from this
phenotype information as represented in suppl. fig. B.8. From the sub-network for zeocin
resistance (fig. 3.21) it became apparent that some ESCRT factors were already annotated
with a decreased resistance to zeocin (marked with “DB” in table 3.4). For four of those
factors the decreased resistance to zeocin was confirmed (fig. 3.12 and marked with “EXP”
in table 3.4). In addition, information about the decreased resistance to zeocin for three fur-
ther ESCRT factors was gained. Although the did2 mutant was described in the SGD [10] to
show decreased resistance to zeocin, too, a clear sensitivity could not be obtained (fig. 3.12).
SNF8
DID2
VPS27
VPS20
STP22 VPS28
phleomycin D1
VPS24
VPS36
Figure 3.21.: Sub-network for the resistance to zeocin (phleomycin D1). The global bipartite drug-sensitivity
network as derived for all ESCRT factors from the phenotype information provided by the SGD [10] is depicted
in suppl. fig. B.8. Drugs are denoted with grey and ESCRT factors with blue nodes. Red edges encode a
decreased resistance to zeocin of a certain escrt mutant. Network manipulation and visualisation was done with
Cytoscape [213].
In summary, the data indicated that the whole ESCRT family is rescuing a cdc13-1 defective
telomere-cap and that escrt mutants are sensitive to DNA damage.
3.3. TLM Genes and the ESCRT System: An in silico
Examination
Despite all the presented experiments, no clear functional causality could be derived
so far. Therefore, I conducted further in silico analyses in order to get more insights
into the functional relationship of telomere length maintenance and the ESCRT sys-
tem.
3.3.1. PPI Network of ESCRT Factors and Telomere Related Proteins
Initially, I investigated a manually curated Saccharomyces cerevisiae interaction network
(provided by Christine Brun) to explore the connections of telomere related proteins and
the ESCRT family. As this network consisted exclusively of experimentally verified binary
PPIs, it represented a highly reliable interaction source. Shortest path analyses between
the set of telomere related proteins (TRPs) and the ESCRT factors revealed that they
were mostly connected by more than one traverse step (fig. 3.22). The rationale behind this
analysis was that the shortest path between two vertices has the smallest number of edges
and thus the least nodes to traverse, enabling the discovery of novel functional relationships.
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Finding pathways with only one traverse protein within a global PPI-network, could yield
regulatory or functional information about the connected proteins. “Proteins connecting
pairs of other proteins with well-defined biological functions [...] have a higher probability
to share that function, as compared to those selected at random” [236,237]. The set of TRPs
comprised all subunits of the CST (Cdc13, Stn1, and Ten1) capping complex, the Ku com-
plex (Yku70, Yku80), the MRX complex (Mre11, Rad50, and Xrs2), and the proteins Rif1,
Rif2, Rap1, Exo1, Est1, Est2, Tel1, and Mec1. Nonetheless, the shortest paths between three
ESCRT factors (Vps27, Hse1, and Stp22) and Cdc13 had a distance of only two or one tra-
verse protein, each. Remarkably, those ESCRT factors were also two steps away from Rad53.
Figure 3.22.: Matrix of shortest path distances between members of the ESCRT family and telomere related
proteins. Shortest path investigation was done using the igraph library of R [206,212].
Figure 3.23 represents the induced sub-network for all those PPIs having a distance of two. In
there, Cdc13, Rad53 and the ESCRT-0 complex, especially Vps27, form a dense sub-network.
In detail, Vps27 (ESCRT-0) is linked with Cdc13 by seven protein kinases (PKs) in parallel
(suppl. table C.4). The PPI-NW contains 29 interaction partners for Cdc13 of which 16 are
related to protein phosphorylation (P = 2.10e−12, YeastMine GO-BP enrichment [192]).
As all nodes interlinking Vps27 and Cdc13 are PKs and as such associated with protein
phosphorylation (P = 4.8e−7, YeastMine GO-BP enrichment [192]), I tested whether this en-
richment for PK edges was significant. Hence, I derived the representative contingency table
(table 3.5) and a two-sided Fisher’s Exact test was calculated, resulting in a p-value of 8.4e−3.
This p-value indicated that the amount of PK edges was not to be expected by chance.
Table 3.5.: Contingency table for the PK edges connecting Cdc13 and Vps27. The p-value of this overlap was
8.4e−3.
protein phosphorylation protein phosphorylation
Cdc13 neighbour is Vps27 7 0 7
Cdc13 neighbour is Vps27 9 13 22
16 13
∑
29
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Figure 3.23.: Induced sub-network for all vertices between TRPs and ESCRT factors having a shortest path
distance of two. The underlying binary PPI-network was provided by Christine Brun. Overall the network contains
31 vertices and 64 edges. The used symbols correspond to the encoding genes.
Moreover, a cytoskeletal protein binding protein (Sla1) is connecting Tel1 and Mec1
to Hse1 (ESCRT-0) and Stp22 (ESCRT-I). Mec1 and Tel1 are both DNA damage
checkpoint kinases that are known to be required for telomerase activation [69]. In the
presence of DNA damage, they activate Rad9 leading to Rad53 phosphorylation and
subsequent cell cycle arrest (section 1.2.2 and fig. 3.19). Hse1 is linked to Rad53 by
Sla1 and two further proteins associated with the actin cytoskeleton (Aim3 and Las17,
suppl. table C.4).
Altogether the PPI-NW analysis suggested a strong connection of ESCRT-0 to the telomeric
system via Cdc13.
3.3.2. Expression Changes Upon ESCRT Gene Deletions
Furthermore, I analysed gene expression data obtained genome-wide for deletion strains
corresponding to one-quarter of the baker’s yeast genes [179]. These expression pro-
files were measured for strains kept under standard growth conditions allowing the
study of a particular gene perturbation without side effects caused by special envir-
onmental conditions. Twelve deletion strains corresponding to ESCRT factor encoding
genes were contained within the samples of this data (fig. 3.24). Most of them were an-
notated with a clear cdc13-1 rescue effect (table 3.4). Seven of the nine escrt ∩ tlmshort
mutants were among those twelve deletion strains. Thus, the included escrt mutants
reflected those that showed the strongest phenotypical association to telomere maintenance.
As described in section 2.1.3, I extracted a matrix of expression values for telomere related
protein (TRP) encoding genes (targets, rows) and escrt mutants (samples, columns). Fig-
ure 3.25 shows this matrix. Only significant changes in expression were plotted (log2(FC)
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Figure 3.24.: Venn diagram representing the
ESCRT genes contained within as responsive
classified samples in the expression data of
Kemmeren et al. [179]. Deletion strains of
the genes highlighted in red exhibited shorter
telomeres (tlm mutants) and those marked
with an asterisks showed a clear rescue of the
temperature sensitivity of cdc13-1 (table 3.4).
with P ≤ 0.05). In general, deletion of ESCRT genes affected the expression of TRP
genes only occasionally. However, the scale of the fold-changes (FCs) ranged from -
0.35 – 0.31, so that these FCs could not be considered as being reliable and the mat-
rix in fig. 3.25 was to be interpreted that the deletion of any ESCRT gene does not
influence the expression of TRP encoding genes. This interpretation was supported
by the circumstance that the scale of the FCs ranged from -3.4 – 3.4 for all target
genes. In all contained escrt mutants, another ESCRT gene was the most up-regulated
gene, and one of the following three genes was most down-regulated: ARG3 (involved
in arginine biosynthesis), Q0060 (a mitochondrial gene), or YDR133C (dubious sys-
tematic open reading frame identifier that is unlikely to encode a functional protein).
Figure 3.25.: Matrix of gene expression
values. Columns refer to ESCRT gene de-
letion strains (samples) and rows contain
TRP encoding (target) genes. Only signific-
ant changes in expression were plotted. The
colour and size of the circles encode the
log2(FC) with a p-value ≤ 0.05. The gene
expression data was taken from Kemmeren
and colleagues [179].
Nevertheless, having found experimental evidence that the whole ESCRT family rescues
cdc13-1 capping-defective telomeres, I attempted to find up- or down-regulated KEGG
pathways [5–7] upon disruption of the ESCRT machinery. To this end, a gene set enrich-
ment analysis (GSEA) against a pre-ranked list of genes was performed. In a preparatory
step, the target genes were ranked in descending order by the t-statistic from a Student’s
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t-Test for all escrt samples versus the remaining samples. Figure 3.26 summarises the results.
Figure 3.26.: Volcano plot of up- or down-regulated pathways upon disruption of the ESCRT machinery. A GSEA
for KEGG pathways [5–7] against a pre-ranked list of genes was carried out using the GSEA software offered by
the Broad Institute of MIT and Harvard [214,215]. The gene expression data was taken from Kemmeren and
colleagues [179]. Pathways highlighted in red reached a FDR ≤ 25% and those in grey did not. A NES > 0
indicates pathways up-regulated in the escrt strains and a NES < 0 reflects down-regulated pathways. NES,
normalised enrichment score.
The GSEA highlighted pathways that are known to be up- or down-regulated in response to
environmental stress and revealed no peculiarities about the relationship of TLM and the ES-
CRT family. Keeping the manifold cellular sites in mind that the ESCRT system is acting on,
it is plausible that already its disruption puts cells under stress. In the environmental stress
response, e.g. growth-related processes and nucleotide biosynthesis are repressed, while path-
ways required for survival are induced (e.g. autophagy, intracellular signal, and vacuolar func-
tions) [238].
3.3.3. Genetic Interaction Score Exploration for ESCRT Factors
The Lydall laboratory derived a genetic interaction score (GIS) from a “Quantitative
Fitness Analysis on thousands of yeast strains containing mutations affecting telomere-
capping proteins (Cdc13 or Yku70) in combination with a library of systematic gene
deletion mutations” [201]. Hereby, they were able to systematically identify suppressors or
enhancers of the capping defects caused by either disrupting CST- or Ku-complex telomere
capping. In order to find more information that can be used to understand the functional
association of telomere length maintenance and the ESCRT system, I briefly plotted the
GISs for yku70 yfg∆ mutants against the GISs of cdc13-1 yfg∆ mutants and marked short
tlm and escrt mutants (fig. 3.27). Overall, the data set contained merely six ESCRT
genes of which VPS27 was the only TLM gene. As can be seen in fig. 3.27, all escrt
mutants received a positive GIS with cdc13-1, thus suppressing its defect and supporting
the experimental results (suppl. fig. B.7 and table 3.4). The escrt mutants were spread all
over the positive cdc13-1 GIS range. They did not form clusters that could have been used
to infer additional knowledge about the causality of the defect suppression. Interestingly,
the escrt mutants yielded only negative GISs in combination with YKU70 deletion. In
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Figure 3.27.: Plot of the GIS for yku70 yfg∆ mutants against the GIS of cdc13-1 yfg∆ mutants. Short tlm
and escrt mutants were highlighted as follows: Yellow, short tlm mutants; blue, escrt mutants that showed
telomere shortening; green, remaining escrt mutants; grey, all other data points. Data was extracted from
Addinall et al. [201].
contrast to the cdc13-1 double mutants, escrt mutants enhanced the yku70 defect. However,
as the Ku complex is involved in NHEJ, too, it is difficult to interpret observations gathered
by Ku perturbations and assign them to either NHEJ or telomere homoeostasis. I did not
evaluate the influences of this complex on telomeres in the background of ESCRT deletions.
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4 Conclusion
When the absence or aberrance of one component is shown to stop a system working, we
have to be careful how we interpret this.
(Denis Noble, [18])
The present dissertation aimed at a systems biological analysis of the genetic regulation
effecting telomere homoeostasis. Telomeres represent special structural and functional units
forming the ends of eukaryotic chromosomes. Dysfunctional telomeres can give rise to severe
imbalance of the genomic stability and reduced integrity that are vital to every cell and
organism. A myriad of human syndromes, neurodegenerative diseases, immunodeficiency
as well as cancer are associated with defects in factors sensing and responding to DNA
damages [26–30] and thus, to telomeres, too. Although profound knowledge has already been
gained about telomere biology in general and its homoeostasis, we are far from understand-
ing it in all its details and complexity — especially if it comes to mammalian telomeres
(section 1.3). As described in section 1.5.2, Saccharomyces cerevisiae serves as an excellent
model organism to study telomere biology and to transfer the gained knowledge to humans.
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4.1. The ESCRT System is Linked to Telomere Length
Maintenance
The system-wide exploration of the signals regulating telomere length maintenance was
based on a list of genes — telomere length maintenance (TLM) genes — from Saccharomyces
cerevisiae whose respective deletions were found to affect telomere length (increased shorten-
ing or lengthening) [183–185,195,197].
At first, I performed a comprehensive and unbiased analysis to get an overview of the
genes within the TLM list by testing it for enrichment of specific KEGG pathways [5–7]
or functional categories (MIPS FunCat; [8,9]). Surprisingly, the top-ranking KEGG path-
way for short tlm mutants was endocytosis with a corrected p-value of 2.6e−5 (two-sided
Fisher’s Exact test, table 3.1), while the remaining pathways were to be expected in
the context of (dysfunctional) telomere maintenance (e.g. nucleotide metabolism or DNA
damage repair). The enrichment for endocytosis was basically due to an accumulation of
nine out of nineteen endosomal sorting complex required for transport (ESCRT) factors
within the set of short tlm mutants (P = 8.8e−9, two-sided Fisher’s Exact test, tables 3.2
and 3.3).
ESCRT factors define a system of five multi-protein complexes which is involved in de-
forming and scissioning cytosol filled membrane stalks (e.g. MVB formation [107,116–118],
cytokinesis [106,119–121], and enveloped viral budding [106,122,123]; section 1.4.1). However,
they are linked to genomic stability and integrity, too, as deletion of certain ESCRT proteins
were found to cause defects in chromosomal segregation in humans [130] and in yeast [131]. In
humans, ESCRT proteins are also associated with chromatin remodelling [129]. Nonetheless,
except for Rog et al. [198], there is no literature describing any link or mechanistic insights
into the association of telomere length maintenance and vesicular traffic or endosomal sort-
ing. Rog and colleagues have analysed how telomere maintenance is influenced by a subset
of proteins belonging to the family of vacuolar protein sorting (VPS) [198] of which ESCRT
factors represent the class E VPS subfamily [103–105]. Although they have revealed that the
exertion of influence on telomere length by the tested VPS genes depends on telomerase and
the Ku complex while being independent of Tel1 and Rap1, Rog and colleagues could only hy-
pothesise about the causal link between telomere homoeostasis and vacuolar sorting mechan-
isms [165,198].
4.1.1. Deletion of VPS27 Rescues Dysfunctional Telomeres by Impairing
Exo1-Mediated Resection
With respect to the significant enrichment of ESCRT factors within the short tlm mutants
and the little knowledge about the relationship of telomere homoeostasis and vacuolar
sorting, I chose to perform a more in-depth experimental analysis of this association.
For this, I decided for VPS27 as a representative of the enriched genes for the experi-
mental investigations. Vps27 and Hse1 form the heterodimeric ESCRT-0 complex. Both
proteins are conserved throughout the group of opisthokonts (animals and fungi) [103].
According to Prag et al., ESCRT-0 is a multifunctional complex that (i) is required for
recognising and sorting ubiquitinated cargo molecules into multi-vesicle bodies, and (ii)
ensures efficient recycling of late Golgi proteins like the carboxypeptidase Y (CPY, a
vacuolar protease) sorting receptor [239]. In the absence of the Hse1 core domain, Vps27 can
form a stable monomer, whereas Hse1 aggregates and is degraded if expressed in isolation of
Vps27 [239].
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Shachar et al. have shown that in VPS27 deleted cells, telomeres are shorter than the wild-
type length of 350 bp [195]. I was able to validate this shortening effect in vps27 mutants,
but only for Y’-element containing (fig. 3.2a telomeres, in agreement with Shachar et al.)
and not for a X-only (fig. 3.2b, no pronounced shortening) telomere. Thus, the deletion
of VPS27 did not affect all telomeres equally. For testing whether telomerase function is
disturbed in a VPS27 deleted background, senescence and the rate of telomere shortening
was recorded and compared to est2 mutants in which telomerase-dependent telomere
elongation is not working properly and therefore these mutants senesce faster [88]. The
rate of senescence (fig. 3.3a) as well as telomere shortening (fig. 3.3c) was similar in
est2 vps27 double mutants compared to est2 single mutants suggesting that telomerase-
dependent telomere elongation is corrupted in VPS27 deleted cells. Data from Chang
and colleagues supports the finding of accelerated senescence for est2 vps27 mutants
as the average profile of est1 escrt double mutants (fig. 3.3b, dark red line) was more
similar to the archetype for accelerated entry to senescence (fig. 3.3b, light blue line)
than to normal senescence (fig. 3.3b, light grey line) [203] indicating that most likely a
deletion of any ESCRT factor results in accelerated entry to senescence. The indications
that the telomerase-dependent telomere elongation is corrupted in VPS27 deleted cells
is further underlined by data from the Kupiec laboratory showing that telomere elonga-
tion was drastically decreased in vps27 mutants in response to ethanol [13,240], although
previous work has discovered that exposure to ethanol stress generally leads to increased
telomere elongation by taking advantage of the same mechanisms as under normal condi-
tions [199].
In addition to proper telomere elongation, telomere homoeostasis relies on a functional
capping system, especially of the 3’ ssDNA overhang. The Cdc13-Stn1-Ten1 (CST) complex
shelters this overhang from Exo1-mediated resection as part of a DNA damage response
(DDR) that is not desirable at telomeres (section 1.3.2.3 and fig. 1.13). Besides being the key
player of this capping complex, Cdc13 is involved in the recruitment of telomerase during
telomere replication (section 1.3.2.2 and fig. 1.12). Thus, the question arose whether and
how the deletion of VPS27 affects cdc13-1 (capping-) defective telomeres. As CDC13 is an
essential gene, only a temperature-sensitive allele (cdc13-1 ) can be used to study CDC13
impairment [43]. Examining the viability of the corresponding temperature-sensitive strain
in combination with the deletion of VPS27 revealed an increased viability of cdc13-1 cells
at non-permissive temperatures by this deletion (fig. 3.5). This finding is in concordance
with an already reported synthetic rescue of cdc13-1 mutants by the deletion of HSE1 [200].
Hence, ESCRT-0 seems to protect cells from uncapped telomeres. As the 5’ end of un-
capped telomeres is degraded by the exonuclease Exo1 leading to a robust cell-cycle arrest
(section 1.3.2.3 and fig. 3.4), a dysfunctional Exo1 would explain the rescue effect of VPS27
deletion on cdc13-1 defective telomeres. Degrading the 5’ end of telomeres leads to an
increased amount of telomeric single-stranded overhangs. Indeed, the telomeric overhang
was decreased in cdc13-1 vps27 double mutants subsequent to the induction of telomere un-
capping by heat shock (fig. 3.7). Furthermore, overexpression of Exo1 in cdc13-1 vps27 cells
(but not an empty vector) abolished the aforementioned rescue effect (fig. 3.8), supporting
the idea of a defective Exo1-mediated resection upon VPS27 deletion. A malfunction of
Exo1 can be caused either by decreased protein levels or improper localisation. At first,
no reliable changes in the protein levels of Exo1 were neither detected in vps27 single
(figs. 3.9a and 3.9b) nor in cdc13-1 vps27 double mutants (figs. 3.9c and 3.9d). Additionally,
normal degradation of Exo1 was observed in double mutants (fig. 3.10). Due to a weak
GFP-signal, imaging of GFP-labelled Exo1 in the mutants in question failed and therefore
the possibility of Exo1-localisation problems as reason for the seen phenotypes cannot be ex-
cluded.
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The 5’–3’ resection mechanism of Exo1 is also important for the HR DSB repair pathway (sec-
tion 1.2.2 and figs. 1.5 and 3.11). Hence, vps27 cells were examined in the light of HR. On one
hand, VPS27 deleted cells were sensitive to zeocin induced DSBs (fig. 3.12) and on the other
hand the growth capabilities of a HR proficient strain were slightly decreased in the presence
of VPS27 deletion (fig. 3.14). Those results point to an impaired homologous recombination
upon deletion of VPS27. Consistent with the idea of impaired Exo1-mediated resection at un-
capped telomeres, dysfunctional Exo1 action could also explain these observations. However,
overexpression of Exo1 did not have any effect on the sensitivity of vps27 mutants to zeocin
(fig. 3.15).
As all results strongly suggested that Exo1-mediated resection is prevented in VPS27 de-
leted cells, Prof. Longhese was asked to test the resection efficiency in those mutants. They
have developed an assay to follow the 5’–3’ resection activity of Exo1 after the induction of
a DSB at the mating type locus [223,229]. No difference in the resection kinetics between
the wild-type and vps27 mutants (fig. 3.16) were observed. But as the induction of the DSB
was less efficient in the mutant than in the wild-type, the absence of a difference in the
resection efficiency is unreliable and a resection defect is still possible. Furthermore, several
experiments were conducted to verify the hypothesis of an impaired resection in vps27
mutants. First, the deletion of VPS27 did not rescue every temperature-sensitive yeast strain
(suppl. fig. A.3). Second, the rescue of cdc13-1 defective telomeres was not due to a check-
point defect (figs. 3.18 and 3.20), and third, autophagy was not involved in that rescue (ap-
pendix A).
Altogether, the experimental data supports a model (fig. 4.1) in which deletion of VPS27
diminishes Exo1-mediated 5’–3’resection of ssDNA overhangs. Although this is beneficial for
dysfunctional telomeres, it impairs telomere replication and HR to repair DSBs elsewhere
in the genome. In homologous recombination, Exo1-mediated resection is vital to prepare
the DNA lesion for subsequent homology search and strand invasion (fig. 1.5). Improper
resection renders the foundation of HR impossible, so that the main DNA damage repair
pathway of S or G2 phase is suppressed, stalling the cell cycle. The hypothesis of a hampered
HR mechanism is supported by the data indicating that vps27 mutants are sensitive to
DSBs induced by zeocin (fig. 3.12) and that HR proficient cells exhibited decreased viability
in the presence of VPS27 deletion (fig. 3.14). In case of 3’ capping defective telomeres,
the ssDNA is mistakenly recognised as DNA damage, stimulating the cell’s DNA damage
repair mechanisms and resulting in a robust cell cycle arrest. Dampened Exo1-mediated
resection is helpful in this scenario as the amount of arising telomeric overhang by 5’–3’
resection is decreased. Several findings support this model: (i) deletion of VPS27 rescued
the temperature sensitivity of cdc13-1 mutants (fig. 3.5), (ii) cdc13-1 vps27 double mutants
had less telomeric overhangs than cdc13-1 single mutants after induction of telomere
uncapping by heat shock (fig. 3.7), and (iii) overexpression of Exo1 abolished the rescue
effect. However, Exo1-mediated resection is also required during the regular replication of
eroded telomeres as it reconstitutes the G-tail following DNA replication (section 1.3.2.1
and fig. 1.11). The overhang itself serves as target site for Cdc13 binding. Depending on cell
cycle regulated post-translational modifications, Cdc13 forms either a complex with Est1
to recruit telomerase or with Stn1 and Ten1 to protect the telomeric overhang [241]. Hence,
according to the cell cycle phase, faulty resection hinders telomere elongation (S phase) or
telomeric overhang capping. Nonetheless, the proposed model is not only able to explain
the observations gained in the context of a defective Cdc13 (cdc13-1 vps27 mutants), but
also explains the data pointing to an improper telomerase-dependent telomere elongation
in vps27 mutants (figs. 3.2 and 3.3). Only the improved viability of cdc13-1 exo1 vps27
mutants (fig. 3.17) indicating independence of Exo1 and Vps27 argues against the described
model.
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Figure 4.1.: Model of impaired Exo1-mediated 5’–3’ resection by the deletion of VPS27 which is beneficial
for dysfunctional telomeres, but impairs telomere replication and homologous recombination to repair DSBs
elsewhere in the genome. Proper Exo1-mediated resection at DSB sites is required to prepare the lesion for
subsequent homology search and strand invasion. Otherwise homologous recombination is not possible. Uncapped
telomeres are recognised as DNA damage, initiating DNA damage response (DDR). 5’–3’ resection is fundamental
to regular telomere replication. Following DNA replication, it reconstitutes the telomeric overhang that serves as
binding site for Cdc13. Depending on the cell cycle stage, Cdc13 is either bound in a complex with Est1 to recruit
telomerase or it forms the Cdc13-Stn1-Ten1 (CST) capping complex to shelter the G-tail from unfavourable
DDR mechanisms. Grouping is indicated by coloured backgrounds.
4.1.2. Rather the Whole ESCRT System Than Only VPS27?
Based on the fact that only nine out of nineteen ESCRT factor encoding genes were enriched
in the TLM gene list I decided to test whether all or only some ESCRT factor deletions
lead to a rescue of cdc13-1 ’s temperature sensitivity and show a decreased resistance to
DSBs. Experimental data from the present thesis and existing data from the Saccharomyces
Genome Database database suggest that the whole ESCRT family is rescuing a cdc13-1
defective telomere-cap (suppl. fig. B.7) and that any ESCRT factor deletion results in in-
creased sensitivity to DNA double-strand breaks (figs. 3.12 and 3.21). The assumption that
the whole ESCRT system is necessary for proper maintenance of telomere length is strongly
supported by data from Vera Babin: In her work it was observed that all escrt mutants ex-
posed to ethanol stress show a weaker response to ethanol than the wild-type, whereas vps27
and snf8 exhibited the strongest effects [13,240]. Moreover, the telomere elongation kinetics
of six escrt mutants (vps27, snf8, vps20, snf7, did4, doa4 ) in the presence of a Cdc13-Est1
fusion protein were evaluated. This fusion protein enforces telomerase to be tethered to
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the telomeric overhang that results in vigorous telomere elongation in wild-type cells [242].
Usage of this fusion protein allows distinguishing between defective telomerase recruitment
and malfunctioning telomerase activation. Tethering telomerase to the telomere would by-
pass a defective recruitment mechanism and lead to wild-type levels of telomere elongation.
However, if activation of telomerase is affected by the deletion of a particular ESCRT gene,
telomere elongation would be still reduced in the presence of this Cdc13-Est1 fusion protein.
In comparison to wild-type levels, telomere elongation was still reduced in all tested escrt
mutants, even with the fusion protein. The same held true under ethanol stress in the pres-
ence of the Cdc13-Est1 fusion protein in vps27 and snf7 mutants [13,240]. According to the
rationale of the fusion protein assay, those observations would assume that ESCRT factors
are required for the activation of telomerase. Nevertheless, a defective Exo1-mediated
resection could lead to an insufficient single-stranded overhang, which is a prerequisite
for telomeric Cdc13 binding and subsequent telomere elongation. Therefore, the model
proposed in fig. 4.1 explains the decreased telomere elongation response upon deletion of any
ESCRT factor, especially VPS27, as well as the results from the Cdc13-Est1 fusion protein as-
say.
For the purpose of gaining more insights into the functional relationship of telomere length
maintenance and the ESCRT system, several in silico analyses were performed. First, an
investigation of the protein-protein-interactions (PPIs) between the ESCRT system and
telomere related proteins (TRPs) revealed that only the ESCRT-0 complex and Stp22
(ESCRT-I) are densely connected to the set of TRPs (fig. 3.23). Putting it more precisely,
Vps27 is linked by seven protein kinases (PKs) in parallel to Cdc13. This enrichment for
PKs yielded a p-value of 8.4e−3. Second, deletion of any ESCRT gene did not influence the
expression of TRP encoding genes (fig. 3.25). A GSEA highlighted pathways that are known
to be up- or down-regulated in response to stress (fig. 3.26), but gave no new insights into the
relationship of TLM and the ESCRT family. Keeping the manifold cellular sites in mind that
the ESCRT system is acting on, it is plausible that its disruption leads to a stress response.
Finally, a dataset of genetic interaction scores for cdc13-1 yfg∆ [201] was checked for genes
whose deletion have similar effects on cdc13-1 mutants like the ESCRT deletions. As the
ESCRT factors are spread all over the range of cdc13-1 defect suppression levels (fig. 3.27)
and do not cluster with particular genes, I decided not to look further into the neighbouring
genes.
In conclusion, the present dissertation enriches the current knowledge and understanding
of telomere length maintenance with a model of hampered Exo1-mediated resection by the
deletion of VPS27 (fig. 4.1) and the plausible hypothesis that the whole ESCRT system is
required for proper telomere length maintenance. The model integrates the cdc13-1 rescue
with the observed telomerase defect. Impaired Exo1-mediated resection results in too little
3’ overhang such that Cdc13 binding is suppressed, preventing either telomerase recruitment
or telomeric overhang capping (according to cell cycle phase). Furthermore, a PPI network
analysis revealed that Cdc13 and Vps27 are tightly interlinked by several PKs in parallel,
leaving room to speculate that they serve in a feedback loop to regulate telomere homoeo-
stasis via the ESCRT machinery, whereat Vps27 represents the entry point to it. Indeed, Mor-
van and co-workers showed that recruitment of the ESCRT machinery depends on the phos-
phorylation of Vps27 [243].
4.2. Future Perspectives
As pointed out in section 1.5.1, Saccharomyces cerevisiae serves as an excellent model
organism to study telomere biology. Both, telomere length maintenance and the ESCRT
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system share many structural and functional characteristics between yeast and mam-
mals. A major difference is that the ESCRT factors are essential to mammals [155],
which is not the case for yeast cells. This fact has to be kept in mind when transferring
knowledge about the ESCRT family from baker’s yeast to mammals. It is quite likely
that “most dominant ESCRT mutations [...] cause prenatal death” [155] and that under
stress-free conditions one intact allele of an ESCRT factor encoding gene is sufficient
to maintain viability. Moreover, disruption of ESCRT factors bears potential oncogen-
icity [155]. However, data from various model organisms and tumour samples have as
yet failed to find “a unifying concept of how the ESCRT machinery or loss thereof
would contribute to cancer” [244]. In general, the role of ESCRT factors in tumourigen-
esis can be accounted for by either deregulated mitogenic signalling (sustained receptor
signalling due to lack of endocytosis) [107, 244] or cytokinetic defects resulting in an-
euploidy [155,244].
Having found evidence that the ESCRT machinery is involved in telomere length homoeo-
stasis, ESCRT factors could represent new targets to tackle telomerase reactivation and
up-regulation in tumour cells which is a well-known hallmark of human cancer [95], after
all 85–90% of them show telomerase up-regulation. Additionally, the inhibition of one or
multiple ESCRT factor(s) could be used to hyper-sensitise cells to DNA damage. This in
turn could be combined with radio- or chemotherapy inflicting damage to kill cancer cells.
Hyper-sensitising cells to DNA damage might allow lower dosage of chemotherapeutics or
x-rays. As most of the ESCRT factors are associated with human diseases to a varying de-
gree (section 1.4.4 and Stuffers et al. [155]), and as the ESCRT system is involved in various
critical cellular processes (section 1.4.1), targeting the whole ESCRT system is not advisable.
Especially, artificial disruption of ESCRT-III and associated proteins would be difficult
to control in mammals due to their involvement in crucial nuclear functions (chromatin
remodelling [129], chromosomal segregation [130], and nuclear envelope reformation [127])
and cytokinesis [106,119–121]. In addition, ESCRT-III is the most ancient and conserved
ESCRT complex [107, 109], and sufficient to achieve minimal ESCRT function [103, 133],
which is emphasising its requirement. Compared with that, ESCRT-0 is well-suited for
additional examinations to test its suitability as drug target. First, it has evolved rather
recently [109,133] and might therefore be substitutable more easily and cells may cope better
with its loss. Second, up to now ESCRT-0 is not associated with any of the aforementioned
nuclear functions or ESCRT functions beyond MVB, that is its dysfunction might not
cause side effects as severe as in other ESCRT disruptions. The suitability of ESCRT-0 as
an anti-cancer drug target is further strengthened by data from Toyoshima and colleagues
showing that Hgs (mammalian homologue of Vps27) is up-regulated in several tumour
entities (e.g. melanoma, cervix, and liver) and that its down-regulation by siRNA “reduced
the tumourigenic potential” [244,245]. Nevertheless, observations made in the present thesis
in S. cerevisiae have to be thoroughly verified when translated to humans or mammals in gen-
eral.
Nonetheless, additional experimental investigations of the association between telomere
length maintenance and the ESCRT system in yeast would be advisable to strengthen and
to expand the current findings. Exploring the effect of an ESCRT inhibitor on cdc13-1
cells in yeast would be interesting as this would mimic the deletion of an ESCRT factor
and could limit them to the most promising drug targets. Yibmantasiri et al. repor-
ted a compound — neothyonidioside — that causes the same morphological defects
as the deletion of VPS27 or VPS17 [204]. To the best of my knowledge, this is the
only compound specifically targeting a member of the ESCRT family in baker’s yeast.
All other available drugs inhibit the whole endocytosis pathway which is not appropri-
ate.
83
4. Conclusion
I chose VPS27 for an in-depth experimental analysis leading to the model just discussed
(fig. 4.1). VPS27 was also amongst the ESCRT factors with the strongest phenotypes in
terms of non-responsiveness to ethanol stress or in the presence of a Cdc13-Est1 fusion
protein [13,240]. Although the presented data strongly supports this model, it would be
beneficial to further verify it. The lack or decrease of resection in vps27 mutants has to
be established and potential localisation problems of Exo1 should be examined with an
approach allowing better resolution and accuracy. Establishing the localisation route of
Exo1 from the cytosol (site of translation) into the nucleus would be beneficial, too, as
this could provide new indications if and at which point ESCRT factors or only Vps27
might interfere. Another follow-up strategy could be visualisation of Vps27 and tracking it
in cdc13-1 cells before and after induction of telomere uncapping. In any case it will be
important to continue to compare vps27 mutants with cdc13-1 vps27 and cdc13-1 mutants
(dysfunctional telomeres) as well as with the wild-type (as control). Of course, all proposed
follow-ups could be performed with other escrt mutants, too, albeit VPS27 is the most
promising target due to the current findings and its role within the ESCRT machinery.
84
A Supplemental Experiments
85
A. Supplemental Experiments
Additional Experiments to Explore the Association of TLM and
the ESCRT System
In the context of this work and in addition to the experiments presented in chapter 3, several
further experiments were conducted to investigate assumptions raised by previous experi-
ments, but not following the main research scope of the present thesis.
Exo1 Overexpression Does Not Rescue Y’-Telomere Length in vps27 Mutants
Shachar et al. reported a telomere shortening effect upon VPS27 deletion for Y’-element
containing telomeres [195] that was also visible in the telomere length measurements
presented in fig. 3.2. Having received multiple hints that Exo1 might be malfunctioning
in VPS27 deleted cells, I examined whether overexpressing EXO1 in vps27 mutants
rescues the telomere shortening. Therefore, the same galactose-inducible EXO1 overex-
pression plasmid or the respective empty vector control as used in section 3.2.3.2 was
introduced into the wild-type and vps27 mutants. Afterwards, the resulting strains were
grown for at least 150 generations by serial restreaks on SGalRaf-Leu plates. The DNA
from all strains was extracted and subjected to telomere PCR to measure the length of six
Y’-telomeres. Figure A.1 represents the quantification of the underlying agarose gel (fig. B.9).
wild-type EV wild-type OE vps27 EV vps27 OE
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Figure A.1.: Quantification of the telomere PCR (fig. B.9) for wild-type and vps27 cells containing either an
EXO1 overexpression plasmid (OE) or the corresponding empty vector control (EV) measuring the length of six
Y’ telomeres. The bars represent the median of the respective data points.
According to the quantification in fig. A.1, the telomere length was not affected by overex-
pressing EXO1. This experiment was only conducted for Y’-element containing telomeres,
as the X-only telomere length difference (fig. 3.2b) was not as pronounced as for the Y’-
telomeres (fig. 3.2a).
Slight Rescue of STN1 Defect by Deletion of VPS27
As Cdc13 is part of the Cdc13-Stn1-Ten1 (CST) complex capping the telomeric overhang,
the question arose whether deletion of VPS27 does only rescue a cdc13-1 capping-defective
telomere or if the remaining CST subunits exhibit the same effect. Therefore, a temperature-
sensitive allele of STN1 (stn1-13 ) was utilised, because all three genes encoding the different
CST subunits are essential. Equivalently to the viability spotting assay for the cdc13-1
vps27 mutant, a stn1-13 vps27 mutant was constructed and examined for its viability at non-
permissive temperatures (> 30 ◦C).
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(a)
@25°C @30°C @31°C
wild-type
stn1-13
sae2
vps27
stn1-13sae2
stn1-13vps27
sae2vps27
sae2stn1-13vps27
wild-type
stn1-13
sae2
vps27
stn1-13sae2
stn1-13vps27
sae2vps27
sae2stn1-13vps27
(b)
Figure A.2.: Temperature rescue spotting at the indicated temperatures. Wild-type cells and cells of the indicated
mutants were spotted in duplicates in 10-fold serial dilutions onto standard YPD plates and incubated for (a)
three or (b) four days.
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However, this double mutant did not show any clear increase in viability and the viability of
the stn1-13 single mutant was quite weak at non-permissive temperatures (fig. A.2a). Cells
harbouring the stn1-13 allele are generally less viable than cdc13-1 mutants as the defect
of the stn1-13 allele is more severe. Although CDC13 is essential, too, the point mutation
in stn1-13 mutants causes a stronger deactivation of the respective protein, resulting in
stronger phenotypes than in cdc13-1 mutants. Introducing a deletion of SAE2 slightly
improves the viability of stn1-13 mutants because this diminishes nuclease activity at
uncapped telomeres. As described in section 1.3.3, Sae2 is another nuclease acting at sites
of ssDNA ends, such as uncapped telomeres. I performed a viability spotting assay of all de-
rivatives from crossing a stn1-13 vps27 double mutant to a sae2 mutant. The triple mutant
exhibited increased viability at higher temperatures compared to the single mutant stn1-13
(fig. A.2b), pointing to a rescue effect of VPS27 deletion on any CST telomere capping de-
fects.
Rescue by The Deletion of VPS27 is Specific to The CST Complex
In order to ensure that the deletion of VPS27 is not rescuing every temperature-sensitive
mutant, I randomly chose three strains from the temperature-sensitive collection and the
vps27 yfts double mutant was constructed with each of them. All genotypes derived from
the individual crossings were examined in a viability spotting assay at different temperatures.
@23°C @27°C @30°C @34°C @37°C
wild-type
vps27
arc15-0
acr15-0vps27
wild-type
vps27
arc15-0
acr15-0vps27
wild-type
vps27
arp7-E411K
arp7-E411Kvps27
wild-type
vps27
arp7-E411K
arp7-E411Kvps27
wild-type
vps27
gfa1-97
gfa1-97vps27
wild-type
vps27
gfa1-97
gfa1-97vps27
Figure A.3.: Spotting assay for testing the viability of randomly chosen temperature-sensitive mutants at higher
temperatures in the presence of VPS27 deletion. Cells of the indicated genotypes were spotted in duplicates
10-fold serially diluted onto standard YPD plates and incubated for three days.
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From comparing the growth spots of the individual temperature-sensitive single mutants and
the corresponding double mutants in fig. A.3, it became apparent that the deletion of VPS27
is not enhancing the viability of every temperature-sensitive mutant. Hence, the rescue effect
for cdc13-1 mutants reported herein was not just arbitrary.
Cdc13 Protein Levels in VPS27 Deleted Cells
The protein levels of Cdc13 in vps27 mutants were measured after growth to exponential
phase under standard conditions (YPD medium, 30 ◦C). This Western Blot strongly suggests
decreased levels of Cdc13 upon deletion of VPS27.
(a) Western Blot. (b) Quantification.
Figure A.4.: Western Blot for measuring Cdc13 protein levels in vps27 mutants. Protein samples were collected
after growth to exponential phase at 30 ◦C. Protein levels were measured for two biological replicates. (a) shows
the underlying membrane quantified in (b). The upper lane of the membranes represent the Cdc13 signal and
the lower lanes correspond to actin as loading control. The quantification indicates the relative amount of Cdc13
over actin. Figure B.10d depicts the corresponding Ponceau staining.
Autophagy Does Not Link ESCRT Factors And Telomere Homoeostasis
One possible explanation for the association of ESCRT factors and telomere maintenance
was autophagy. “Studies of nematodes, flies and mammals have revealed that the ESCRT
machinery has a role in autophagy [142]” (see also section 1.4.2.2). It has been shown that
the disruption of the ESCRT machinery leads to autophagosome accumulation and neuro-
degenerative diseases [124,143,144]. Furthermore, Djeddi et al. have found evidence that in
escrt mutants autophagy is induced as adaptive response for cell survival to counteract the
formation of enlarged endosomes [126]. Moreover, Robert and colleagues have reported that
Exo1 and Sae2 are degraded via the autophagy pathway [246, 247], indirectly linking te-
lomere homoeostasis to autophagy. Figure A.5a summarises the aforementioned associations.
In order to explore whether autophagy is linking the ESCRT system to telomere main-
tenance, an ATG5 deletion strain and the cdc13-1 vps27 double mutant were crossed.
Deletion of ATG5 has previously been described to effectively block autophagy in yeast
and mammalian cells [248–250]. The constructed triple mutant atg5 cdc13-1 vps27 and the
corresponding single and double mutants were examined together with the wild-type in a
temperature rescue spotting. In fig. A.5b the triple mutant slightly surpassed the cdc13-1
vps27 double mutant in its growth abilities, suggesting that autophagy is not involved in
the functional association of VPS27 deletion and its rescue of cdc13-1 capping-defective te-
lomeres.
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(a) Autophagy and its links to TLM and the ESCRT system.
(b) Temperature rescue spotting.
Figure A.5.: (a) Schematic summary of the associations of autophagy to the ESCRT system and telomere
homoeostasis. Deletion of any ESCRT factor leads to autophagosome accumulation [124,126,143,144] and
induces autophagy [126]. Besides, Exo1 and Sae2 are degraded via autophagy [246,247]. (b) Viability spotting
at different temperatures of the indicated mutants and the wild-type. Cells were spotted in duplicates 10-fold
serially diluted onto standard YPD plates that were incubated for three days.
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in silico Analysis of The Relation between TLM And Ageing in
Saccharomyces cerevisiae
Data from the following section contributed to the manuscript “The relationship between te-
lomere length, cellular aging and fitness in Saccharomyces cerevisiae” by Harari et al. that is
currently in preparation [14].
As discussed in section 1.3.4, telomere erosion plays a critical role in ageing. I briefly
explored the relation of TLM genes and the genes related to life span in baker’s yeast.
Since more than fifty years budding yeast serves as model organism to study cellular and
organismal ageing while harbouring two different types of ageing [251–253]. The number of
daughter cells stemming from one mother cell prior to senescence is defined as replicative
ageing (RA) or ageing (proliferative capacity) [251, 254, 255]. Chronological ageing (CA)
describes “the length of time that a non-dividing yeast cell survives” [255]. Hence, yeast al-
lows studying both mitotic (e.g. epithelial or stem cells) and post-mitotic cells (e.g. muscles
and brain) individually and in parallel within a simple unicellular organism [251,254,255].
(a) (b)
(c) (d) (e) (f)
(g) (h) (i) (j)
Figure A.6.: Overlap of TLM and ageing related genes. Venn diagrams showing the overlap of genes associated
with telomere length maintenance and (a) chronological ageing or (b) replicative ageing. The p-values were
calculated with a Fisher’s Exact test. Please note that the complete set of TLM genes in panel (a) and (b)
contains additional TLM genes for which no telomere phenotype was annotated.
The Animal Ageing and Longevity Database (AnAge) [1] combines curated data on ageing
and life span in animals, inter alia data about the RA and CA of S. cerevisiae. Thus,
I used this database for evaluating the overlap of TLM genes with genes affecting life
span in yeast. Forty-one TLM genes have been annotated to affect chronological life span
(P = 0.014, fig. A.6a), whereas 63 TLM genes have been associated with replicative ageing
(P = 0.001, fig. A.6b). As expected, genes whose deletion led to telomere shortening were
clearly enriched for decreased RA (P = 0.001, fig. A.6i), as well as for decreased CA
(P = 0.006, fig. A.6g). There was no significant enrichment of short tlm mutants, increased
CA (P = 0.390, fig. A.6c), or RA (P = 0.706, fig. A.6e). In addition, long tlm mutants were
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not significantly associated with increased RA (P = 1, fig. A.6f) or CA (P = 0.187, fig. A.6d).
Interestingly, nineteen gene deletions have been annotated with decreased RA and their
deletion led to telomere lengthening (P = 0.017, fig. A.6j). In contrast to this observation,
there was no significant relation between long tlm mutants and decreased CA (P = 0.844,
fig. A.6h).
Table A.1.: Genes associated with telomere length maintenance and ageing. Genes occurring multiple times are
marked as follows (ageing phenotype – tlm phenotype): il, increased-long, ds, decreased-short, dl, decreased-long.
Gene symbols used in this table do not occur in the list of approved gene symbols.
TLM
Phenotype Gene Symbols
chronological ageing
increased short ADE12, CSR2, PDX3, PRS3, RNH201, TLC1, VPS75, YTA7
long CYR1 il
decreased short
APE3, ARF1, HDA2, MEC1, MRE11, MRPL38 ds, MRT4, NMD2,
PHO85 ds, RAD50, RPL13B, SAP30, SGF73, SIF2, SIR3, UPF3, VPS41 ds,
YEL033W, YKU70 ds, YKU80
long ARD1, MAK10dl, RAD27, SSN3 dl, TIF1, TIF2, YBR284W
replicative ageing
increased short IPK1, PMR1, RPL12B, RPL1B, RPL34B, URE2
long CYR1 il, IPK1, RPS18A, TIF1
decreased short
ARG2, CTK1, DOA4, DUN1, GTR1, HST1, LDB19, LST7, MRPL38 ds,
PCL6, PCP1, PHO85 ds, RPN4, RPP1A, SMI1, SWD1, SWD3, TFP1,
TLC1, UBP8, VAM7, VPS20, VPS21, VPS25, VPS27, VPS34, VPS41 ds,
WHI2, YFH1, YIL077C, YKU70 ds, YPT7
long
ATG17, CDC13, CDH1, FMP26, HSP104, MAK10 dl, MAK3, MED1,
NSR1, PUB1, RIF1, RPS17A, RPS27B, RPS4A, RPS4B, SOL2, SSN3 dl,
VRP1, YPL105C
Table A.1 lists all genes found within the phenotype specific overlaps. Most of these genes
occurred only in one overlap. However, ten genes were members of two different intersec-
tions. Of those ten, three indicated heterogeneous knock-out effects. TLC1 deletion showed
telomere shortening and increased CA, but also decreased RA. Deletion of TIF1 led to te-
lomere lengthening and decreased CA, but also increased RA. IPK1 deletion has been associ-
ated with an increase in RA and has been annotated with both, a long and a short tlm pheno-
type (within the original TLM gene list).
The laboratory of our Israeli cooperation partner Prof. Martin Kupiec has investigated
the relationship of TLM and life span experimentally. Their data revealed mainly that
chronological ageing is not affected by telomere length, although my enrichment ana-
lyses found telomere shortening to be associated with decreased chronological ageing
(fig. A.6g). In general, most of the overlaps between ageing related and TLM genes were
not significant and those that were significant comprised more or less expected inter-
sections. Knowing that upon a critical shortening of telomeres cells enter senescence
(fig. 1.16), the intersection of decreased RA and short tlm mutants was not surprising
(fig. A.6i). Only the association of decreased RA and long tlm mutants was counter intuitive
(fig. A.6j). An enrichment test with the nineteen genes corresponding to the latter overlap
92
for pathways or GO terms using the YeastMine functionality [192] revealed no significant res-
ults.
Materials and Methods Data processing and analyses were performed using R [206]. The
complete ageing data table for yeast (HAGR-ID 04235) was downloaded from the AnAge
database, build 17 [1]. This data set consisted of 825 genes of which 362 were related to chro-
nological ageing and 551 to replicative ageing. Some genes (88) were annotated to affect both
ageing types. Genes with contradictory life span annotations were excluded from the ana-
lysis.
For overlap examinations, the systematic open reading frame identifiers (ORF IDs) were
used. If required, identifier mappings were applied using the Bioconductor [207] package for
yeast annotations (org.Sc.sgd.db [208]). After partitioning into replicative and chronological
ageing subsets, enrichment of TLM genes was calculated individually in both. Statist-
ical significance of the intersections was calculated with the default two-sided Fisher’s
Exact test of R [206]. Venn diagrams were created using Inkscape (v0.48, inkscape.org).
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(a) cis regulation of telomere length.
(b) Different telomere length states within one nucleus.
Figure B.2.: Telomere length homoeostasis is achieved by a negative feedback loop involving Rap1, Rif1, and
Rif2. (a) Principles of the cis-acting telomere length regulation. Telomerase action increases the number of
bindings sites for Rap1 that is recruiting Rif1 and Rif2. The more Rap1-Rif1-Rif2 complexes are bound to the
telomere, the stronger telomerase is inhibited. Due to suppressed telomerase, telomeres shorten leading to the
loss of Rap1 binding sites and reactivation of telomerase. In this manner, telomeres are kept in a dynamic length
equilibrium. (b) Within one nucleus, telomeres of different lengths exist and not all telomeres are replicated in
the course of one cell cycle. Only short telomeres are elongated, as for them the suppressive capacity of the
Rap1-Rif1-Rif2 complexes has diminished. This model has been widened by Teixeira et al. by the knowledge how
telomerase is inhibited (fig. 1.14). The figure has been taken from Smogorzewska and de Lange [63].
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Figure B.4.: Image of the agarose gel quantified in fig. 3.2 for measuring telomere length for wild-type and
vps27 cells of six Y’ telomeres as well as of the 1L telomere. The gel was run for 30min at 100V. As the fourth
lane for the vps27 mutant and 1L telomere gave no clear band, it was not quantified.
102
(a) 6 Y’ telomeres.
(b) 1L telomere.
Figure B.5.: Image of the agarose gel quantified in fig. 3.3c for measuring the rate of telomere shortening during
senescence of est2 single and est2 vps27 double mutants. Telomere length was measured for samples 1–5 d of
the senescence curve in fig. 3.3a. The gels were run for 30min at 100V.
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Figure B.6.: Image of the membrane quantified in fig. 3.7 for quantifying the amount of 3’ ssDNA at the
telomeric ends in cdc13-1 single and cdc13-1 vps27 double mutants at permissive temperature and after heat
shock at 30 ◦C.
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(a) ESCRT complex 0.
(b) ESCRT complex I.
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(c) ESCRT complex II.
(d) ESCRT complex III.
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(c) ESCRT complex III associated.
(d) ESCRT system associated.
Figure B.7.: Temperature rescue spotting for all cdc13-1 escrt mutants. The indicated strains were spotted
10-fold serially diluted onto standard YPD plates and incubated at permissive (23 ◦C and 25 ◦C) as well as
non-permissive (27 ◦C and 28 ◦C) temperatures for three days. Each cdc13-1 escrt mutant and its respective
single mutants were spotted in biological duplicates.
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Figure B.9.: Image of the agarose gel quantified in fig. A.1 for measuring the length of six Y’ telomeres for
wild-type and vps27 cells containing either an EXO1 overexpression plasmid (OE) or the corresponding empty
vector control (EV). The gels were run for 2.5 h at 100V.
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B. Supplemental Figures
(a) (b)
(c) (d)
Figure B.10.: Ponceau stainings corresponding to the Western Blots in this work. (a), figs. 3.9a and 3.9b; (b),
figs. 3.9c and 3.9d; (c), figs. 3.10a and 3.10b; (d), figs. A.4a and A.4b. Please see the particular captions for
details on the individual experiments.
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Table C.1.: List of experiments conducted in the context of the present thesis.
Experiment ID Figure
DDR check spotting vps27 (HR/NHEJ proficient strains) A fig. 3.14
DNA damage spotting escrts B fig. 3.12
DNA damage spotting rad52 vps27 C fig. 3.13
DNA damage spotting vps27 with Exo1 OE D fig. 3.15
Dot blot (telomeric overhang) E figs. 3.7 and B.6
Exo1 resection assay (Longhese lab) F fig. 3.16
Imaging Exo1-GFP G
Rate of telomere shortening H figs. 3.3c and B.5
Senesencecurve I fig. 3.3a
Telomere length in vps27 J figs. 3.2 and B.4
Temperature rescue spotting atg5 cdc13-1 vps27 K fig. A.5b
Temperature rescue spotting cdc13-1 escrts L fig. B.7
Temperature rescue spotting cdc13-1 exo1 vps27 M fig. 3.17
Temperature rescue spotting cdc13-1 rad53-11 vps27 N fig. 3.20
Temperature rescue spotting cdc13-1 vps27 O fig. 3.5
Temperature rescue spotting cdc13-1 vps27 Exo1 OE P fig. 3.8
Temperature rescue spotting sae2 stn1-13 vps27 Q fig. A.2b
Temperature rescue spotting stn1-13 vps27 R fig. A.2a
Temperature rescue spotting vps27 addTSs S fig. A.3
UP-DOWN assay T fig. 3.18
Western blot Cdc13 levels in vps27 U figs. A.4 and B.10d
Western blot Exo1 degradation in cdc13-1 vps27 V figs. 3.10 and B.10c
Western blot Exo1 levels in cdc13-1 vps27 W figs. 3.9c and B.10b
Western blot Exo1/Sae2 levels in vps27 X figs. 3.9a and B.10a
Y’ telomere length with Exo1 OE in vps27 Y figs. A.1 and B.9
Table C.2.: Functional categories from MIPS [8,9] enriched with tlm mutants corresponding to non-essential
genes. Enrichment was calculated based on the default two-sided Fisher’s Exact test within R [206]. Multiple
testing correction was done with the FDR correction method.
tlm
Phenotype Functional Category P-Value
Corrected
P-Value
short
organization of chromosome structure 6.730e−12 1.346e−11
DNA damage response 5.872e−8 1.174e−7
vacuolar/lysosomal transport 1.821e−7 3.643e−7
DNA conformation modification (e.g. chromatin) 3.588e−7 7.177e−7
transcription elongation 5.137e−5 0.000 10
transcription repression 6.702e−5 0.000 13
DNA synthesis and replication 0.000 11 0.000 22
protein targeting, sorting and translocation 0.000 13 0.000 26
DNA repair 0.000 16 0.000 31
cell cycle checkpoints 0.000 18 0.000 37
general transcription activities 0.000 29 0.000 59
transcriptional control 0.000 46 0.000 92
vesicular transport (Golgi network, etc 0.001 98 0.003 95
RNA degradation 0.002 36 0.004 72
regulation of phosphate metabolism 0.003 12 0.006 25
G2/M transition of mitotic cell cycle 0.003 26 0.006 51
polynucleotide degradation 0.003 96 0.007 92
phosphate metabolism 0.004 26 0.008 52
chromosome condensation 0.004 46 0.008 93
modification by acetylation, deacetylation 0.006 55 0.013 10
meiotic recombination 0.010 63 0.021 26
modification by phosphorylation, dephosphorylation,
autophosphorylation 0.011 64 0.023 29
Continued on next page.
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Continued from previous page.
tlm
Phenotype Functional Category P-Value
Corrected
P-Value
short
posttranslational modification of amino acids (e.g.
hydroxylation, methylation) 0.012 20 0.024 41
actin cytoskeleton 0.012 24 0.024 47
regulation of C-compound and carbohydrate metabolism 0.012 95 0.025 89
meiosis I 0.013 50 0.026 99
regulation of DNA processing 0.014 78 0.029 56
intra Golgi transport 0.016 38 0.032 77
endocytosis 0.016 88 0.033 76
rRNA processing 0.033 84 0.033 84
translational control 0.038 65 0.038 65
proteasomal degradation (ubiquitin/proteasomal pathway) 0.019 72 0.039 44
lysosomal and vacuolar protein degradation 0.020 24 0.040 49
regulator of transcription factor 0.021 36 0.042 72
DNA recombination 0.043 83 0.043 83
vacuole or lysosome 0.022 86 0.045 73
vacuole or lysosome 0.022 86 0.045 73
long
ribosomal proteins 2.526e−9 5.052e−9
rRNA processing 0.000 99 0.001 98
DNA recombination 0.001 42 0.002 84
metabolism of secondary products derived from primary
amino acids 0.001 90 0.003 81
DNA damage response 0.003 95 0.003 95
mitotic cell cycle and cell cycle control 0.002 04 0.004 08
nuclear and chromosomal cycle 0.003 74 0.007 49
DNA repair 0.008 18 0.008 18
modification by acetylation, deacetylation 0.013 44 0.013 44
polyphosphoinositol mediated signal transduction 0.007 11 0.014 22
DNA synthesis and replication 0.017 74 0.017 74
organization of chromosome structure 0.017 74 0.017 74
RNA binding 0.009 64 0.019 28
general transcription activities 0.030 57 0.030 57
kinase activator 0.016 34 0.032 68
translational control 0.030 90 0.038 65
homeostasis of phosphate 0.020 66 0.041 33
Table C.3.: Overview of the original tlm phenotypes as defined in [183–185,195,197].
Original Category Abbreviation Length Difference New Category
Very short VS > 150 bp shorter
Short S 50–150 bp shorter
Slightly short SS < 50 bp shorter
Very long VL > 150 bp longer
Long L 50–150 bp longer
Slightly long SL < 50 bp longer
113
C. Supplemental Tables
Table C.4.: Proteins connecting ESCRT-0 and Cdc13 or Rad53 in the PPI-network presented in fig. 3.23.
Descriptions were derived from YeastMine [192].
Gene Symbol Description from YeastMine In-Between
AIM3 Protein that inhibits barbed-end actin filament
elongation
Hse1 and Rad53
LAS17 Actin assembly factor Hse1 and Rad53
SLA1 Cytoskeletal protein binding protein Hse1 and Rad53, Stp22 and Rad53
BCK1 MAPKKK acting in the protein kinase C signalling
pathway
Vps27 and Cdc13
DBF2 Serine/threonine kinase involved in transcription
and stress response
Vps27 and Cdc13
KSP1 Serine/threonine protein kinase Vps27 and Cdc13
PRK1 Protein serine/threonine kinase Vps27 and Cdc13, Hse1 and Cdc13
PRR2 Serine/threonine protein kinase Vps27 and Cdc13
YCK2 Palmitoylated plasma membrane-bound casein
kinase I (CK1) isoform
Vps27 and Cdc13
YPL150W Protein kinase of unknown cellular role Vps27 and Cdc13, Vps27 and Rad53
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